STUDYID|DOMAIN|USUBJID|TUSEQ|TULNKID|TUTESTCD|TUTEST|TUORRES|TUSTRESC|TULOC|TULAT|TUDIR|TUPORTOT|TUMETHOD|TULOBXFL|TUBLFL|TUEVAL|TUEVALID|TUACPTFL|VISITNUM|TAETORD|EPOCH|TUDTC|TUDY
e|TU|35f5401f-575a-44dc-9141-8084716a5b70|1|[?]|TUMERGE|Tumor Merged|[?]|LOCOREGIONAL|FOOT DIGIT 5|CONTRALATERAL|UPPER|HEMI|STRESS ECHOCARDIOGRAPHY|Y||INTERVIEWER|FORENSIC PATHOLOGIST|U|1|1|TREATMENT|2020-10-26|16
e|TU|8a863a88-67d8-4e50-bafa-c3146591f046|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|DISTANT|NASAL BONE|LEFT|PROXIMAL|PARTIAL|HPLC|||INTERVIEWER|PEDIATRIC NEUROLOGIST|N|1|1|SCREENING|2021-03-07|78
e|TU|f8e8acef-d26d-40c0-9bf0-fe7ac24c9fea|1|[?]|TUMERGE|Tumor Merged|[?]|NEW BONE LESION|MAIN BRONCHUS, LEFT|IPSILATERAL|SUPERIOR|MULTIPLE|PULSE OXIMETRY|||INVESTIGATOR|MICROSCOPIST 3|Y|1|7|WASHOUT|2020-10-28|96
e|TU|0558cb35-f542-4f9a-a7e7-18b1d71be69c|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|TARGET NODULE|CORPUS UTERI|CONTRALATERAL|INTERMEDIATE|ALL|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|||CLINICAL RESEARCH COORDINATOR|PATHOLOGIST 1|N|1|2|TREATMENT|2021-02-19|71
e|TU|a9cf4d21-c2a8-4f32-b932-f05d2d317400|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|NON-MEASURABLE|PROXIMAL INTERPHALANGEAL JOINT 4 OF THE HAND|CONTRALATERAL|ROSTRAL|ENTIRE|SPIROMETRY|||CLINICAL STUDY SPONSOR|MICROSCOPIST 3|U|1|1|TREATMENT|2020-07-08|15
e|TU|0389257f-50de-4a05-8f2a-69c068374337|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|TARGET NODULE|PELVIS|UNILATERAL|TEMPORAL|MULTIPLE|DIFFUSION TENSOR MRI|||SIGNIFICANT OTHER|FORENSIC PATHOLOGIST|Y|1|5|SCREENING|2020-11-25|58
e|TU|279ca0c7-7c4e-4cd7-a3b6-87bc5c037352|1|[?]|TUSPLIT|Tumor Split|[?]|TARGET NODULE|PULMONARY VALVE, RIGHT CUSP|RIGHT|PROXIMAL|ENTIRE|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|||SIBLING|RADIOLOGIST 2|Y|1|5|SCREENING|2021-01-16|42
e|TU|ca4e757f-268f-4f3f-b0d0-950bf9c26b08|1|[?]|TUSPLIT|Tumor Split|[?]|NON-TARGET ENHANCING|C1 VERTEBRA|UNILATERAL|OCCIPITAL|MULTIPLE|MALDI|||INVESTIGATOR|READER 3|N|1|4|TREATMENT|2020-12-29|17
e|TU|ad402b62-0625-431b-9bd7-ffd6124610f3|1|[?]|TUMIDENT|Tumor Identification|[?]|BONE LESION|INTERVENTRICULAR SEPTUM|LATERAL|LATERAL|SINGLE|LIQUID SCINTILLATION COUNTING|||CLINICAL RESEARCH ASSOCIATE|ADJUDICATOR 3|Y|1|1|TREATMENT|2020-12-15|91
e|TU|d76b0f55-541c-491d-9162-4c133c9509f1|1|[?]|LESIDENT|Lesion Identification|[?]|NON-TARGET EXTRA NODAL|RIGHT CORONARY ARTERY OSTIUM|CONTRALATERAL|MIDLINE|MULTIPLE|HPLC/IEX|Y||DOMESTIC PARTNER|NEUROLOGIST 1|Y|1|4|TREATMENT|2020-08-19|97
e|TU|146059d8-5652-41cd-b484-c6e5d8ea540f|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|LOCATION OF INTEREST|CRANIAL NERVE|CONTRALATERAL|CAUDAL|SEGMENT|MACRO BROTH DILUTION|Y||FRIEND|DEVELOPMENTAL PSYCHOLOGIST|N|1|4|TREATMENT|2020-10-09|54
e|TU|3d5f1964-b65c-4a0a-bb5b-1689308754d8|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|NEW TARGET|INTERNAL ILIAC LYMPH NODE|RIGHT|CENTRAL|ENTIRE|DIFFUSION WEIGHTED MRI|Y||CLINICAL RESEARCH COORDINATOR|RATER 1|U|1|7|WASHOUT|2021-01-18|85
e|TU|129dc836-068a-463e-b789-a0d05c60605d|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|LOCATION OF INTEREST|HAND DIGIT 2|RIGHT|PERIVENTRICULAR|ENTIRE|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|||FAMILY MEMBER|ONCOLOGIST|NA|1|7|SCREENING|2020-08-29|64
e|TU|9ef8a6d4-8326-4050-be85-e9f8983f55c1|1|[?]|LESIDENT|Lesion Identification|[?]|NOT MEASURED|FEMUR SHAFT|LEFT|INNER|MULTIPLE|TRANSESOPHAGEAL ECHOCARDIOGRAPHY||Y|INTERVIEWER|UROLOGIST|U|1|7|SCREENING|2020-12-14|47
e|TU|b91c4469-b3be-467f-8512-b73cf561e168|1|[?]|TUSPLIT|Tumor Split|[?]|BONE LESION|FINGER FLEXOR MUSCLES|LEFT|ROSTRAL|SEGMENT|IMPEDANCE CONDUCTIVITY|||ADJUDICATION COMMITTEE|MICROSCOPIST 1|N|1|5|WASHOUT|2020-08-12|96
e|TU|3637e1e0-8c0c-45cc-b139-e812a589f940|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|NON-TARGET NODAL|OLECRANON|CONTRALATERAL|DISTAL VOLAR|ENTIRE|JAEGER EYE CHART|||INDEPENDENT ASSESSOR|PATHOLOGIST 2|Y|1|1|SCREENING|2020-11-21|93
e|TU|23385974-5fcd-4c36-b9fa-2fbb3841f182|1|[?]|LESIDENT|Lesion Identification|[?]|NON-MEASURABLE|SMALL INTESTINE|IPSILATERAL|DEEP|MULTIPLE|AUTOREFRACTION||Y|NON-HEALTH CARE PROFESSIONAL|NEUROLOGIST|U|1|5|FOLLOW-UP|2020-12-02|15
e|TU|b76a836f-57ee-4e3d-89c4-31fdef04e5fe|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|TARGET NODULE|EPIGLOTTIS|LEFT|UPPER FLEXOR SURFACE|SEGMENT|IN VITRO GENE EXPRESSION ASSAY||Y|INVESTIGATOR|RADIOLOGIST 2|Y|1|1|FOLLOW-UP|2021-02-26|92
e|TU|f1327e16-08c6-4ef0-852e-13c095a94c00|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|LOCOREGIONAL|SKIN OF THE TRUNK|RIGHT|DISTAL|ALL|GRAM STAIN|Y||SIBLING|RADIOLOGIST 2|Y|1|7|TREATMENT|2020-06-03|18
e|TU|52de3d1f-e750-49f3-9cfa-09ac97a5dd4b|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|DISTANT|METATARSOPHALANGEAL JOINT|IPSILATERAL|HIND|ENTIRE|HIGH LEVEL AMINOGLYCOSIDE SCREEN|||SIBLING|PHYSIOTHERAPIST|Y|1|6|TREATMENT|2021-03-06|60
e|TU|e8065021-c163-41c8-8a76-5f0c1c3a06c4|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|NEW BONE LESION|RETROPHARYNGEAL LYMPH NODE|LEFT|SUPERIOR|ALL|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|||PROXY|DEVELOPMENTAL PSYCHOLOGIST|NA|1|3|TREATMENT|2020-12-17|19
e|TU|854a9218-995e-47f4-87ab-e58d20f56d19|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|NON-TARGET|COLON, SPLENIC FLEXURE|UNILATERAL|PERIVENTRICULAR|ALL|BIOIMPEDANCE SPECTROSCOPY|||ADJUDICATOR|MICROSCOPIST|Y|1|5|TREATMENT|2020-11-20|7
e|TU|7865f4e0-11d8-45f7-b0d1-0fd7bb4c1311|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|BONE LESION|AORTIC ARCH|IPSILATERAL|DISTAL|ALL|IN VITRO GENE EXPRESSION ASSAY|Y||DOMESTIC PARTNER|FORENSIC PATHOLOGIST|Y|1|6|FOLLOW-UP|2020-07-17|36
e|TU|08944dcd-a62d-4932-bb15-a8f15cc73229|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|TARGET NODULE|CAPITATE BONE|IPSILATERAL|INNER|PARTIAL|FUNCTIONAL MRI|||PROXY|UROLOGIST|NA|1|4|WASHOUT|2021-03-21|98
e|TU|1d7df560-695a-41fe-9226-4cc206b05f48|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|NEW TARGET|SHOULDER|CONTRALATERAL|UPPER|MULTIPLE|EPSILOMETER||Y|SIGNIFICANT OTHER|RATER 1|Y|1|1|TREATMENT|2020-12-01|2
e|TU|12c802a8-862c-45a4-b12c-a6f920772534|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|BENIGN|FIRST OBTUSE MARGINAL BRANCH ARTERY|RIGHT|OCCIPITAL|MULTIPLE|FLUORIMETRY|||SPOUSE|READER 2|N|1|1|TREATMENT|2020-07-02|25
e|TU|1ac2ce3b-f73f-4a46-a8fe-ea44dfc635a3|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|NEW BONE LESION|CEREBRUM|CONTRALATERAL|FRONTAL|HEMI|JAFFE REACTION|||SIGNIFICANT OTHER|FORENSIC PATHOLOGIST|NA|1|3|TREATMENT|2020-12-30|47
e|TU|6c1628af-ea1b-40ea-80fd-667bcfc29a4b|1|[?]|TUMERGE|Tumor Merged|[?]|BONE LESION|INFERIOR PUBIC RAMUS|RIGHT|POSTERIOR|ALL|WRIGHT STAIN|||ADJUDICATION COMMITTEE|PATHOLOGIST 1|NA|1|4|TREATMENT|2020-10-03|58
e|TU|96114171-59a0-4543-b3ec-c7796ae8ee92|1|[?]|LESIDENT|Lesion Identification|[?]|LOCOREGIONAL|T4 VERTEBRA|CONTRALATERAL|BASAL|ENTIRE|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|||GUARDIAN|UROLOGIST|N|1|6|TREATMENT|2021-01-10|57
e|TU|0070d42d-c864-4a83-a3c9-4c8ca7de51de|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|NEW NON-TARGET|CHOROID|LEFT|MIDLINE|ALL|PHASE-CONTRAST MRI|||CLINICAL RESEARCH COORDINATOR|ADJUDICATOR|U|1|4|WASHOUT|2020-09-09|35
e|TU|a2ec3389-6f5f-44a3-a6dd-f6177a805791|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|NON-TARGET|SARTORIUS MUSCLE|UNILATERAL|SUBCORTICAL|HEMI|MODIFIED ACID FAST STAIN||Y|ADJUDICATOR|ONCOLOGIST|U|1|2|TREATMENT|2020-12-27|81
e|TU|cc562042-9641-460d-862e-d6923dd4207d|1|[?]|NTIND|Non-Target Indicator|[?]|NEW TARGET|BRAIN STEM|CONTRALATERAL|ANTEROPOSTERIOR|HEMI|ANGIOGRAPHY|||VENDOR|READER|Y|1|3|FOLLOW-UP|2020-06-03|17
e|TU|d0a4f2af-eb3c-4f04-b16d-b3ef5a8d0646|1|[?]|TUSPLIT|Tumor Split|[?]|NOT MEASURED|BUTTOCK|CONTRALATERAL|OCCIPITAL|SINGLE|FLUORESCENT LIFETIME IMAGING MICROSCOPY|Y||PROXY|ADJUDICATOR 3|N|1|1|WASHOUT|2020-08-03|14
e|TU|d90f2824-692e-403f-b1ca-5b6462c93a75|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|REGIONAL|SKIN OF THE BUTTOCK|LEFT|INFERIOR|PARTIAL|LISSAMINE GREEN STAIN|||NON-HEALTH CARE PROFESSIONAL|RATER 2|Y|1|1|WASHOUT|2020-08-12|38
e|TU|ee0e55e1-6107-4a3c-85b4-cb48300153e8|1|[?]|NTIND|Non-Target Indicator|[?]|NEW|TIBIA SHAFT|LATERAL|ANTEROMEDIAL|ENTIRE|PULSE OXIMETRY||Y|SIGNIFICANT OTHER|MICROSCOPIST 2|Y|1|2|FOLLOW-UP|2020-06-18|34
e|TU|6aa37bb3-85aa-427f-9e56-a776257f1548|1|[?]|TUMIDENT|Tumor Identification|[?]|DISTANT|PERICARDIUM|RIGHT|PROXIMAL|MULTIPLE|MANUAL CLOT DETECTION||Y|GUARDIAN|ONCOLOGIST 2|N|1|1|FOLLOW-UP|2020-12-05|31
e|TU|592c5ea9-d4ca-4c3a-a836-6d88f2b93303|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|NEW NON-TARGET|EPIGASTRIC LYMPH NODE|IPSILATERAL|CRANIAL|ENTIRE|ANGIOGRAPHY|||PROXY|OPHTHALMOLOGIST|U|1|1|WASHOUT|2020-05-26|18
e|TU|940d4614-b41a-44d3-b878-6e19ee22f24b|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|TARGET|PERICARDIUM|UNILATERAL|CAUDAL|SINGLE|HEMATOXYLIN AND EOSIN STAIN|||CAREGIVER|READER 1|Y|1|4|TREATMENT|2020-08-09|44
e|TU|e2edd4f0-926b-4514-bf3f-7449f248343f|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|UNKNOWN|SHOULDER JOINT TENDONS|LATERAL|ANTEROPOSTERIOR|SEGMENT|ANTIMICROBIAL COMBINATION TESTING|||ADJUDICATOR|ONCOLOGIST 1|N|1|1|TREATMENT|2021-01-14|84
e|TU|215d711d-c98a-4f7b-ba41-d2c06ad70ddd|1|[?]|LESIDENT|Lesion Identification|[?]|TARGET NODULE|CUBOID BONE|RIGHT|TEMPORAL|ENTIRE|MICRODENSITOMETRY|||INDEPENDENT ASSESSOR|RATER 2|U|1|7|TREATMENT|2020-09-20|94
e|TU|493a53ef-01ab-470c-9bbe-7c2aa48b946b|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|NEW|SUPERFICIAL LYMPH NODE|IPSILATERAL|TIP|HEMI|REAL-TIME POLYMERASE CHAIN REACTION ASSAY|||HEALTH CARE PROFESSIONAL|READER 3|U|1|2|TREATMENT|2020-07-12|9
e|TU|ba33de14-b676-4389-a863-a7fa3edb8543|1|[?]|LESIDENT|Lesion Identification|[?]|NOT MEASURED|ENDOMETRIAL CAVITY|BILATERAL|HIND|PARTIAL|REAL-TIME POLYMERASE CHAIN REACTION ASSAY|Y||CLINICAL RESEARCH COORDINATOR|ADJUDICATOR 1|U|1|3|TREATMENT|2021-01-01|69
e|TU|24801f05-79be-433d-8124-85580bc14c4f|1|[?]|TUSPLIT|Tumor Split|[?]|NON-TARGET EXTRA NODAL|BRAIN VENTRICLE|LEFT|ANTERIOR|MULTIPLE|INTRAVASCULAR ULTRASOUND|Y||ADJUDICATION COMMITTEE|ONCOLOGIST 2|N|1|6|TREATMENT|2020-09-09|10
e|TU|02df80f9-2337-4abd-9452-41cd83dec8ba|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|DISEASE SITE|OCULOMOTOR NERVE|RIGHT|CAUDAL|ALL|ACRIDINE ORANGE STAIN|||VENDOR|RATER 1|U|1|5|FOLLOW-UP|2020-08-02|8
e|TU|d9eea93b-f9f9-466c-aa8a-a250baff18ef|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|NEW BONE LESION|ADDUCTOR HALLUCIS MUSCLE, TRANSVERSE HEAD|BILATERAL|LOWER|PARTIAL|HANSEL STAIN|Y||NON-HEALTH CARE PROFESSIONAL|READER 3|Y|1|1|TREATMENT|2020-08-23|30
e|TU|35a59f6a-2712-4d1b-a954-f1418d4b9168|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|NEW NON-TARGET|FAT PAD|LEFT|FACIAL|HEMI|U-HPLC/MS/MS|Y||CHILD|RATER 2|N|1|4|FOLLOW-UP|2020-10-29|3
e|TU|ecfa7c81-fd68-4b8c-8305-65e1ecbff67f|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|LOCAL|NUCLEUS OF DIAGONAL BAND|RIGHT|PARIETO-OCCIPITAL|SEGMENT|ENDPOINT DILUTION ASSAY|||VENDOR|NEUROLOGIST|U|1|5|WASHOUT|2021-01-06|67
e|TU|7fa3d0ff-fd49-4114-bebe-1c27765f01b8|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|TARGET|OCULOMOTOR NERVE|BILATERAL|ROSTRAL|PARTIAL|IMMUNODIFFUSION|Y||ADJUDICATION COMMITTEE|OPHTHALMOLOGIST|Y|1|5|TREATMENT|2020-06-03|31
e|TU|d041952e-4aa6-4b37-9cec-127adce2eabb|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|DISTANT|FLEXOR HALLUCIS LONGUS MUSCLE|CONTRALATERAL|CENTRAL|SINGLE|ECHOCARDIOGRAPHY|Y|Y|HEALTH CARE PROFESSIONAL|OPTOMETRIST|U|1|4|TREATMENT|2020-12-14|76
e|TU|7f0ceec0-eda9-40ea-b2e8-90ba6bf3d115|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|NON-TARGET ENHANCING|C7 VERTEBRA|LATERAL|DEEP|ALL|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|||CLINICAL RESEARCH COORDINATOR|RATER|Y|1|1|TREATMENT|2020-07-23|54
e|TU|9fc393da-4665-4be5-a869-856c45ddcf13|1|[?]|NTIND|Non-Target Indicator|[?]|NEW BONE LESION|ANTERIOR HORN OF THE LATERAL VENTRICLE|LATERAL|HIND|ALL|HEMAGGLUTINATION INHIBITION ASSAY||Y|ADJUDICATOR|NEUROLOGIST|U|1|1|WASHOUT|2020-07-12|34
e|TU|cddc1541-4de9-45e7-bb61-15a2d5baca6f|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|NON-TARGET ENHANCING|HYPOGLOSSAL NERVE|LEFT|ANTERIOR|PARTIAL|KINETIC MICROPARTICLE IMMUNOASSAY|Y||CHILD|MICROSCOPIST|U|1|1|WASHOUT|2021-03-31|81
e|TU|303c6dbe-59f9-4016-baa1-8506c0c1ee09|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|NON-TARGET ENHANCING|CALF|IPSILATERAL|MEDIAL|HEMI|SPIRAL CT|||ADJUDICATION COMMITTEE|OTOLARYNGOLOGIST|N|1|2|TREATMENT|2021-03-21|95
e|TU|fee3c810-3d76-4db4-9272-6b4e8fd14088|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|NOT MEASURED|JOINT|CONTRALATERAL|ANTEROMEDIAL|MULTIPLE|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE||Y|ADJUDICATION COMMITTEE|ONCOLOGIST|NA|1|7|TREATMENT|2021-02-26|83
e|TU|d5125e6c-2ab6-4286-8ce0-0011f1e08fbb|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|NEW|SKIN OF THE BUTTOCK|BILATERAL|OCCIPITAL|HEMI|OLIGO ACGH|||INDEPENDENT ASSESSOR|MICROSCOPIST 1|NA|1|4|TREATMENT|2020-08-12|45
e|TU|2e6e4c1d-4976-4f32-bd2e-8db09440f7b3|1|[?]|LESIDENT|Lesion Identification|[?]|UNKNOWN|PERIFACIAL LYMPH NODE|LATERAL|LOWER FLEXOR SURFACE|SEGMENT|LISSAMINE GREEN STAIN|Y||INDEPENDENT ASSESSOR|RADIOLOGIST|Y|1|1|WASHOUT|2020-08-17|26
e|TU|47fad45a-9a4c-47ee-a863-089d979523b5|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|NEW NON-TARGET|LUNG, RIGHT, INFERIOR LOBE, ANTERIOR BASAL SEGMENT|LEFT|APICAL|ALL|ELECTROPHORESIS||Y|NON-HEALTH CARE PROFESSIONAL|ENDOCRINOLOGIST|NA|1|3|WASHOUT|2020-12-02|66
e|TU|317b8b6d-9638-44a3-816f-7f3fca1e01a3|1|[?]|TUSPLIT|Tumor Split|[?]|BONE LESION|SYNOVIAL FLUID|RIGHT|ROSTRAL|PARTIAL|BALLPOINT PEN TECHNIQUE||Y|CLINICAL RESEARCH ASSOCIATE|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|N|1|5|TREATMENT|2020-06-06|24
e|TU|3bad8e12-9a92-4227-a3f6-b3eac8fa57ec|1|[?]|TUMIDENT|Tumor Identification|[?]|DISEASE SITE|COCCYGEAL VERTEBRA|LEFT|INFERIOR|HEMI|MRI WITHOUT CONTRAST|||NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST 1|NA|1|5|TREATMENT|2020-09-26|88
e|TU|e7cee930-54f6-482e-b782-01aed0f0db06|1|[?]|TUMIDENT|Tumor Identification|[?]|NON-MEASURABLE|CAROTID ARTERY|BILATERAL|CAUDAL|HEMI|MECHANICAL CLOT DETECTION||Y|SPOUSE|RADIOLOGIST 1|N|1|7|TREATMENT|2021-02-05|39
e|TU|4f0e0353-bd4b-45ee-9e21-40489b5f8d2f|1|[?]|TUMIDENT|Tumor Identification|[?]|DISEASE SITE|SKIN OF THE CHEST|UNILATERAL|DISTAL|SINGLE|DC SHEATH FLOW||Y|FAMILY MEMBER|DERMATOLOGIST|Y|1|3|TREATMENT|2021-03-20|68
e|TU|f754ae7d-0776-41c0-988c-8cf2879d85da|1|[?]|TUMERGE|Tumor Merged|[?]|NON-TARGET|RENAL FOSSA|CONTRALATERAL|PROXIMAL VOLAR|SINGLE|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|||CAREGIVER|RADIOLOGIST 1|N|1|2|FOLLOW-UP|2020-11-14|68
e|TU|8a8d8c31-ae36-4a64-90da-ba5eb473e420|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|NON-TARGET|TONGUE|BILATERAL|UPPER EXTENSOR SURFACE|HEMI|BRDU CELLULAR PROLIFERATION ASSAY|||GUARDIAN|OPTOMETRIST|N|1|4|TREATMENT|2020-06-29|14
e|TU|482e40c9-2908-4269-b93c-61c311e9fde3|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|TARGET NODAL|LUNG, LEFT, SUPERIOR LOBE, ANTERIOR SEGMENT|LATERAL|PROXIMAL|SINGLE|FLUORIMETRY|Y||CAREGIVER|UROLOGIST|NA|1|4|TREATMENT|2020-08-22|47
e|TU|f7cfb281-0556-4316-9373-65edf63c4b23|1|[?]|LESIDENT|Lesion Identification|[?]|MEASURED|PITUITARY GLAND|LEFT|PROXIMAL VOLAR|SINGLE|NEXT GENERATION SEQUENCING|||CLINICAL STUDY SPONSOR|READER 3|Y|1|4|TREATMENT|2020-07-12|23
e|TU|e0b03cb9-aa73-48c8-b05b-4a506ecf077b|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|DISEASE SITE|INTERNAL MAMMARY LYMPH NODE|CONTRALATERAL|ANTERIOR|SEGMENT|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|Y||CLINICAL RESEARCH ASSOCIATE|RATER|N|1|4|TREATMENT|2021-03-31|90
e|TU|9ed8a578-a82a-423a-81ca-ee87f98d62f7|1|[?]|NTIND|Non-Target Indicator|[?]|NOT MEASURED|PULMONARY ARTERY BRANCH|LEFT|ANTEROTEMPORAL|ENTIRE|QUANTITATIVE CORONARY ANGIOGRAPHY|||CLINICAL RESEARCH ASSOCIATE|PATHOLOGIST 2|NA|1|3|TREATMENT|2020-09-03|11
e|TU|2214af46-1072-4328-bf3d-f4fe9cd97d9b|1|[?]|LESIDENT|Lesion Identification|[?]|BONE LESION|PARATRACHEAL LYMPH NODE|LEFT|ANTEROMEDIAL|PARTIAL|LC/MS/MS|||HEALTH CARE PROFESSIONAL|MICROSCOPIST 2|U|1|6|TREATMENT|2020-11-12|35
e|TU|7e56eb43-62a6-45ac-9476-1d0655595a04|1|[?]|TUSPLIT|Tumor Split|[?]|NEW NON-TARGET|CHEST WALL|RIGHT|ANTEROMEDIAL|PARTIAL|REVERSE TRANSCRIPTASE PCR|||CLINICAL STUDY SPONSOR|RATER 2|U|1|3|WASHOUT|2021-03-01|46
e|TU|73a8e85a-0b5f-496b-b164-afc4d1f02de2|1|[?]|TUMERGE|Tumor Merged|[?]|NEW TARGET|TIBIA|LEFT|TIP|SEGMENT|SLIT LAMP|||CLINICAL RESEARCH ASSOCIATE|READER 1|NA|1|4|TREATMENT|2020-07-03|14
e|TU|84f74359-c79b-4f1c-8119-a4993b071973|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|BONE LESION|SKIN OF THE LOWER LIMB|LEFT|CENTRAL|HEMI|ERGOSPIROMETRY||Y|FAMILY MEMBER|ADJUDICATOR 2|N|1|1|TREATMENT|2020-07-17|76
e|TU|d6ff71b7-6a5f-415f-8267-15c9c1f5585c|1|[?]|LESIDENT|Lesion Identification|[?]|NON-TARGET ENHANCING|GENITALIA|RIGHT|OUTER|SINGLE|GRAM STAIN|||CAREGIVER|ONCOLOGIST|NA|1|2|SCREENING|2020-11-30|34
e|TU|cd0c969e-61c6-4c65-ac19-4ee247f5009a|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|TARGET NODAL|INTERPHALANGEAL JOINT 2|CONTRALATERAL|ANTERIOR|SINGLE|IVY INCISION METHOD|Y|Y|INTERVIEWER|OTOLARYNGOLOGIST|U|1|4|SCREENING|2020-11-09|71
e|TU|1fff484d-0a68-42cd-8eff-bc4fe4da945c|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|NEW BONE LESION|URINARY SYSTEM|RIGHT|PROXIMAL VOLAR|HEMI|SCINTIGRAPHY|Y||CHILD|ADJUDICATOR 3|Y|1|5|FOLLOW-UP|2021-03-16|57
e|TU|e2c20e9a-0ac5-4907-96de-472bee70bd79|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|DISTANT|CEREBRAL SUBCORTEX|UNILATERAL|CENTRAL|HEMI|QUANTITATIVE CORONARY ANGIOGRAPHY|Y||FRIEND|PATHOLOGIST 1|U|1|2|SCREENING|2021-01-17|54
e|TU|6064ca8c-b723-4d05-914a-bb547d86fcc5|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|NEW BONE LESION|LEFT VENTRICULAR EPICARDIUM|LATERAL|FACIAL|ALL|PHOTOMETRIC CLOT DETECTION|||GUARDIAN|MICROSCOPIST 1|U|1|1|WASHOUT|2020-05-31|8
e|TU|8effbbff-acda-4718-89f1-e30a418f6bae|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|NEW TARGET|TIBIO-PERONEAL TRUNK|LATERAL|HIND|HEMI|ELECTROGASTROGRAPHY|Y||NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST 3|U|1|4|TREATMENT|2020-11-20|24
e|TU|859b16a5-f6a2-40cc-8e01-18c112b1969e|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|LOCATION OF INTEREST|ABDOMINAL REGION|BILATERAL|LOWER MEDIAL|PARTIAL|COMPLEMENT FIXATION|||GUARDIAN|PATHOLOGIST 1|N|1|7|WASHOUT|2020-08-30|22
e|TU|36b457ef-4cf6-4043-a836-49368ebf3f1c|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|NEW BONE LESION|KNEE JOINT TENDONS|UNILATERAL|FRONTAL|ENTIRE|HEMAGGLUTINATION ASSAY|||SPOUSE|ENDOCRINOLOGIST|U|1|2|TREATMENT|2020-09-02|27
e|TU|31f33e38-bba6-4c8a-b563-14afaabae5d7|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|LOCAL|SHOULDER JOINT TENDONS|RIGHT|ANTEROLATERAL|ENTIRE|LC-FL|||ADJUDICATOR|ADJUDICATOR|Y|1|5|TREATMENT|2020-06-23|2
e|TU|6794dffe-333b-425b-8883-26f6e5ba0797|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|NEW TARGET|MAXILLA|CONTRALATERAL|FORE|ENTIRE|PERIODIC ACID SCHIFF STAIN|Y||CLINICAL RESEARCH ASSOCIATE|PATHOLOGIST|NA|1|6|TREATMENT|2020-07-09|10
e|TU|d7d9a12d-6bb1-44a2-a008-6a5bae013d40|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|BENIGN|CHOROID|RIGHT|PROXIMAL VOLAR|MULTIPLE|PAP STAIN|||INDEPENDENT ASSESSOR|READER 2|NA|1|2|TREATMENT|2020-07-07|40
e|TU|45897452-8f5a-458d-9a43-13237460ba48|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|NON-TARGET|WRIST JOINT FLEXOR MUSCLES|RIGHT|DEEP|HEMI|SPIRAL CT|||CAREGIVER|RATER 1|N|1|1|TREATMENT|2020-11-12|11
e|TU|16eb981f-2118-4658-a83f-93d925c410c9|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|DISEASE SITE|BUTTOCK|BILATERAL|CRANIAL|HEMI|ENDPOINT DILUTION ASSAY||Y|HEALTH CARE PROFESSIONAL|NEUROLOGIST|U|1|4|TREATMENT|2020-12-18|12
e|TU|3f3ade8a-e27b-4f20-8b4d-69c7bae520c1|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|LOCAL|RETROCRURAL LYMPH NODE|RIGHT|PROXIMAL|PARTIAL|WHOLE EXOME SEQUENCING|Y||SPOUSE|RATER|N|1|5|WASHOUT|2021-03-08|66
e|TU|d99a6a66-accf-4a8e-b696-b6d5b4ce249c|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|TARGET|PORTAL LYMPH NODE|RIGHT|MIDLINE|PARTIAL|DIFFUSION WEIGHTED MRI|Y|Y|CLINICAL RESEARCH COORDINATOR|RADIOLOGIST 2|Y|1|6|TREATMENT|2021-04-26|97
e|TU|874f491c-5d55-4738-86b7-b1200b16d106|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|BENIGN|RIGHT POSTERIOR ATRIOVENTRICULAR ARTERY|RIGHT|INNER|SINGLE|MUGA|||STUDY SUBJECT|FORENSIC PATHOLOGIST|U|1|6|TREATMENT|2021-04-06|98
e|TU|281ccdef-794c-49ad-9616-6f6f68dd4543|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|TARGET|DISTAL RIGHT CORONARY ARTERY CONDUIT|CONTRALATERAL|LOWER MEDIAL|HEMI|IMPEDANCE CONDUCTIVITY||Y|INTERVIEWER|NEUROLOGIST|N|1|1|TREATMENT|2020-07-08|44
e|TU|b1179e10-e8fe-472c-a511-d6d460571857|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|MEASURED|NAIL|IPSILATERAL|SUBCORTICAL|MULTIPLE|CARDIAC THERMODILUTION|||HEALTH CARE PROFESSIONAL|ENDOCRINOLOGIST|NA|1|2|SCREENING|2020-10-15|84
e|TU|6362cf42-f286-4151-bdf7-38fcc5639eed|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|DISTANT|INTERPHALANGEAL JOINT 5|CONTRALATERAL|PERIPHERAL|ENTIRE|HPLC|||INVESTIGATOR|OTOLARYNGOLOGIST|Y|1|5|WASHOUT|2020-10-19|52
e|TU|8e28e3ab-0060-43f7-b033-c16bd77c0e29|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|MEASURED|CHOROID|LATERAL|FRONTAL|HEMI|WRIGHT-GIEMSA STAIN|||CLINICAL STUDY SPONSOR|OPHTHALMOLOGIST|Y|1|1|SCREENING|2021-02-14|86
e|TU|d0f0a002-b5cd-468a-98ff-e0eeaa5969e7|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|TARGET EXTRA NODAL|PERIRECTAL LYMPH NODE|RIGHT|MEDIAL|SINGLE|CONGO RED STAIN|||PARENT|FORENSIC PATHOLOGIST|NA|1|2|TREATMENT|2020-07-25|38
e|TU|0c1fcd0e-847b-4bf1-82c1-5d749742cc5b|1|[?]|TUMIDENT|Tumor Identification|[?]|LOCATION OF INTEREST|EXTRAHEPATIC PERIHILAR BILE DUCT REGION|RIGHT|LOWER FLEXOR SURFACE|ENTIRE|IMPEDANCE CONDUCTIVITY||Y|ADJUDICATOR|RATER|N|1|5|FOLLOW-UP|2020-07-04|22
e|TU|43880587-c397-402d-886b-9b666e3fe455|1|[?]|LESIDENT|Lesion Identification|[?]|NEW NON-TARGET|POSTEROLATERAL SEGMENTAL ARTERY|RIGHT|CRANIAL|SEGMENT|IRON HEMATOXYLIN STAIN||Y|PARENT|DERMATOLOGIST|Y|1|2|FOLLOW-UP|2020-10-08|89
e|TU|807f83d2-9364-4ee4-855d-304f3e252555|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|REGIONAL|SOLE|LATERAL|INTERMEDIATE|SEGMENT|IODINE STAIN|Y|Y|PROXY|RADIOLOGIST 1|U|1|3|TREATMENT|2020-05-19|15
e|TU|45dd95cd-857f-4cbd-89d7-640a8ed74fd8|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|NON-MEASURABLE|MUSCULOSKELETAL SYSTEM|BILATERAL|CENTRAL|SEGMENT|MALDI|||SPOUSE|READER 2|NA|1|7|TREATMENT|2021-01-21|53
e|TU|81c33633-6ade-45fe-a78e-0e853d8aa9c2|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|BONE LESION|PRONATOR QUADRATUS MUSCLE|LEFT|NASAL|MULTIPLE|PUPILLOMETRY|Y||VENDOR|READER 3|NA|1|2|TREATMENT|2020-09-29|55
e|TU|62f3a2a8-f181-4d95-a9b3-a94cd71594a3|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|REGIONAL|BUTTOCK|CONTRALATERAL|ANTEROTEMPORAL|ENTIRE|THERMAL IONIZATION MASS SPECTROMETRY|Y||PROXY|READER 3|NA|1|2|WASHOUT|2020-08-13|22
e|TU|7d6e9afe-919e-481a-87d5-bbaf7ca2ec6c|1|[?]|NTIND|Non-Target Indicator|[?]|NON-TARGET EXTRA NODAL|GLOSSOPHARYNGEAL NERVE|UNILATERAL|DEEP|SINGLE|MAPH||Y|CHILD|RADIOLOGIST 1|NA|1|2|SCREENING|2020-11-02|72
e|TU|84ccf2f8-8b9d-486c-8aad-a11bc45ed4f5|1|[?]|TUMIDENT|Tumor Identification|[?]|LOCOREGIONAL|KIDNEY, LOWER LOBE|CONTRALATERAL|ANTEROPOSTERIOR|SINGLE|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|||PARENT|ADJUDICATOR 3|NA|1|7|FOLLOW-UP|2021-01-21|4
e|TU|21740641-69bb-49a9-a86d-2444914f6d12|1|[?]|LESIDENT|Lesion Identification|[?]|LOCAL|PARAPHARYNGEAL LYMPH NODE|UNILATERAL|ROSTRAL|HEMI|PEAK FLOWMETRY|Y||GUARDIAN|MICROSCOPIST|NA|1|6|TREATMENT|2020-07-01|55
e|TU|c3984f41-30a0-49a4-a8bd-f36fad4621a8|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|NEW|BRAIN STEM|IPSILATERAL|OUTER|PARTIAL|ACID FAST STAIN|Y||STUDY SUBJECT|MICROSCOPIST 2|Y|1|7|TREATMENT|2020-09-08|92
e|TU|1ae9a175-fd7a-4215-adc4-ce6bd220f94d|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|LOCATION OF INTEREST|SHOULDER|BILATERAL|UPPER|ALL|APPLANATION TONOMETRY|||SPOUSE|PATHOLOGIST 2|Y|1|5|TREATMENT|2021-01-17|6
e|TU|0f85b859-187d-4c6b-8873-33c0f18d3e3c|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|NOT MEASURED|TRAPEZOID BONE|IPSILATERAL|MIDLINE|ENTIRE|LIGHT MICROSCOPY|Y||INDEPENDENT ASSESSOR|DEVELOPMENTAL PSYCHOLOGIST|U|1|7|TREATMENT|2020-09-17|65
e|TU|5e383a9d-dc97-4352-8add-d55a1a566b9f|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|NON-TARGET ENHANCING|VASTUS INTERMEDIUS MUSCLE|CONTRALATERAL|MIDLINE|SINGLE|THICK SMEAR|||INTERVIEWER|ONCOLOGIST 2|Y|1|4|WASHOUT|2020-09-22|5
e|TU|3eda746b-fb97-4950-a528-1d4ae5d3653a|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|NON-TARGET EXTRA NODAL|L6 VERTEBRA|IPSILATERAL|ROSTRAL|HEMI|IN VITRO GENE EXPRESSION ASSAY|Y||ADJUDICATOR|NEUROLOGIST 2|N|1|3|FOLLOW-UP|2020-08-15|73
e|TU|a3b72841-3401-4dcc-9d06-75438b408d0b|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|NON-TARGET|CORONARY ARTERY, LEFT|IPSILATERAL|LOWER|SINGLE|ELECTROMYOGRAPHY|||ADJUDICATOR|PATHOLOGIST 1|Y|1|2|TREATMENT|2020-11-12|17
e|TU|4393406e-bda5-42e4-a752-a8121004b7ef|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|TARGET NODULE|RIB 1|UNILATERAL|SUPERFICIAL|SINGLE|PET/CT SCAN WITHOUT CONTRAST||Y|CLINICAL STUDY SPONSOR|MICROSCOPIST|U|1|1|FOLLOW-UP|2021-01-13|87
e|TU|d70f5903-3d94-422b-8f69-212f015b54c9|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|TARGET EXTRA NODAL|NUCLEUS ACCUMBENS|CONTRALATERAL|PROXIMAL|SEGMENT|COMPLEMENT FIXATION|||CLINICAL RESEARCH ASSOCIATE|DEVELOPMENTAL PSYCHOLOGIST|NA|1|7|FOLLOW-UP|2020-07-15|67
e|TU|ef772266-faf1-4904-8ac3-19cbc3ea7d36|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|MEASURED|PERIHILAR LYMPH NODE|IPSILATERAL|LOWER|MULTIPLE|IN SITU HYBRIDIZATION|||HEALTH CARE PROFESSIONAL|READER 2|Y|1|6|WASHOUT|2021-01-01|5
e|TU|c0f9c36c-1ae5-4f80-b936-0afe3f661746|1|[?]|TUSPLIT|Tumor Split|[?]|NEW NON-TARGET|SKIN OF THE INFRASCAPULAR REGION|LATERAL|VOLAR|PARTIAL|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|Y||CHILD|NEUROLOGIST 2|U|1|6|TREATMENT|2020-08-01|28
e|TU|f17b5630-e782-4135-8a50-4a9bb2fe63b1|1|[?]|TUSPLIT|Tumor Split|[?]|NEW TARGET|SAPHENOUS VEIN|LATERAL|FORE|ALL|ENZYMATIC COLORIMETRY|||PARENT|ONCOLOGIST 1|NA|1|5|FOLLOW-UP|2021-01-04|46
e|TU|8bdb40c9-1e44-45ae-bf08-81ea635fd762|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|NON-TARGET EXTRA NODAL|RIGHT POSTERIOR DESCENDING ARTERY|LATERAL|LOWER MEDIAL|SINGLE|PHASE-CONTRAST MRI|||INVESTIGATOR|NEUROLOGIST 1|U|1|2|TREATMENT|2021-03-05|72
e|TU|c010dfcb-c1bb-4b4f-b58c-f4986ee86384|1|[?]|TUMERGE|Tumor Merged|[?]|DISEASE SITE|BLADDER, FUNDUS|UNILATERAL|PERIPHERAL|SINGLE|INDIA INK STAIN|||CLINICAL RESEARCH COORDINATOR|ADJUDICATOR 2|U|1|6|TREATMENT|2021-02-08|33
e|TU|296f8314-5a07-47b5-8796-31afe709b379|1|[?]|NTIND|Non-Target Indicator|[?]|NON-TARGET ENHANCING|LOWER GASTROINTESTINAL TRACT LYMPH NODE|UNILATERAL|PERIPHERAL|HEMI|HIGH RESOLUTION CT||Y|INVESTIGATOR|ENDOCRINOLOGIST|NA|1|6|TREATMENT|2020-07-20|22
e|TU|ae1e4047-f4d7-47fa-a5f6-974f9a9c2a48|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|MEASURED|CARDIAC WALL|CONTRALATERAL|SUPERIOR|HEMI|ELECTRICAL IMPEDANCE MYOGRAPHY|||CAREGIVER|DEVELOPMENTAL PSYCHOLOGIST|Y|1|4|SCREENING|2021-01-19|47
e|TU|b06043ae-8251-4df8-ab6d-0ceb269c1a42|1|[?]|TUSPLIT|Tumor Split|[?]|NEW NON-TARGET|THYROID GLAND, RIGHT LOBE|LATERAL|HIND|PARTIAL|FLUORESCENT LIFETIME IMAGING MICROSCOPY||Y|INVESTIGATOR|ADJUDICATOR 2|NA|1|2|WASHOUT|2021-02-26|42
e|TU|d4fb5b9e-e244-4818-be3d-dbb57faacd43|1|[?]|TUSPLIT|Tumor Split|[?]|NON-TARGET|MEDULLA OBLONGATA|IPSILATERAL|UPPER|ENTIRE|IMMUNOPRECIPITATION|Y||NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST|U|1|1|WASHOUT|2021-02-01|96
e|TU|7e6cbcf1-7175-4b46-b82f-32189cfcf6bb|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|LOCAL|LACRIMAL GLAND|IPSILATERAL|DORSAL|ENTIRE|KARYOTYPING|Y||FRIEND|CLINICAL PATHOLOGIST|N|1|4|SCREENING|2020-08-01|29
e|TU|26e6a3e9-7e84-4c99-b1b9-0608b6d73512|1|[?]|TUSPLIT|Tumor Split|[?]|TARGET|DORSALIS PEDIS ARTERY|LATERAL|LOWER|ALL|FREEZING POINT DEPRESSION|||PARENT|OPHTHALMOLOGIST|Y|1|1|WASHOUT|2021-02-23|50
e|TU|b1215705-4c22-43bd-aa65-58bd8745f081|1|[?]|TUMIDENT|Tumor Identification|[?]|TARGET EXTRA NODAL|METACARPAL BONE 4|IPSILATERAL|OCCIPITAL|PARTIAL|IHC|||CAREGIVER|RADIOLOGIST 1|N|1|5|TREATMENT|2020-09-02|59
e|TU|b99c6528-af4e-42f5-8d2d-18943b57d55a|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|NEW NON-TARGET|TRAPEZOID BONE|IPSILATERAL|OUTER|ALL|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|||ADJUDICATOR|OPTOMETRIST|Y|1|7|SCREENING|2021-01-02|79
e|TU|6848e438-51ca-4a7d-8f81-26c375969a64|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|LOCAL|RETROAURICULAR LYMPH NODE|CONTRALATERAL|LOWER EXTENSOR SURFACE|SINGLE|QUANTITATIVE CORONARY ANGIOGRAPHY|Y|Y|CLINICAL RESEARCH COORDINATOR|NEUROLOGIST|N|1|3|WASHOUT|2020-12-01|29
e|TU|a6e11c33-7905-42d2-bda9-671d756d4c51|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|DISTANT|T1 VERTEBRA|CONTRALATERAL|ANTEROPOSTERIOR|PARTIAL|MUGA|||CLINICAL RESEARCH ASSOCIATE|PATHOLOGIST|N|1|4|TREATMENT|2020-11-03|99
e|TU|441d3bc1-c95e-4e52-bd1b-7713f3a2cd8c|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|TARGET NODAL|PROXIMAL INTERPHALANGEAL JOINT 5|RIGHT|PERIVENTRICULAR|SINGLE|REFLECTANCE SPECTROSCOPY|Y|Y|INDEPENDENT ASSESSOR|PEDIATRIC NEUROLOGIST|U|1|1|FOLLOW-UP|2021-01-31|90
e|TU|8ef37b54-b463-43a4-879f-3ad653c4fef4|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|NON-TARGET NODAL|NASOPHARYNX|CONTRALATERAL|PARIETO-OCCIPITAL|HEMI|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|||INTERVIEWER|HEMATOLOGIST|Y|1|6|TREATMENT|2020-10-16|45
e|TU|cf10035c-4d44-4512-810b-c267d1c8821b|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|BONE LESION|OBTURATOR EXTERNUS MUSCLE|LATERAL|VOLAR|ALL|SPIRAL CT|Y||PROXY|NEUROLOGIST|Y|1|1|TREATMENT|2020-07-26|70
e|TU|f24e5ff9-ebe2-4dfe-88ed-1705eb410c9b|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|NEW TARGET|AXILLA|BILATERAL|SUBCORTICAL|ALL|DIFFUSION TENSOR MRI|Y||SIGNIFICANT OTHER|OTOLARYNGOLOGIST|U|1|1|TREATMENT|2020-10-12|82
e|TU|a1e0035a-3328-4966-8664-82e53a44eb59|1|[?]|TUMIDENT|Tumor Identification|[?]|NEW TARGET|DISTAL FEMUR R1|RIGHT|DISTAL VOLAR|MULTIPLE|FLUORIMETRY|||SIGNIFICANT OTHER|ENDOCRINOLOGIST|U|1|5|TREATMENT|2020-10-29|90
e|TU|771377fd-724f-4056-b2ea-84e1adab1f47|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|BENIGN|ACROMION|UNILATERAL|OUTER|ALL|FREEZING POINT DEPRESSION|||FRIEND|RATER 2|U|1|5|WASHOUT|2020-12-23|55
e|TU|8e3ae12f-e4d8-4bcd-b444-979496e0cfe1|1|[?]|NTIND|Non-Target Indicator|[?]|UNKNOWN|TRAPEZOID-CAPITATE JOINT|CONTRALATERAL|MIDLINE|SEGMENT|ARTERIAL SPIN LABELING FUNCTIONAL MRI|Y|Y|INDEPENDENT ASSESSOR|ONCOLOGIST|NA|1|2|WASHOUT|2020-09-26|44
e|TU|3aea0861-8f67-4717-93ce-c1e322f151d9|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|NEW BONE LESION|HEEL OF THE HAND|RIGHT|OCCIPITAL|SINGLE|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION||Y|SPOUSE|NEUROLOGIST 2|U|1|4|SCREENING|2020-10-02|59
e|TU|4fbe2ae7-4b86-4706-845c-d1f22f1a822f|1|[?]|TUMERGE|Tumor Merged|[?]|DISTANT|HEEL OF THE HAND|LATERAL|INTERMEDIATE|HEMI|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|||SPOUSE|READER|N|1|3|TREATMENT|2020-12-08|74
e|TU|ec63ad33-0411-4d12-af68-e2cda3a3f1ac|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|NON-TARGET NON-ENHANCING|UTERUS|LATERAL|LOWER MEDIAL|ENTIRE|PALM METHOD|||PARENT|RADIOLOGIST 2|Y|1|1|TREATMENT|2021-01-09|20
e|TU|39f51bd8-5edc-4434-92d4-7d8b683a6c32|1|[?]|NTIND|Non-Target Indicator|[?]|NEW NON-TARGET|SKIN OF THE BACK|BILATERAL|ANTEROTEMPORAL|ENTIRE|EEG|||GUARDIAN|RATER|Y|1|5|TREATMENT|2020-10-12|33
e|TU|80565a22-8cec-46a2-abd7-91daf0767035|1|[?]|TUSPLIT|Tumor Split|[?]|LOCATION OF INTEREST|AORTIC VALVE ANNULUS|UNILATERAL|NASAL|SEGMENT|NO INFORMATION|||CHILD|ONCOLOGIST 2|Y|1|1|TREATMENT|2021-03-09|50
e|TU|585a254e-c36b-44cf-b8a9-335fb98e0fd2|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|NON-TARGET ENHANCING|FLEXOR DIGITORUM LONGUS MUSCLE|RIGHT|LOWER|ALL|FISH|||CAREGIVER|CARDIOLOGIST|NA|1|6|TREATMENT|2020-12-02|54
e|TU|9ee3632d-4e99-4a46-b0b9-237467d97ca0|1|[?]|TUSPLIT|Tumor Split|[?]|BENIGN|PERITONEAL CAVITY|LATERAL|VENTROLATERAL|PARTIAL|REBOUND TONOMETRY|||GUARDIAN|FORENSIC PATHOLOGIST|U|1|7|TREATMENT|2020-10-05|36
e|TU|be576e43-f39f-4e7b-9df3-e3a3e1f52d7d|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|NEW BONE LESION|FOOT PHALANX|BILATERAL|SUPERIOR|MULTIPLE|FLUORESCEIN STAIN|||INDEPENDENT ASSESSOR|RATER 1|U|1|1|FOLLOW-UP|2020-09-05|91
e|TU|34b2090b-13ac-4fb2-8d87-eca2839a62f2|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|DISTANT|INTERPHALANGEAL JOINT 5 OF THE HAND|UNILATERAL|VOLAR|ALL|REBOUND TONOMETRY|||CLINICAL RESEARCH COORDINATOR|RADIOLOGIST|NA|1|2|TREATMENT|2020-06-07|10
e|TU|bfc19b4b-51bb-4056-9195-8bd2db53a497|1|[?]|LESIDENT|Lesion Identification|[?]|NON-TARGET NON-ENHANCING|CORPUS CALLOSUM, GENU|LEFT|DISTAL|MULTIPLE|TEMPLATE INCISION METHOD||Y|ADJUDICATOR|OPTOMETRIST|U|1|7|TREATMENT|2020-10-19|95
e|TU|8620aadd-f97d-4bc1-9466-7e5a96ccc66f|1|[?]|TUMERGE|Tumor Merged|[?]|MEASURED|LEFT VENTRICULAR APICAL ANTERIOR SEGMENT|UNILATERAL|PERIVENTRICULAR|ENTIRE|CONTRAST ENHANCED PET SCAN|||FAMILY MEMBER|RATER 2|N|1|2|TREATMENT|2020-11-28|78
e|TU|64a70103-14bf-42f4-808b-fbdecec8bd4f|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|NEW|LEFT VENTRICULAR MID INFEROSEPTAL SEGMENT|CONTRALATERAL|HIND|ENTIRE|ALCIAN BLUE STAIN|Y||DOMESTIC PARTNER|RADIOLOGIST 1|NA|1|5|FOLLOW-UP|2020-10-27|58
e|TU|00f3949b-b14a-47c5-942c-2ab71e03e40f|1|[?]|TUSPLIT|Tumor Split|[?]|UNKNOWN|SUDORIFEROUS GLAND|RIGHT|INFERIOR|HEMI|VENTILATION PERFUSION LUNG SCAN|||SPOUSE|FORENSIC PATHOLOGIST|Y|1|7|FOLLOW-UP|2021-03-20|70
e|TU|bf3676e3-b1aa-48cc-b5ae-ac6427d2b7d6|1|[?]|TUMIDENT|Tumor Identification|[?]|BENIGN|MEDIAL FEMORAL CONDYLE|CONTRALATERAL|DEEP|PARTIAL|DOUBLE IMMUNODIFFUSION|Y||VENDOR|READER 1|Y|1|4|TREATMENT|2021-01-19|33
e|TU|c0d878ab-28d2-4c98-b1a9-26cd3fd3fd1e|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|NON-MEASURABLE|FLEXOR HALLUCIS LONGUS MUSCLE|LEFT|OCCIPITAL|ALL|IN SITU HYBRIDIZATION|||GUARDIAN|OPHTHALMOLOGIST|N|1|5|TREATMENT|2020-10-04|87
e|TU|44ca1fe6-76d2-4a94-9854-1ddbde638803|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|TARGET|JUGULAR VEIN|BILATERAL|FRONTAL|SINGLE|FLUORIMETRY|||VENDOR|ONCOLOGIST 1|Y|1|7|WASHOUT|2020-10-03|86
e|TU|edc935ed-3b94-43fa-9b7f-facf6eb6780e|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|NON-TARGET NON-ENHANCING|RIGHT CORONARY ARTERY, RIGHT POSTERIOR DESCENDING, RIGHT POSTERIOLATERAL AND ACUTE MARGINAL BRANCHES|LATERAL|LOWER EXTENSOR SURFACE|PARTIAL|STRESS ECHOCARDIOGRAPHY|Y||FRIEND|ADJUDICATOR|N|1|3|SCREENING|2021-01-15|52
e|TU|f997ad2a-e9b1-4341-96d5-caef4bcb7196|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|NON-TARGET EXTRA NODAL|SUDORIFEROUS GLAND|UNILATERAL|DISTAL|ALL|MOUSE PROTECTION ASSAY|||PARENT|ADJUDICATOR|NA|1|6|FOLLOW-UP|2020-07-29|61
e|TU|5a56874f-10e4-4cd0-842f-19552a04d1bd|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|NEW NON-TARGET|ESOPHAGUS, ABDOMINAL|BILATERAL|PERIPHERAL|SINGLE|DARK FIELD MICROSCOPY|Y||CAREGIVER|ADJUDICATOR 3|NA|1|4|FOLLOW-UP|2020-09-07|89
e|TU|f1d4ebe5-fc72-447b-8872-67e971ff471b|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|NEW|EXTENSOR DIGITORUM BREVIS MUSCLE|LEFT|ANTEROMEDIAL|SEGMENT|MUGA|||CLINICAL RESEARCH ASSOCIATE|RATER 2|N|1|4|FOLLOW-UP|2021-01-23|86
e|TU|2a141b73-e336-4701-9067-8d51d532596b|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|LOCATION OF INTEREST|FLOOR OF MOUTH|BILATERAL|PERIVENTRICULAR|PARTIAL|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|||INVESTIGATOR|ONCOLOGIST 2|N|1|7|FOLLOW-UP|2020-08-10|69
e|TU|4adf9a2c-3c43-4289-8156-1a109791580c|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|TARGET NODULE|TRICUSPID VALVE, POSTERIOR ANNULUS|IPSILATERAL|ANTEROLATERAL|PARTIAL|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY||Y|SIBLING|MICROSCOPIST|U|1|2|FOLLOW-UP|2020-12-22|40
e|TU|1781d0c2-60c1-49df-98ed-e7dbc63e5b40|1|[?]|TUMIDENT|Tumor Identification|[?]|REGIONAL|CORONARY ARTERY, LEFT|LATERAL|SUPERIOR|PARTIAL|TRANSTHORACIC ECHOCARDIOGRAPHY|Y||HEALTH CARE PROFESSIONAL|OPHTHALMOLOGIST|N|1|3|TREATMENT|2020-08-03|82
e|TU|1b2eda86-2d2c-4fdc-a88e-409ea5180603|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|LOCAL|MIDDLE PHALANX 2 OF THE HAND|IPSILATERAL|FORE|SINGLE|AUTOMATED COUNT|Y||SIBLING|PATHOLOGIST|NA|1|3|SCREENING|2020-08-05|88
e|TU|fc02184a-dfba-4964-be3a-cfa5f5d7200e|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|TARGET|OMENTUM|IPSILATERAL|FACIAL|ALL|CT SCAN|||SIGNIFICANT OTHER|PATHOLOGIST 1|U|1|2|TREATMENT|2020-06-06|21
e|TU|37c59cfa-b952-4d16-a675-5e3b3a2e0288|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|MEASURED|RADIUS SHAFT|CONTRALATERAL|ANTEROLATERAL|ENTIRE|TONOMETRY|Y||SIBLING|READER 1|NA|1|6|TREATMENT|2020-07-24|66
e|TU|11130b2c-e9fd-4a50-87ee-5dfa19199eba|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|NEW NON-TARGET|MEDIASTINUM|LATERAL|ANTEROPOSTERIOR|PARTIAL|RADIOGRAPHY|||SIGNIFICANT OTHER|CARDIOLOGIST|Y|1|5|SCREENING|2020-12-12|19
e|TU|08e4310f-f868-4858-a321-f33a21a771e8|1|[?]|LESIDENT|Lesion Identification|[?]|TARGET EXTRA NODAL|HEART, RIGHT VENTRICULAR FREE WALL|LEFT|DORSAL|ENTIRE|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION||Y|STUDY SUBJECT|ONCOLOGIST|Y|1|3|TREATMENT|2020-06-29|55
e|TU|29edf133-8b5b-46d5-bf7a-f75af4658417|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|NON-TARGET EXTRA NODAL|HIP ADDUCTORS|LEFT|BASAL|SINGLE|WRIGHT STAIN|||CHILD|UROLOGIST|U|1|7|FOLLOW-UP|2020-11-18|98
e|TU|49756233-e18f-4187-8d48-3b6b4fa7e5c2|1|[?]|LESIDENT|Lesion Identification|[?]|NON-TARGET|CARDIOVASCULAR SYSTEM|CONTRALATERAL|ANTEROMEDIAL|SEGMENT|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|||PARENT|MICROSCOPIST|Y|1|6|SCREENING|2020-09-29|61
e|TU|7a046104-7215-4708-9d85-66683ceb8fe8|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|NON-TARGET ENHANCING|LIVER, QUADRATE LOBE|CONTRALATERAL|FORE|ALL|DISK DIFFUSION|||PARENT|PATHOLOGIST 2|N|1|7|TREATMENT|2020-12-09|64
e|TU|6a22373a-8b46-4b5a-94b2-fee3bcd59dda|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|LOCAL|ULNAR ARTERY|BILATERAL|PROXIMAL|ENTIRE|PALPATION|||NON-HEALTH CARE PROFESSIONAL|ONCOLOGIST 2|N|1|3|TREATMENT|2021-04-22|96
e|TU|bcbe7d50-2ebe-483a-9d71-dce4094f864e|1|[?]|LESIDENT|Lesion Identification|[?]|NEW TARGET|ULNA|IPSILATERAL|PERIVENTRICULAR|ENTIRE|CLIP|||INTERVIEWER|UROLOGIST|N|1|7|TREATMENT|2020-06-04|20
e|TU|2550ba24-7bcf-41e2-9eae-536e13d4b345|1|[?]|TUMIDENT|Tumor Identification|[?]|TARGET NODULE|ABDUCTOR POLLICIS BREVIS MUSCLE|CONTRALATERAL|UPPER EXTENSOR SURFACE|SEGMENT|DYNAMIC LIGHT SCATTERING|||CHILD|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|U|1|6|WASHOUT|2021-02-18|39
e|TU|aeec3c61-c825-482e-b77e-a9b8e0bb1f68|1|[?]|TUMIDENT|Tumor Identification|[?]|TARGET|L2-L3 INTERVERTEBRAL SPACE|BILATERAL|DISTAL|SINGLE|TRANSMISSION ELECTRON MICROSCOPY|Y||FRIEND|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|Y|1|1|TREATMENT|2020-08-17|13
e|TU|6ec23671-252e-4dc9-b919-88254fce68a5|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|NEW|INFRACLAVICULAR LYMPH NODE|RIGHT|ANTEROLATERAL|PARTIAL|NEXT GENERATION SEQUENCING||Y|CLINICAL RESEARCH COORDINATOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|U|1|2|TREATMENT|2020-10-10|84
e|TU|db59e5e1-ccda-480b-8955-da5157e16c4a|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|TARGET|SUDORIFEROUS GLAND|LEFT|TEMPORAL|ENTIRE|MAGNETIC RESONANCE ANGIOGRAPHY||Y|PARENT|OTOLARYNGOLOGIST|NA|1|1|FOLLOW-UP|2020-07-09|66
e|TU|1dce856e-b7cb-4899-b27f-87ab8d918df4|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|NEW|HILAR LYMPH NODE|CONTRALATERAL|PERIVENTRICULAR|ALL|OPHTHALMOSCOPY|Y|Y|CLINICAL STUDY SPONSOR|HEMATOLOGIST|U|1|4|TREATMENT|2020-09-15|13
e|TU|7449180b-e226-4e97-a059-8760f6523f77|1|[?]|TUMIDENT|Tumor Identification|[?]|NOT MEASURED|CIRCUMFLEX, OBTUSE MARGINALS, LEFT POSTEROLATERAL AND LEFT POSTERIOR DESCENDING ARTERY BRANCHES|CONTRALATERAL|LATERAL|HEMI|PANENDOSCOPY||Y|VENDOR|PATHOLOGIST|N|1|3|TREATMENT|2020-07-21|27
e|TU|f077c497-b0f0-4a20-b448-608b0cc6ab36|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|TARGET|SACROILIAC JOINT|RIGHT|PROXIMAL VOLAR|SINGLE|REFLECTANCE SPECTROSCOPY|||INTERVIEWER|ONCOLOGIST|Y|1|6|SCREENING|2020-07-22|54
e|TU|172f12c6-0d7f-4e9b-be14-b64b94a26f9a|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|NEW TARGET|HEART, RIGHT VENTRICULAR WALL|LATERAL|VENTROLATERAL|SINGLE|SNP ARRAY|||CLINICAL RESEARCH COORDINATOR|RADIOLOGIST 1|N|1|2|FOLLOW-UP|2020-08-23|82
e|TU|3f7c46ac-fe30-4ef3-a581-99c064a85efa|1|[?]|TUMERGE|Tumor Merged|[?]|TARGET NODULE|SUPERIOR PUBIC RAMUS|LATERAL|NASAL|MULTIPLE|HPLC/MS/MS|Y||CAREGIVER|READER|Y|1|6|TREATMENT|2021-02-03|33
e|TU|8d944400-df75-4ec7-8fb4-239eb0f6de9d|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|NON-TARGET EXTRA NODAL|MEDIAN NERVE|LEFT|LOWER EXTENSOR SURFACE|PARTIAL|CLOT DETECTION|||CLINICAL RESEARCH COORDINATOR|RADIOLOGIST|NA|1|4|WASHOUT|2020-11-21|70
e|TU|7b201f93-bd8c-4507-a7b7-27a02e364647|1|[?]|TUMERGE|Tumor Merged|[?]|REGIONAL|POSTERIOR POLE OF THE EYE|IPSILATERAL|DISTAL|HEMI|NON-INVASIVE DIELECTRIC SENSING|||CLINICAL RESEARCH COORDINATOR|RATER 1|N|1|6|TREATMENT|2021-01-09|27
e|TU|fbc3f1fc-c3e7-4db5-8156-77ba9a459073|1|[?]|TUMIDENT|Tumor Identification|[?]|REGIONAL|LEFT VENTRICULAR BASAL ANTEROSEPTAL SEGMENT|IPSILATERAL|LOWER|PARTIAL|ISHIHARA COLOR PLATES|||NON-HEALTH CARE PROFESSIONAL|ADJUDICATOR 1|N|1|1|TREATMENT|2020-08-23|28
e|TU|3611b798-9b3d-4173-b23e-3017939847e0|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|NON-MEASURABLE|OLFACTORY NERVE|IPSILATERAL|CRANIAL|HEMI|RYAN BLUE STAIN|||ADJUDICATION COMMITTEE|ADJUDICATOR|N|1|7|SCREENING|2020-08-09|16
e|TU|f651799b-9723-4c2c-88d1-de2f347e9a69|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|DISTANT|RIGHT VENTRICULAR ENDOCARDIUM|LEFT|VOLAR|PARTIAL|EEG|Y||ADJUDICATION COMMITTEE|OTOLARYNGOLOGIST|N|1|6|WASHOUT|2020-09-05|83
e|TU|51c6f0e2-6a67-40cd-aac8-fd4cd0188b42|1|[?]|NTIND|Non-Target Indicator|[?]|NON-TARGET|METATARSOPHALANGEAL JOINT|UNILATERAL|DISTAL|ENTIRE|STATIC PERIMETRY||Y|ADJUDICATOR|NEUROLOGIST|Y|1|2|TREATMENT|2021-01-01|84
e|TU|29b16c31-df0e-493c-a777-46113b904879|1|[?]|TUMERGE|Tumor Merged|[?]|NEW TARGET|LEFT VENTRICULAR MID INFEROLATERAL SEGMENT|UNILATERAL|CENTRAL|MULTIPLE|MAGNETIC RESONANCE ANGIOGRAPHY|||INVESTIGATOR|CLINICAL PATHOLOGIST|Y|1|5|SCREENING|2020-07-05|38
e|TU|56b7d8fb-23b2-4f0a-9bc6-8e6621937251|1|[?]|TUMIDENT|Tumor Identification|[?]|NON-TARGET|AORTIC VALVE, NON-CORONARY CUSP|CONTRALATERAL|POSTERIOR|MULTIPLE|REFLECTANCE SPECTROSCOPY|Y|Y|FAMILY MEMBER|PATHOLOGIST|N|1|1|TREATMENT|2020-10-10|81
e|TU|118914c8-9f6a-47c8-b427-296a99547756|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|NON-TARGET EXTRA NODAL|FOREARM|RIGHT|FORE|ALL|DISK DIFFUSION|||PARENT|MICROSCOPIST 1|U|1|1|TREATMENT|2021-01-12|89
e|TU|9b936ec9-01d9-4626-8d6d-83f3a1aefd96|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|NEW|ANAL VERGE|BILATERAL|INNER|SINGLE|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|||SIGNIFICANT OTHER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|N|1|7|TREATMENT|2021-02-28|91
e|TU|571cbffe-c3e1-4f18-a9f7-cf11a4058f2c|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|LOCAL|SCAPHOID-LUNATE-CAPITATE JOINT|IPSILATERAL|FORE|PARTIAL|MAGNETIC RESONANCE ELASTOGRAPHY|Y|Y|NON-HEALTH CARE PROFESSIONAL|ADJUDICATOR 3|NA|1|4|TREATMENT|2021-01-16|18
e|TU|7a5ae465-03b9-4006-a29e-94822ed857aa|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|LOCAL|METACARPAL BONE 2|IPSILATERAL|SUBCORTICAL|PARTIAL|QUANTITATIVE ULTRASOUND|||GUARDIAN|DERMATOLOGIST|N|1|2|WASHOUT|2020-08-13|52
e|TU|179801c9-6c40-4d58-b8a6-6f2cee9c9d58|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|DISTANT|INTERPHALANGEAL JOINT 4 OF THE FOOT|BILATERAL|DISTAL|HEMI|TEST STRIP|||CLINICAL RESEARCH COORDINATOR|NEUROLOGIST 1|U|1|2|SCREENING|2020-10-06|24
e|TU|2e4cd860-734a-40b0-bde5-ca08297415a9|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|NEW|GLOBUS PALLIDUS|UNILATERAL|CRANIAL|SEGMENT|OPTICAL DENSITY MEASUREMENT||Y|NON-HEALTH CARE PROFESSIONAL|RADIOLOGIST 1|N|1|6|FOLLOW-UP|2020-12-13|28
e|TU|3f1854fb-d14e-4699-888b-d5042fa9327c|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|NON-TARGET NODAL|KIDNEY, CORTEX|UNILATERAL|ROSTRAL|HEMI|BAC ACGH|||FRIEND|MICROSCOPIST 3|N|1|7|SCREENING|2020-08-30|36
e|TU|f6e37eba-e224-47f3-baa0-59dfdfb47b70|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|TARGET EXTRA NODAL|FALCIFORM LIGAMENT|UNILATERAL|LOWER MEDIAL|HEMI|MRI WITHOUT CONTRAST|Y||GUARDIAN|MICROSCOPIST 1|N|1|5|FOLLOW-UP|2021-02-05|67
e|TU|8298b45d-16ff-42ef-8404-0f3ce628f9e5|1|[?]|NTIND|Non-Target Indicator|[?]|BONE LESION|HAND PHALANX|RIGHT|VENTROLATERAL|SEGMENT|KLEIHAUER-BETKE|Y||NON-HEALTH CARE PROFESSIONAL|HEMATOLOGIST|NA|1|7|WASHOUT|2020-10-03|74
e|TU|ee5c6623-5cb4-4f18-99b0-6373328abc1d|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|NON-TARGET NODAL|CIRCUMFLEX ARTERY AV GROOVE CONTINUATION ARTERY|LATERAL|UPPER|ENTIRE|U-HPLC/MS/MS|Y||SPOUSE|READER 3|NA|1|6|TREATMENT|2020-07-21|50
e|TU|f8d6576b-b300-4c5f-8f5a-6bb35250d576|1|[?]|TUMERGE|Tumor Merged|[?]|LOCOREGIONAL|SUBCLAVIAN VEIN|LATERAL|INTERMEDIATE|MULTIPLE|MULTIPLE BREATH WASHOUT|||ADJUDICATOR|HEMATOLOGIST|Y|1|5|TREATMENT|2020-08-17|63
e|TU|8635a6b3-d16e-432c-90bf-53f1494dbe5e|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|BONE LESION|EYE, ANTERIOR CHAMBER|IPSILATERAL|CENTRAL|SEGMENT|MICROARRAY|||SPOUSE|ENDOCRINOLOGIST|N|1|6|TREATMENT|2020-11-27|42
e|TU|2cda4297-410a-49e4-949c-deb3dc4c6656|1|[?]|TUMERGE|Tumor Merged|[?]|NON-TARGET ENHANCING|CEREBELLUM|UNILATERAL|ANTEROMEDIAL|PARTIAL|SLIT LAMP PHOTOGRAPHY|Y|Y|CHILD|READER 3|U|1|2|SCREENING|2020-06-20|10
e|TU|a74b51fe-34f5-4c8f-971f-d42e15f9cf41|1|[?]|TUMERGE|Tumor Merged|[?]|NON-TARGET NON-ENHANCING|BUTTOCK|BILATERAL|TIP|ALL|PHASE CONTRAST MICROSCOPY|Y|Y|FAMILY MEMBER|RATER 2|U|1|3|TREATMENT|2021-02-12|24
e|TU|9e82141b-e2b9-42c7-b813-b79bda2bd216|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|NON-TARGET EXTRA NODAL|T4 VERTEBRA|RIGHT|POSTERIOR|PARTIAL|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|||ADJUDICATOR|RATER 2|Y|1|1|TREATMENT|2020-07-15|55
e|TU|4b432c61-c620-4c5e-8aad-411facc0f4db|1|[?]|NTIND|Non-Target Indicator|[?]|NON-MEASURABLE|GASTROINTESTINAL TRACT, LOWER|LATERAL|DISTAL|ENTIRE|DROPLET DIGITAL PCR|Y|Y|ADJUDICATOR|INTERNIST|N|1|7|SCREENING|2020-10-15|41
e|TU|1a1e6863-26da-4b5d-b82a-5703e3e9056e|1|[?]|LESIDENT|Lesion Identification|[?]|TARGET|PULMONARY TRUNK|RIGHT|PROXIMAL|ALL|PULMONARY ANGIOGRAPHY|||VENDOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|N|1|1|TREATMENT|2021-03-11|85
e|TU|8c8053d1-adae-4d45-870e-cf4ad2475c74|1|[?]|NTIND|Non-Target Indicator|[?]|NON-TARGET NON-ENHANCING|FLEXOR POLLICIS LONGUS MUSCLE|LEFT|PARIETO-OCCIPITAL|PARTIAL|MICROPARTICLE ENZYME IMMUNOASSAY|||CHILD|OPTOMETRIST|U|1|2|TREATMENT|2020-07-16|76
e|TU|c3b911a8-116e-4940-80a2-7128db004f4a|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|NON-TARGET NODAL|CARPOMETACARPAL JOINT 5|IPSILATERAL|NASAL|PARTIAL|TRANSTHORACIC ECHOCARDIOGRAPHY|||CLINICAL STUDY SPONSOR|ONCOLOGIST 1|NA|1|1|TREATMENT|2020-12-14|35
e|TU|401d66ba-bc00-4495-ba5d-796068dd1fd6|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|BENIGN|RECTUM|LATERAL|UPPER EXTENSOR SURFACE|PARTIAL|ATOMIC ABSORPTION SPECTROMETRY||Y|CAREGIVER|RADIOLOGIST 1|U|1|6|TREATMENT|2020-08-19|79
e|TU|f8113725-4deb-48a1-876a-ba168a6d2cee|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|NON-TARGET NON-ENHANCING|CORONARY SINUS|CONTRALATERAL|ANTEROTEMPORAL|ALL|TRIPLE-PHASE MRI SCAN|||FRIEND|ADJUDICATOR 3|NA|1|1|TREATMENT|2021-03-21|68
e|TU|f056c174-b6da-4df6-bf95-2e31911939fb|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|NON-TARGET EXTRA NODAL|PROXIMAL INTERPHALANGEAL JOINT 5|LEFT|BASAL|SEGMENT|SISH|||SIBLING|INTERNIST|Y|1|2|TREATMENT|2021-02-24|80
e|TU|b265eb9f-88e1-42d8-83a5-4bc40e46ab54|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|LOCAL|MIDDLE PHALANX 5 OF THE HAND|UNILATERAL|PROXIMAL VOLAR|HEMI|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|||FRIEND|ONCOLOGIST 2|N|1|7|TREATMENT|2020-11-11|66
e|TU|57b7f30f-5f2a-425d-8bf2-fd5915cac481|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|LOCAL|URETHRA, PENILE|UNILATERAL|NASAL|ENTIRE|SURFACE PLASMON RESONANCE|||HEALTH CARE PROFESSIONAL|PEDIATRIC NEUROLOGIST|NA|1|2|TREATMENT|2021-03-02|53
e|TU|02d9a74a-abc8-4b47-a4d4-a196d339f621|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|LOCAL|UNCINATE PROCESS OF PANCREAS|CONTRALATERAL|DISTAL|PARTIAL|DIGITAL PCR ARRAY|Y||SPOUSE|CLINICAL PATHOLOGIST|U|1|4|TREATMENT|2020-09-28|24
e|TU|81480f83-206f-40c0-a5a4-f75b31cda363|1|[?]|NTIND|Non-Target Indicator|[?]|LOCATION OF INTEREST|LYMPH NODE|CONTRALATERAL|SUPERIOR|ALL|IMPULSE OSCILLOMETRY|||INDEPENDENT ASSESSOR|MICROSCOPIST 1|U|1|7|TREATMENT|2020-11-16|4
e|TU|2b183b69-3ed8-4356-b9e2-0988128de3f2|1|[?]|TUMERGE|Tumor Merged|[?]|LOCATION OF INTEREST|TRIANGULAR BONE|LATERAL|APICAL|MULTIPLE|MICRONEUTRALIZATION ASSAY|||NON-HEALTH CARE PROFESSIONAL|READER 3|N|1|4|TREATMENT|2020-10-16|10
e|TU|6ed8a749-81c0-4998-817d-efc86cfaa091|1|[?]|TUMIDENT|Tumor Identification|[?]|TARGET EXTRA NODAL|URETHRA|LEFT|PERIVENTRICULAR|SINGLE|CINEANGIOGRAPHY|||INTERVIEWER|ONCOLOGIST 2|N|1|1|TREATMENT|2020-06-06|11
e|TU|b0f061e5-5dc0-422d-8d96-e7b1af8bda6b|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|NON-TARGET|OLECRANON|BILATERAL|INTERMEDIATE|PARTIAL|THERMAL IONIZATION MASS SPECTROMETRY||Y|PARENT|PATHOLOGIST|N|1|2|FOLLOW-UP|2021-03-03|54
e|TU|e6162980-e240-4924-a13a-dde28b2345cd|1|[?]|TUMERGE|Tumor Merged|[?]|NEW TARGET|ALVEOLUS|LEFT|SUPERFICIAL|HEMI|FLOCCULATION|||NON-HEALTH CARE PROFESSIONAL|DERMATOLOGIST|U|1|7|TREATMENT|2020-09-01|31
e|TU|3dc9c666-8be3-4cfa-88d4-b18647e08d00|1|[?]|TUSPLIT|Tumor Split|[?]|NON-MEASURABLE|SKIN OF THE EAR|IPSILATERAL|ANTEROPOSTERIOR|MULTIPLE|IMMUNOTURBIDIMETRY|||STUDY SUBJECT|READER 2|NA|1|1|WASHOUT|2020-06-28|25
e|TU|6aed5c2d-d5b1-4969-9a8a-14a79a839dbc|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|NON-TARGET NODAL|LUNG, LEFT, SUPERIOR LOBE, ANTERIOR SEGMENT|RIGHT|PERIPHERAL|PARTIAL|IMMUNOASSAY|||CHILD|MICROSCOPIST 2|NA|1|4|WASHOUT|2021-03-19|65
e|TU|b3da6961-98dc-4f83-9cf4-dbc7f4a91c61|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|DISTANT|VOMER|LATERAL|SURFACE|SEGMENT|FLUORESCENT ENZYME IMMUNOASSAY|||INTERVIEWER|CARDIOLOGIST|NA|1|5|TREATMENT|2020-12-12|33
e|TU|2738b933-c71d-4239-a093-6b4aa7cc41df|1|[?]|TUSPLIT|Tumor Split|[?]|NON-MEASURABLE|OPTIC DISC|CONTRALATERAL|LOWER MEDIAL|HEMI|PERIODIC ACID SCHIFF STAIN|||FAMILY MEMBER|ADJUDICATOR 2|Y|1|2|WASHOUT|2020-06-23|36
e|TU|68b9ff4e-9694-4545-a752-4d3ac0e89fda|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|TARGET EXTRA NODAL|SINUS|CONTRALATERAL|ANTERIOR|MULTIPLE|EPSILOMETER|Y||NON-HEALTH CARE PROFESSIONAL|RATER|N|1|2|TREATMENT|2021-02-26|59
e|TU|0f0ec179-5100-4a3d-9f93-54140aca7d30|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|NEW|ESOPHAGEAL LYMPH NODE|UNILATERAL|PROXIMAL VOLAR|ALL|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|||PARENT|MICROSCOPIST 1|NA|1|3|SCREENING|2020-10-24|70
e|TU|6affe43d-e455-40af-8478-dc38019e89e1|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|NOT MEASURED|MUCOSA OF THE LIP|RIGHT|FRONTAL|ALL|PHASE-CONTRAST MRI|||INTERVIEWER|RADIOLOGIST 2|NA|1|4|TREATMENT|2020-08-21|75
e|TU|1c090c96-0a6c-45dd-b862-0aa3d9d579cb|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|NON-TARGET ENHANCING|RETROCRURAL LYMPH NODE|RIGHT|ROSTRAL|ALL|IMMUNODIFFUSION|||STUDY SUBJECT|NEUROLOGIST 1|U|1|4|SCREENING|2020-07-04|37
e|TU|e0258c95-7bcc-4b54-895c-f290a1364b5c|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|LOCOREGIONAL|AZYGOS VEIN|UNILATERAL|UPPER EXTENSOR SURFACE|PARTIAL|SIZE EXCLUSION CHROMATOGRAPHY|Y||SIBLING|HEMATOLOGIST|Y|1|2|FOLLOW-UP|2021-03-19|92
e|TU|7218f9ae-0119-4633-a8d3-7d98b2ae1671|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|DISTANT|THYROID GLAND, RIGHT LOBE|BILATERAL|SURFACE|MULTIPLE|QUANTITATIVE ULTRASOUND||Y|FRIEND|DERMATOLOGIST|NA|1|3|TREATMENT|2021-03-28|84
e|TU|f8c938ff-21c8-4d0b-9335-08d2865543ab|1|[?]|TUMERGE|Tumor Merged|[?]|MEASURED|HEART, RIGHT VENTRICLE|LEFT|DISTAL VOLAR|SEGMENT|CELL OF ORIGIN ASSAY|||CAREGIVER|ADJUDICATOR|U|1|5|TREATMENT|2020-08-02|93
e|TU|7176f852-7392-4636-800f-3aad48e93065|1|[?]|LESIDENT|Lesion Identification|[?]|NON-MEASURABLE|EAR, OUTER|RIGHT|APICAL|HEMI|ANGIOGRAPHY||Y|STUDY SUBJECT|NEUROLOGIST 1|Y|1|5|WASHOUT|2021-03-23|76
e|TU|753d5d9d-ec84-46f5-a933-b18b8e3a6b0e|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|UNKNOWN|VAGUS NERVE|BILATERAL|SURFACE|ALL|PHASE CONTRAST MICROSCOPY|Y||FRIEND|INTERNIST|Y|1|4|WASHOUT|2020-11-19|52
e|TU|69e41d6b-57f7-48b0-be7a-29fca953f8d9|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|NEW|PELVIS|UNILATERAL|ROSTRAL|SINGLE|LEAD CITRATE STAIN|||GUARDIAN|DERMATOLOGIST|N|1|1|TREATMENT|2020-11-24|37
e|TU|a38eb4fc-2422-4d4a-a435-58ae9bf42589|1|[?]|NTIND|Non-Target Indicator|[?]|NON-TARGET NON-ENHANCING|TRICUSPID VALVE, POSTERIOR ANNULUS|CONTRALATERAL|ROSTRAL|MULTIPLE|MS/MS|||SIGNIFICANT OTHER|MICROSCOPIST 1|NA|1|3|SCREENING|2021-01-20|68
e|TU|12ae2530-f9f6-4e7d-9daa-fdfaacb1c747|1|[?]|LESIDENT|Lesion Identification|[?]|LOCATION OF INTEREST|RADIUS-LUNATE JOINT|BILATERAL|CAUDAL|PARTIAL|HEMATOXYLIN AND EOSIN STAIN|||CAREGIVER|MICROSCOPIST 3|N|1|1|TREATMENT|2020-10-30|44
e|TU|29e42c28-c2f8-4c27-9a6d-12f0d5fa4ab3|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|REGIONAL|HEART, LEFT ATRIAL APPENDAGE|RIGHT|OCCIPITAL|SEGMENT|SLOAN LETTER EYE CHART 2.5%||Y|ADJUDICATION COMMITTEE|HEMATOLOGIST|U|1|3|WASHOUT|2021-03-16|84
e|TU|dd518f55-0280-445d-a29f-10f09b21fd53|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|TARGET NODAL|INFERIOR VENA CAVA|RIGHT|BASAL|ENTIRE|GIEMSA STAIN|||VENDOR|READER 2|U|1|3|WASHOUT|2020-07-23|76
e|TU|49a972da-dfad-438e-b5bc-26ee6b955a59|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|NEW TARGET|GLOMERULUS|LEFT|FRONTAL|ALL|CONFOCAL MICROSCOPY|Y||INVESTIGATOR|HEMATOLOGIST|U|1|2|TREATMENT|2020-07-30|46
e|TU|502a42a7-2ed6-46b9-9b10-728f849334b6|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|NOT MEASURED|INTERPHALANGEAL THUMB JOINT|BILATERAL|LOWER EXTENSOR SURFACE|ENTIRE|LC-FL|||DOMESTIC PARTNER|DERMATOLOGIST|NA|1|4|FOLLOW-UP|2021-01-19|69
e|TU|61cce2a8-16d6-4cb3-91fc-71f1f2f02551|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|NOT MEASURED|CEREBRAL SUBCORTEX|LATERAL|VOLAR|ENTIRE|ENZYMATIC COLORIMETRY|Y||DOMESTIC PARTNER|RATER 2|Y|1|5|SCREENING|2020-10-18|2
e|TU|40c048ea-d637-426b-8afe-2da3a6961528|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|NEW NON-TARGET|ANKLE MORTISE|IPSILATERAL|PERIVENTRICULAR|SEGMENT|MULTIPLEXED BEAD BASED IMMUNOASSAY|Y|Y|CHILD|PATHOLOGIST 1|Y|1|7|TREATMENT|2020-08-29|57
e|TU|4d03b209-bd53-47f5-8251-f9fb2074bc38|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|NON-TARGET EXTRA NODAL|SECOND RIGHT POSTEROLATERAL ARTERY|BILATERAL|DORSAL|PARTIAL|FLUOROSCOPY||Y|PROXY|ONCOLOGIST 1|NA|1|5|FOLLOW-UP|2021-03-07|74
e|TU|35f01eda-1acb-4700-8285-c8cd4b69b524|1|[?]|TUMERGE|Tumor Merged|[?]|TARGET EXTRA NODAL|URACHAL TRACT|CONTRALATERAL|PERIVENTRICULAR|MULTIPLE|MICROBIAL CULTURE|Y||ADJUDICATOR|RATER 2|N|1|2|WASHOUT|2020-11-12|53
e|TU|9df97277-7d07-4020-bae0-dfa982f21c8d|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|NOT MEASURED|POSTEROLATERAL SEGMENTAL ARTERY|CONTRALATERAL|LOWER EXTENSOR SURFACE|ALL|SNELLEN EYE CHART|||CHILD|NEUROLOGIST 2|U|1|2|TREATMENT|2021-01-17|86
e|TU|d1b522d5-557a-4361-a9da-292aa601fbc3|1|[?]|TUMERGE|Tumor Merged|[?]|LOCOREGIONAL|RETROPHARYNGEAL LYMPH NODE|IPSILATERAL|INFERIOR|SEGMENT|ERGOSPIROMETRY|||INTERVIEWER|MICROSCOPIST 1|U|1|5|TREATMENT|2020-11-18|50
e|TU|c6343fe8-6005-4fe8-b3e6-cfcb56c2d360|1|[?]|TUMERGE|Tumor Merged|[?]|TARGET NODAL|ANTRUM PYLORI|LEFT|ROSTRAL|HEMI|NEPHELOMETRY|Y||INDEPENDENT ASSESSOR|RATER|Y|1|5|FOLLOW-UP|2020-10-09|84
e|TU|da2d0844-3608-4927-9103-cb7c52dd2c96|1|[?]|TUMERGE|Tumor Merged|[?]|UNKNOWN|ANTERIOR CINGULATE CORTEX|IPSILATERAL|DISTAL VOLAR|HEMI|REFRACTOMETRY|Y|Y|INDEPENDENT ASSESSOR|PATHOLOGIST|NA|1|6|SCREENING|2021-02-23|38
e|TU|30b6f8a7-4512-462d-a162-45c3dad853e5|1|[?]|NTIND|Non-Target Indicator|[?]|NEW BONE LESION|ABDOMINAL SKIN|BILATERAL|APICAL|ENTIRE|SXA SCAN||Y|FRIEND|RADIOLOGIST 2|U|1|5|TREATMENT|2021-03-01|99
e|TU|1a3808b9-6004-4133-8f59-49905d04655e|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|MEASURED|FINGER EXTENSOR TENDONS|CONTRALATERAL|POSTERIOR|HEMI|INDIRECT IMMUNOFLUORESCENCE|||ADJUDICATOR|INTERNIST|Y|1|1|SCREENING|2020-11-14|17
e|TU|5c91894d-c756-4ade-9fc4-2a64d4acc53f|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|NON-TARGET|ABDOMINAL WALL|IPSILATERAL|ANTEROPOSTERIOR|PARTIAL|NUCLEIC ACID SEQUENCING|||INVESTIGATOR|CARDIOLOGIST|N|1|6|TREATMENT|2021-01-15|6
e|TU|cc9d17ea-ec8b-46bb-af7d-ad19da3cfb20|1|[?]|TUMERGE|Tumor Merged|[?]|TARGET EXTRA NODAL|RECTO-UTERINE POUCH|UNILATERAL|LOWER FLEXOR SURFACE|ENTIRE|ENZYMATIC COLORIMETRY|||PROXY|HEMATOLOGIST|NA|1|1|TREATMENT|2020-10-09|96
e|TU|4a6cff44-d7c3-410f-afe0-a11ae0e8872b|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|REGIONAL|LEG SKIN|LATERAL|DORSAL|SEGMENT|CT SCAN|||VENDOR|RATER|N|1|3|FOLLOW-UP|2020-11-06|62
e|TU|35fd3f79-60b3-4101-ab79-952ca0e8f1ce|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|NON-MEASURABLE|INTERPHALANGEAL JOINT OF THE HAND|IPSILATERAL|VENTRAL|MULTIPLE|PHASE-CONTRAST MRI|Y|Y|FRIEND|READER|Y|1|3|SCREENING|2020-08-23|84
e|TU|37610314-f803-4ffa-a584-ebfe09267a0d|1|[?]|TUMIDENT|Tumor Identification|[?]|UNKNOWN|PROFUNDA FEMORIS VEIN|LEFT|MIDLINE|SINGLE|SNELLEN EYE CHART|||NON-HEALTH CARE PROFESSIONAL|READER 2|Y|1|5|TREATMENT|2020-07-27|37
e|TU|760ec5ce-3ae7-4268-9f76-b83085ad3754|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|LOCOREGIONAL|GREAT TROCHANTER|RIGHT|LOWER EXTENSOR SURFACE|SEGMENT|MECHANICAL CLOT DETECTION|||CLINICAL STUDY SPONSOR|RATER 2|NA|1|5|TREATMENT|2020-10-04|20
e|TU|13773a62-50b1-4b2a-a5c7-ec0e0245a97e|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|NON-TARGET ENHANCING|LAD SEPTAL PERFORATOR ARTERY|IPSILATERAL|LOWER EXTENSOR SURFACE|PARTIAL|SIZE EXCLUSION CHROMATOGRAPHY||Y|PARENT|HEMATOLOGIST|Y|1|1|TREATMENT|2020-07-17|42
e|TU|d0a9940e-a75f-4fcc-8d0c-5a8dae7d9344|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|NON-TARGET ENHANCING|CAPITATE-HAMATE JOINT|CONTRALATERAL|FORE|SEGMENT|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING||Y|CAREGIVER|RADIOLOGIST 1|Y|1|4|TREATMENT|2021-01-18|4
e|TU|8f0ff98a-fd19-4c9f-87ec-96200ced0f82|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|LOCOREGIONAL|XIPHOID PROCESS|IPSILATERAL|FACIAL|SEGMENT|TELLER ACUITY CARDS||Y|ADJUDICATOR|RADIOLOGIST 2|N|1|5|SCREENING|2020-12-25|52
e|TU|d7b41e15-6725-4433-8a35-72629e342b47|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|NON-TARGET|CONJUNCTIVA|IPSILATERAL|HIND|SINGLE|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|||PARENT|ONCOLOGIST 1|NA|1|7|SCREENING|2020-12-04|91
e|TU|aeddc1ed-545c-405e-b1f7-08131961f5ff|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|NOT MEASURED|MEDIASTINAL LYMPH NODE|UNILATERAL|SUPERFICIAL|SEGMENT|JAFFE REACTION|||GUARDIAN|PHYSIOTHERAPIST|Y|1|6|SCREENING|2020-11-24|50
e|TU|3effe272-6a68-4163-a4f3-bd269af6061c|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|NEW NON-TARGET|HAIR BULB|LATERAL|ROSTRAL|HEMI|ARTERIAL SPIN LABELING FUNCTIONAL MRI|||HEALTH CARE PROFESSIONAL|ONCOLOGIST 1|N|1|2|WASHOUT|2021-02-06|32
e|TU|8153c765-a92a-4b0f-9ef3-6ca925337f54|1|[?]|LESIDENT|Lesion Identification|[?]|UNKNOWN|CERVICAL SPINE|IPSILATERAL|OCCIPITAL|ENTIRE|CONGO RED STAIN|||CLINICAL STUDY SPONSOR|DEVELOPMENTAL PSYCHOLOGIST|Y|1|7|TREATMENT|2020-12-02|74
e|TU|8d27cdcf-768e-4630-95b5-da554f6f3b56|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|UNKNOWN|INFRATENTORIAL BRAIN|LATERAL|LOWER MEDIAL|SEGMENT|PULMONARY ANGIOGRAPHY|||ADJUDICATION COMMITTEE|RATER 1|Y|1|5|TREATMENT|2020-11-24|35
e|TU|5c2791ff-aaf6-413f-9827-6e97e2273388|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|NON-TARGET NODAL|SKIN OF THE BACK|IPSILATERAL|DISTAL VOLAR|MULTIPLE|TRICHROME STAIN|||VENDOR|OTOLARYNGOLOGIST|N|1|3|TREATMENT|2020-09-11|15
e|TU|b336d8c2-7bca-404e-aea3-5148d559ea99|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|TARGET NODULE|ANKLE JOINT ANTERIOR EXTENSOR TENDONS|CONTRALATERAL|NASAL|SINGLE|SNP ARRAY||Y|CLINICAL STUDY SPONSOR|READER|NA|1|3|WASHOUT|2020-12-15|97
e|TU|702b2f8f-63b9-44c1-a46d-1a41bc837c32|1|[?]|TUMERGE|Tumor Merged|[?]|NON-TARGET|PYRAMIDAL TRACTS, BRAINSTEM|LEFT|UPPER FLEXOR SURFACE|ENTIRE|SMEAR|||PROXY|OPTOMETRIST|NA|1|6|TREATMENT|2020-07-31|54
e|TU|1261eee1-f073-4419-b0b7-28abd0ec1513|1|[?]|TUSPLIT|Tumor Split|[?]|NON-TARGET NON-ENHANCING|CORONARY ARTERY, LEFT|CONTRALATERAL|TEMPORAL|HEMI|RADIATION DOSIMETRY|Y||GUARDIAN|NEUROLOGIST 1|N|1|1|WASHOUT|2020-11-14|54
e|TU|46eefdf3-c314-4e61-963c-ce7f48c636e5|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|NEW BONE LESION|PARACOLIC GUTTER|LATERAL|POSTERIOR|SINGLE|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|Y|Y|INDEPENDENT ASSESSOR|CLINICAL PATHOLOGIST|Y|1|7|TREATMENT|2021-01-21|33
e|TU|f632159b-8c91-4f0d-81cb-e5b9195588c9|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|NEW BONE LESION|CEREBRAL SUBCORTEX|IPSILATERAL|DISTAL|ENTIRE|PHOTOMETRIC CLOT DETECTION|||CHILD|RADIOLOGIST 1|N|1|4|TREATMENT|2021-03-25|82
e|TU|898a9d2f-338b-41bf-8ac0-c4a025481349|1|[?]|TUMIDENT|Tumor Identification|[?]|LOCATION OF INTEREST|INFERIOR VENA CAVA|IPSILATERAL|VOLAR|MULTIPLE|INDIRECT IMMUNOFLUORESCENCE|||DOMESTIC PARTNER|MICROSCOPIST 3|N|1|7|WASHOUT|2020-05-31|17
e|TU|db3824aa-375d-4e40-a14b-af0e4460914e|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|REGIONAL|TROCHLEAR NERVE|UNILATERAL|UPPER|PARTIAL|CYSTOMETRY|||INVESTIGATOR|READER 3|N|1|4|TREATMENT|2020-06-26|47
e|TU|0ea6be64-32f8-4e10-b993-687ea200e4e9|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|LOCAL|CAPITATE BONE|CONTRALATERAL|CRANIAL|MULTIPLE|MICROBIAL BIOCHEMICAL IDENTIFICATION|||INDEPENDENT ASSESSOR|DEVELOPMENTAL PSYCHOLOGIST|N|1|3|TREATMENT|2021-03-20|61
e|TU|18504c4e-41c8-4c1a-a479-d179ccd318e3|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|TARGET NODULE|AORTIC VALVE|IPSILATERAL|PARIETO-OCCIPITAL|MULTIPLE|LAPAROSCOPY|||GUARDIAN|RATER 2|U|1|1|SCREENING|2020-06-22|10
e|TU|7f211d8a-7478-4082-8d95-4ace9ceee919|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|DISEASE SITE|CARPOMETACARPAL JOINT 1|CONTRALATERAL|FORE|ENTIRE|PUPILLOMETRY|||HEALTH CARE PROFESSIONAL|RATER 1|Y|1|1|WASHOUT|2020-09-29|51
e|TU|0739e140-bcac-4df9-9629-bd0748d1fdd6|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|DISTANT|TIBIOTARSAL JOINT|CONTRALATERAL|PROXIMAL VOLAR|ALL|SLOAN LETTER EYE CHART 2.5%|||CLINICAL RESEARCH COORDINATOR|PATHOLOGIST 2|U|1|6|FOLLOW-UP|2020-10-09|10
e|TU|4d44daf5-8ebc-4d4f-aa33-e8ab9f5442e0|1|[?]|TUSPLIT|Tumor Split|[?]|TARGET NODAL|THIRD DIAGONAL BRANCH ARTERY|UNILATERAL|LOWER EXTENSOR SURFACE|PARTIAL|HPLC|Y||HEALTH CARE PROFESSIONAL|PATHOLOGIST 2|U|1|1|WASHOUT|2021-02-06|57
e|TU|f24b931a-2cdd-4432-a1dd-69c7286f4690|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|MEASURED|ABDOMINAL REGION|BILATERAL|INNER|MULTIPLE|MULTIPLEXED BEAD BASED IMMUNOASSAY||Y|PARENT|READER 2|U|1|3|FOLLOW-UP|2020-06-02|28
e|TU|d394120d-7630-4fcf-a336-482599d88296|1|[?]|LESIDENT|Lesion Identification|[?]|MEASURED|VENA CAVA|RIGHT|FACIAL|PARTIAL|PATHOLOGICAL EVALUATION||Y|CLINICAL RESEARCH COORDINATOR|MICROSCOPIST 1|NA|1|1|TREATMENT|2021-04-19|97
e|TU|bcda1d95-58ed-4991-9395-0b98efc1d9a1|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|NEW|INTERPHALANGEAL JOINT 3|LATERAL|LOWER|PARTIAL|GEL ELECTROPHORESIS|Y||VENDOR|NEUROLOGIST|N|1|2|WASHOUT|2020-12-07|57
e|TU|6999bd5c-0790-42b8-a4ff-e538776b0fb0|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|NEW NON-TARGET|PARIETAL LOBE|IPSILATERAL|UPPER|PARTIAL|ENZYMATIC ULTRACENTRIFUGATION|||CLINICAL RESEARCH ASSOCIATE|PATHOLOGIST 2|Y|1|2|WASHOUT|2020-11-05|92
e|TU|5934d59a-b0f4-4377-a3c3-00d434d3ddfd|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|NEW BONE LESION|FACIAL NERVE|IPSILATERAL|VOLAR|MULTIPLE|DNA MICROARRAY||Y|PARENT|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|NA|1|3|FOLLOW-UP|2021-02-15|66
e|TU|59b0fee3-2294-448e-9837-38bd6b5c794b|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|LOCAL|SEBACEOUS GLAND|CONTRALATERAL|OUTER|HEMI|FLAME PHOTOMETRY|||INDEPENDENT ASSESSOR|ONCOLOGIST 1|N|1|4|TREATMENT|2021-01-28|37
e|TU|d9bdb1e3-4630-423f-be01-4873bce30422|1|[?]|NTIND|Non-Target Indicator|[?]|BENIGN|INTERPHALANGEAL JOINT 2|LEFT|SUPERIOR|SINGLE|SXA SCAN|Y|Y|DOMESTIC PARTNER|ENDOCRINOLOGIST|NA|1|5|FOLLOW-UP|2021-01-22|41
e|TU|7a2e5851-3c3e-46b4-876f-7dd6c8005f9a|1|[?]|TUMERGE|Tumor Merged|[?]|NON-TARGET NON-ENHANCING|CAUDATE NUCLEUS|LEFT|BASAL|ALL|HPLC/MS/MS|||DOMESTIC PARTNER|RATER 1|Y|1|4|WASHOUT|2020-07-07|22
e|TU|5546d86b-6a12-4b5f-b66f-8d85ba4691e6|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|LOCAL|PARASPINAL REGION|IPSILATERAL|CAUDAL|MULTIPLE|WESTERGREN|Y|Y|SPOUSE|CARDIOLOGIST|N|1|2|TREATMENT|2020-07-31|6
e|TU|933c3a61-59a0-4cfb-ae17-45bc48229323|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|NON-MEASURABLE|PARASYMPATHETIC GANGLIA|LEFT|ANTERIOR|ENTIRE|BAC ACGH|||FRIEND|ADJUDICATOR 2|NA|1|3|TREATMENT|2020-09-02|3
e|TU|58d871e3-ef99-48da-ab12-fdfdc2e01da6|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|TARGET NODAL|URETHRA|IPSILATERAL|HIND|MULTIPLE|ZIEHL NEELSEN ACID FAST STAIN|||CLINICAL RESEARCH ASSOCIATE|RADIOLOGIST 1|Y|1|2|FOLLOW-UP|2020-11-30|45
e|TU|ac66129e-3244-4cd8-a235-43b4bfb7dace|1|[?]|TUMIDENT|Tumor Identification|[?]|NON-TARGET EXTRA NODAL|LEFT VENTRICULAR MID INFEROSEPTAL SEGMENT|BILATERAL|DISTAL|MULTIPLE|DYNAMIC CONTRAST ENHANCED MRI|Y|Y|PROXY|READER|Y|1|5|WASHOUT|2020-11-26|38
e|TU|2f2297c4-ed0a-45c2-bbd9-13c945abb67b|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|LOCAL|HEART, VENTRICLE|UNILATERAL|MIDLINE|ENTIRE|HPLC/MS/MS|||FAMILY MEMBER|FORENSIC PATHOLOGIST|U|1|4|SCREENING|2020-09-15|23
e|TU|3d59a754-10bb-4847-93ea-433b43265a2f|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|UNKNOWN|PROXIMAL INTERPHALANGEAL JOINT 5|UNILATERAL|LOWER FLEXOR SURFACE|PARTIAL|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY||Y|NON-HEALTH CARE PROFESSIONAL|NEUROLOGIST 2|Y|1|5|TREATMENT|2021-01-02|80
e|TU|0d3d37a5-2215-4b28-b6f7-7256abcdd97e|1|[?]|TUMIDENT|Tumor Identification|[?]|NON-TARGET EXTRA NODAL|THYROID GLAND ISTHMUS|IPSILATERAL|VOLAR|ALL|HPLC/MS/MS|||STUDY SUBJECT|HEMATOLOGIST|N|1|6|FOLLOW-UP|2021-03-06|55
e|TU|89209495-c485-4eb7-b858-8dc5490d2b64|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|NON-MEASURABLE|SUPRACLAVICULAR FOSSA|LEFT|HIND|PARTIAL|HIGH LEVEL AMINOGLYCOSIDE SCREEN|Y||DOMESTIC PARTNER|READER|Y|1|7|TREATMENT|2020-11-08|72
e|TU|d80522bb-f146-4270-a6e1-326fde50d9ca|1|[?]|LESIDENT|Lesion Identification|[?]|TARGET NODULE|PALATINE BONE|RIGHT|ANTERIOR|ALL|CONFOCAL MICROSCOPY|Y||VENDOR|MICROSCOPIST|Y|1|4|SCREENING|2020-12-27|6
e|TU|3982a462-95f6-4e71-93e5-9df777770067|1|[?]|TUSPLIT|Tumor Split|[?]|NOT MEASURED|PERIURETHRAL REGION|LATERAL|ANTEROPOSTERIOR|PARTIAL|MOUSE PROTECTION ASSAY|||SIGNIFICANT OTHER|DERMATOLOGIST|Y|1|1|TREATMENT|2021-03-19|94
e|TU|f3a3a6ca-2344-4cee-a6a5-59beee9304df|1|[?]|TUSPLIT|Tumor Split|[?]|LOCAL|HEAD|UNILATERAL|UPPER EXTENSOR SURFACE|ENTIRE|LC-FL|||PARENT|HEMATOLOGIST|N|1|5|TREATMENT|2021-01-18|80
e|TU|175cfd82-a6fe-463b-81e5-07ae9e1253db|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|BONE LESION|T5 VERTEBRA|LATERAL|DEEP|ALL|SLOAN LETTER EYE CHART 2.5%|Y||CHILD|PHYSIOTHERAPIST|U|1|1|WASHOUT|2020-08-10|86
e|TU|e19b469c-40d5-4506-8233-a86bebde880d|1|[?]|TUMERGE|Tumor Merged|[?]|MEASURED|PELVIC LYMPH NODE|CONTRALATERAL|ANTERIOR|SINGLE|DIGITAL PCR ARRAY|Y||PROXY|MICROSCOPIST 2|NA|1|2|FOLLOW-UP|2021-02-11|30
e|TU|f280a4a5-9826-4d77-adf1-992284cb3314|1|[?]|TUMERGE|Tumor Merged|[?]|TARGET NODAL|WAIST|UNILATERAL|UPPER|PARTIAL|QUANTITATIVE CORONARY ANGIOGRAPHY|||FRIEND|READER 1|N|1|3|TREATMENT|2021-01-07|29
e|TU|82840929-7800-4254-b60a-8af4786664f6|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|LOCATION OF INTEREST|L3-L4 INTERVERTEBRAL SPACE|BILATERAL|UPPER FLEXOR SURFACE|PARTIAL|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|||ADJUDICATOR|RATER|NA|1|2|TREATMENT|2020-07-16|52
e|TU|dae25bdb-38fd-4852-9a9a-7627368e9497|1|[?]|TUSPLIT|Tumor Split|[?]|BENIGN|POPLITEAL ARTERY BELOW KNEE|UNILATERAL|ROSTRAL|ALL|CELLULAR PROLIFERATION ASSAY|||ADJUDICATOR|MICROSCOPIST 3|N|1|1|WASHOUT|2020-10-21|59
e|TU|9e009737-cd77-4b96-a4af-e9731ef7e9d0|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|DISTANT|LIVER LOBE|UNILATERAL|TEMPORAL|HEMI|ULTRASONOGRAPHIC ELASTOGRAPHY||Y|NON-HEALTH CARE PROFESSIONAL|OTOLARYNGOLOGIST|U|1|7|TREATMENT|2020-11-27|63
e|TU|e7468d01-71b3-47c4-9715-62fe143364cb|1|[?]|NTIND|Non-Target Indicator|[?]|UNKNOWN|INGUINAL REGION|LATERAL|ROSTRAL|PARTIAL|MICROBIAL CULTURE|||FRIEND|RATER 2|U|1|4|TREATMENT|2020-12-24|80
e|TU|6a021859-1b18-4eb5-9548-0e32c0c1edf7|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|NON-TARGET NODAL|SKIN OF THE LIP|BILATERAL|DISTAL VOLAR|ALL|LAPAROSCOPY||Y|SPOUSE|ONCOLOGIST|U|1|5|TREATMENT|2020-07-18|71
e|TU|eb409ec5-4c02-41c8-a11f-03d990818c2a|1|[?]|NTIND|Non-Target Indicator|[?]|TARGET NODULE|AORTA|IPSILATERAL|FORE|SEGMENT|PHASE CONTRAST MICROSCOPY|||PROXY|RATER|N|1|5|TREATMENT|2021-01-16|48
e|TU|2178f542-809d-4306-84e4-26d3b3b370b0|1|[?]|TUMERGE|Tumor Merged|[?]|LOCATION OF INTEREST|ESOPHAGUS, THORACIC|LATERAL|DEEP|ENTIRE|AGAR DILUTION|Y||CLINICAL RESEARCH COORDINATOR|ONCOLOGIST|Y|1|7|FOLLOW-UP|2021-01-25|90
e|TU|da7423fb-461e-43a6-bcb9-aa87051bda0a|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|LOCATION OF INTEREST|HAND PHALANX|RIGHT|VENTRAL|MULTIPLE|IMMUNODIFFUSION|Y||CAREGIVER|RADIOLOGIST 1|NA|1|2|WASHOUT|2020-12-10|77
e|TU|40e4c69f-6115-4f0e-8555-45b12b222801|1|[?]|NTIND|Non-Target Indicator|[?]|BONE LESION|PROXIMAL INTERPHALANGEAL JOINT 5 OF THE FOOT|RIGHT|ANTEROTEMPORAL|SINGLE|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|Y||SPOUSE|PATHOLOGIST 1|U|1|2|TREATMENT|2021-04-15|85
e|TU|1307d7f6-acb6-4096-a907-08345548a82b|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|BONE LESION|PULMONARY VALVE, ANTERIOR CUSP|LEFT|LATERAL|SINGLE|MAPH||Y|CAREGIVER|MICROSCOPIST 1|U|1|1|SCREENING|2020-08-17|91
e|TU|bac23835-1120-43b2-9d99-694bef97f44b|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|NON-TARGET NON-ENHANCING|PRECUNEUS|IPSILATERAL|ANTEROLATERAL|ENTIRE|ELECTRICAL IMPEDANCE MYOGRAPHY|Y||ADJUDICATOR|NEUROLOGIST 2|U|1|5|TREATMENT|2020-06-20|40
e|TU|8cf8f8a1-5c55-4f82-b6bc-109acdf5b514|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|BENIGN|BLOOD|LEFT|ROSTRAL|ALL|FLUORESCENCE ANGIOGRAPHY|||CLINICAL STUDY SPONSOR|RADIOLOGIST|Y|1|2|TREATMENT|2020-12-01|78
e|TU|14cd64f5-f3c8-47a4-b40e-9c5090890870|1|[?]|TUMERGE|Tumor Merged|[?]|NOT MEASURED|BICEPS FEMORIS MUSCLE|LEFT|MEDIAL|PARTIAL|ANTIMICROBIAL COMBINATION TESTING|||INTERVIEWER|ENDOCRINOLOGIST|NA|1|1|WASHOUT|2020-11-10|57
e|TU|ca4a06be-5e6a-4220-9854-e5fe02b384af|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|MEASURED|LIVER|UNILATERAL|UPPER EXTENSOR SURFACE|ENTIRE|ENDOSCOPY|Y||ADJUDICATION COMMITTEE|NEUROLOGIST|N|1|7|WASHOUT|2020-10-09|16
e|TU|55504c69-a659-402b-a0cb-95ab4e08c086|1|[?]|LESIDENT|Lesion Identification|[?]|TARGET NODAL|EARLOBE|LATERAL|TIP|SINGLE|SPECT/CT SCAN|Y||PROXY|UROLOGIST|U|1|3|FOLLOW-UP|2021-02-04|31
e|TU|bffa468a-a27b-4e87-a60d-b5787a03c6f6|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|NON-TARGET NODAL|ACHILLES TENDON|RIGHT|DORSOLATERAL|HEMI|FUNCTIONAL MRI|Y||CLINICAL STUDY SPONSOR|PATHOLOGIST 1|N|1|2|WASHOUT|2021-02-14|86
e|TU|2e25aa76-914f-41e3-82ce-7c56ba2f6271|1|[?]|TUMIDENT|Tumor Identification|[?]|NON-TARGET EXTRA NODAL|LEFT VENTRICULAR MID ANTEROLATERAL SEGMENT|LEFT|TIP|SEGMENT|MOUSE PROTECTION ASSAY|Y||CLINICAL RESEARCH COORDINATOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|U|1|7|FOLLOW-UP|2021-03-05|94
e|TU|12c24fff-080b-4889-a455-ff55d5c0536c|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|TARGET|VAGINAL WALL|IPSILATERAL|INTERMEDIATE|ALL|ICC||Y|ADJUDICATION COMMITTEE|MICROSCOPIST 3|Y|1|6|WASHOUT|2021-04-11|84
e|TU|aecfe062-4e0d-4c91-8b67-1f304c5765ae|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|TARGET EXTRA NODAL|HEART, LEFT ATRIAL APPENDAGE|RIGHT|PERIPHERAL|ALL|ACCELERATOR MASS SPECTROMETRY|Y||VENDOR|MICROSCOPIST 3|U|1|3|SCREENING|2021-04-14|93
e|TU|05a142dc-a779-44cb-ab2e-f961676a3940|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|UNKNOWN|RETINA|LATERAL|MEDIAL|ENTIRE|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|Y||SIBLING|RATER 1|U|1|2|SCREENING|2021-02-12|96
e|TU|498524c5-08c4-41a4-af81-876ab2452f64|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|TARGET NODAL|THALAMUS|RIGHT|VOLAR|HEMI|CELLULOSE TAPE|||GUARDIAN|RATER 1|U|1|2|FOLLOW-UP|2020-12-02|3
e|TU|93490930-01cd-470e-81a3-bcd7a140ccc1|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|LOCOREGIONAL|DISTAL INTERPHALANGEAL JOINT 2 OF THE HAND|BILATERAL|NASAL|PARTIAL|TELLER ACUITY CARDS||Y|INVESTIGATOR|MICROSCOPIST|Y|1|7|FOLLOW-UP|2020-12-27|50
e|TU|fd588c97-c57f-432f-81a0-a116a017c5dd|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|LOCOREGIONAL|FIRST DIAGONAL BRANCH ARTERY|LATERAL|PERIVENTRICULAR|SINGLE|FLOCCULATION|||SPOUSE|RADIOLOGIST 1|Y|1|3|TREATMENT|2020-06-10|17
e|TU|18028efc-33b9-4741-a47a-8fdac0a90e6e|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|NEW|LIVER, CAUDATE LOBE|IPSILATERAL|INTERMEDIATE|MULTIPLE|FLOCCULATION|Y|Y|NON-HEALTH CARE PROFESSIONAL|NEUROLOGIST|N|1|6|FOLLOW-UP|2020-12-15|3
e|TU|ec47a40e-dd7f-47ee-b571-d91ce72c1cf1|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|NON-MEASURABLE|DISTAL INTERPHALANGEAL JOINT 3 OF THE FOOT|CONTRALATERAL|TEMPORAL|HEMI|ELLA|||SPOUSE|READER|U|1|7|TREATMENT|2020-08-02|69
e|TU|08fccce4-64bf-431e-81b0-a96566e77df6|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|MEASURED|THIRD DIAGONAL BRANCH ARTERY|IPSILATERAL|INNER|MULTIPLE|MICROBIAL BIOCHEMICAL IDENTIFICATION|||SPOUSE|PEDIATRIC NEUROLOGIST|N|1|6|TREATMENT|2021-02-27|48
e|TU|0354fab5-5636-4504-8345-af060ad4c90c|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|UNKNOWN|SUBSTANTIA NIGRA|CONTRALATERAL|CRANIAL|MULTIPLE|JAFFE REACTION|Y||FRIEND|ADJUDICATOR 1|N|1|6|TREATMENT|2021-02-07|25
e|TU|f4f1a53a-d621-4f75-b44e-96b959aed03d|1|[?]|NTIND|Non-Target Indicator|[?]|TARGET NODULE|LUNG, HILUM|BILATERAL|ANTERIOR|HEMI|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|||SPOUSE|READER|U|1|3|SCREENING|2021-01-22|23
e|TU|ed392c1a-0167-4ee9-b208-8b0c8d314bb4|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|NEW NON-TARGET|PULMONARY VALVE, LEFT CUSP|UNILATERAL|LOWER MEDIAL|ENTIRE|CELLULOSE TAPE|||STUDY SUBJECT|READER 1|Y|1|1|TREATMENT|2020-09-27|6
e|TU|679423a4-92cf-4a93-8277-282f9b43f2ed|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|BONE LESION|CORONARY ARTERY|IPSILATERAL|BASAL|ALL|STATIC PERIMETRY|||CLINICAL RESEARCH ASSOCIATE|CARDIOLOGIST|N|1|1|SCREENING|2020-10-01|69
e|TU|fb686cda-337b-46aa-b67b-790414201d9a|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|NON-TARGET NON-ENHANCING|GREATER CURVATURE OF THE STOMACH|LEFT|CRANIAL|SINGLE|ELECTROPHORESIS|||ADJUDICATION COMMITTEE|DERMATOLOGIST|N|1|4|SCREENING|2020-07-04|49
e|TU|98d3c31c-8b79-4d8a-a39e-21b0a3fa653b|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|NEW|MIDDLE PHALANX 3 OF THE HAND|CONTRALATERAL|PROXIMAL VOLAR|MULTIPLE|WESTERGREN|Y||PROXY|RATER 2|Y|1|5|SCREENING|2020-10-02|7
e|TU|92d7a180-9353-41f8-93e2-ebcee32a1c63|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|REGIONAL|HEART, LEFT VENTRICLE|IPSILATERAL|INNER|MULTIPLE|CLOT DETECTION|Y||DOMESTIC PARTNER|READER 2|NA|1|5|SCREENING|2020-12-20|24
e|TU|5da18fbc-1274-4cb3-bb6b-b57872b9815b|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|TARGET EXTRA NODAL|RADIAL NERVE|UNILATERAL|LOWER EXTENSOR SURFACE|MULTIPLE|HPLC|||INTERVIEWER|ONCOLOGIST 2|U|1|4|TREATMENT|2020-12-02|56
e|TU|aca1ac29-8b75-4362-a3fd-f42d77f9ffc0|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|LOCAL|BRAIN VENTRICLE|CONTRALATERAL|MEDIAL|ENTIRE|LIGHT MICROSCOPY||Y|PARENT|MICROSCOPIST|U|1|4|SCREENING|2020-12-21|40
e|TU|4a195822-d646-4b22-a3b9-f6642442474d|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|TARGET NODULE|MOTOR CORTEX|LEFT|APICAL|SINGLE|MAMMOGRAPHY|||SIBLING|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|Y|1|4|TREATMENT|2020-08-30|46
e|TU|515808c1-fda7-43bb-91dc-28e2d4e308cd|1|[?]|TUSPLIT|Tumor Split|[?]|NON-TARGET NODAL|PALPEBRAL CONJUNCTIVA|CONTRALATERAL|PROXIMAL VOLAR|ENTIRE|ZIEHL NEELSEN ACID FAST STAIN||Y|CLINICAL STUDY SPONSOR|MICROSCOPIST|NA|1|5|FOLLOW-UP|2020-11-01|65
e|TU|18461665-388d-403b-90e4-2b42fcb4a01a|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|LOCAL|SUBMANDIBULAR LYMPH NODE|BILATERAL|APICAL|HEMI|COMPLEMENT FIXATION||Y|CLINICAL STUDY SPONSOR|RADIOLOGIST 1|NA|1|4|FOLLOW-UP|2020-12-25|93
e|TU|c3d2c2f3-6f3e-4671-b17b-47e6809bcca0|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|TARGET NODULE|SACRUM|RIGHT|VENTRAL|MULTIPLE|SIZE EXCLUSION CHROMATOGRAPHY|Y||DOMESTIC PARTNER|READER 3|NA|1|7|TREATMENT|2020-08-26|22
e|TU|e3ce1661-1b72-4835-88d1-5a6d3655b674|1|[?]|TUMIDENT|Tumor Identification|[?]|DISTANT|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE HAND|RIGHT|FORE|ALL|AMSLER GRID|||INTERVIEWER|RADIOLOGIST 1|U|1|5|TREATMENT|2020-09-16|45
e|TU|240844e9-3dda-438e-81b2-8f6aa4e0427e|1|[?]|TUMIDENT|Tumor Identification|[?]|TARGET NODAL|BILE DUCT|LATERAL|MIDLINE|HEMI|ORCHIDOMETERY|Y||INDEPENDENT ASSESSOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|NA|1|6|SCREENING|2021-02-11|74
e|TU|fccf5c5d-deb6-4f13-a485-afcda3556578|1|[?]|TUSPLIT|Tumor Split|[?]|NEW TARGET|ASCENDING AORTA, SINOTUBULAR JUNCTION|RIGHT|DISTAL|ALL|ACCELERATOR MASS SPECTROMETRY||Y|ADJUDICATION COMMITTEE|RADIOLOGIST|Y|1|5|TREATMENT|2020-08-26|32
e|TU|94620ed0-1ae8-4fa5-a629-9210860b0be9|1|[?]|LESIDENT|Lesion Identification|[?]|NON-TARGET EXTRA NODAL|PARASPINAL REGION|RIGHT|VOLAR|SINGLE|CALCOFLUOR WHITE STAIN||Y|PROXY|DERMATOLOGIST|N|1|2|TREATMENT|2020-09-07|44
e|TU|9c3b6912-19be-435c-87fc-781a08efb847|1|[?]|TUMERGE|Tumor Merged|[?]|TARGET NODAL|PECTORALIS MAJOR MUSCLE|BILATERAL|INNER|ENTIRE|IMPEDANCE CONDUCTIVITY|||CLINICAL RESEARCH COORDINATOR|ADJUDICATOR 1|U|1|6|TREATMENT|2021-04-16|94
e|TU|171a6d85-ba2e-45da-b31b-01651b26e890|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|NEW BONE LESION|STERNUM|UNILATERAL|INTERMEDIATE|ENTIRE|DIRECT SEQUENCING|||PARENT|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|Y|1|6|WASHOUT|2020-08-15|23
e|TU|a8338164-1bb5-4474-9432-4d5a81ab30d8|1|[?]|TUMIDENT|Tumor Identification|[?]|NON-MEASURABLE|ABDUCTOR HALLUCIS MUSCLE|CONTRALATERAL|MEDIAL|ALL|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|||CLINICAL RESEARCH ASSOCIATE|NEUROLOGIST 1|N|1|5|WASHOUT|2021-01-04|35
e|TU|6d64077e-1f18-4bd6-ba86-53d90121f7a9|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|NEW BONE LESION|WRIST JOINT EXTENSOR TENDONS|LATERAL|LOWER EXTENSOR SURFACE|SEGMENT|CALCULATION||Y|CLINICAL STUDY SPONSOR|CARDIOLOGIST|NA|1|5|WASHOUT|2020-08-13|67
e|TU|91d08486-3db7-4c71-a63f-fd060f4ae1a4|1|[?]|TUMIDENT|Tumor Identification|[?]|TARGET|MASTOID PROCESS|UNILATERAL|UPPER|SEGMENT|SICKLE CELL SOLUBILITY TEST|||FRIEND|NEUROLOGIST|NA|1|7|FOLLOW-UP|2021-01-12|28
e|TU|f44ad5ae-71d0-462e-8d57-b5f8fffaf2da|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|NON-TARGET EXTRA NODAL|SPLEEN, HILUM|CONTRALATERAL|CENTRAL|ALL|HPLC/MS||Y|DOMESTIC PARTNER|PATHOLOGIST|Y|1|7|WASHOUT|2020-10-23|80
e|TU|7b8a488a-ffd8-45bd-9b6d-8c16b1f24997|1|[?]|NTIND|Non-Target Indicator|[?]|NON-TARGET EXTRA NODAL|SAPHENOUS VEIN|RIGHT|TEMPORAL|PARTIAL|CLIP|Y||PROXY|DERMATOLOGIST|U|1|3|TREATMENT|2021-03-16|76
e|TU|87998e13-813a-464d-935c-d5513cd0db5e|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|NEW NON-TARGET|SKIN OF THE FINGER|LEFT|HIND|MULTIPLE|MULTIPLE BREATH WASHOUT|||SPOUSE|NEUROLOGIST|N|1|4|TREATMENT|2020-11-09|80
e|TU|7812e96e-ea53-4eb0-8160-d4118c567c9d|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|NOT MEASURED|DISTAL COMMON BILE DUCT|RIGHT|MIDLINE|HEMI|DIRECT SEQUENCING|||PARENT|PATHOLOGIST|U|1|4|TREATMENT|2021-02-10|24
e|TU|f9c6c448-0e3d-421f-a63f-be4aeb965256|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|MEASURED|AXILLARY ARTERY|UNILATERAL|VOLAR|SINGLE|FARR ASSAY|Y||ADJUDICATOR|NEUROLOGIST 1|N|1|3|TREATMENT|2020-12-11|43
e|TU|e8da815a-b53c-46f4-a546-e8553152719f|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|BENIGN|HAND PHALANX|UNILATERAL|INNER|PARTIAL|HPLC/MS|||CAREGIVER|READER 1|N|1|1|FOLLOW-UP|2021-01-17|31
e|TU|701d794b-07b4-4394-a2a4-d31a9f5b743a|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|BENIGN|SUBCLAVIAN VEIN|CONTRALATERAL|SURFACE|SEGMENT|OPTICAL COHERENCE TOMOGRAPHY||Y|INTERVIEWER|NEUROLOGIST|NA|1|4|TREATMENT|2021-03-16|56
e|TU|45a9c2a7-3f0e-4bed-ac5b-e9ef5ba4fffd|1|[?]|NTIND|Non-Target Indicator|[?]|TARGET NODAL|GENITAL TUBERCLE|IPSILATERAL|PERIVENTRICULAR|MULTIPLE|IHC|Y|Y|VENDOR|ONCOLOGIST 2|U|1|5|FOLLOW-UP|2020-12-31|16
e|TU|060a73b7-19d8-4a73-9976-6bbc8a83a6d5|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|NEW TARGET|SUBMANDIBULAR GLAND|RIGHT|HIND|ALL|ELECTROPHORESIS|Y||GUARDIAN|INTERNIST|Y|1|5|TREATMENT|2020-09-08|39
e|TU|fe8b11f0-70b9-4c5e-8075-6cdb4dd95c5a|1|[?]|LESIDENT|Lesion Identification|[?]|LOCAL|PANCREAS, EXOCRINE|UNILATERAL|DEEP|PARTIAL|SCINTIGRAPHY||Y|STUDY SUBJECT|ADJUDICATOR 2|Y|1|4|WASHOUT|2021-03-14|81
e|TU|bb2487c3-cc05-48f8-9031-0e433c07e3d6|1|[?]|LESIDENT|Lesion Identification|[?]|MEASURED|TRICUSPID VALVE, POSTERIOR ANNULUS|RIGHT|SURFACE|MULTIPLE|HPLC/IEX||Y|PARENT|ONCOLOGIST 2|NA|1|1|TREATMENT|2021-01-20|62
e|TU|2661da18-b539-49d8-ac80-9da03c127d21|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|DISEASE SITE|SACRUM|RIGHT|ANTEROPOSTERIOR|ENTIRE|PHASE CONTRAST MICROSCOPY|||SIGNIFICANT OTHER|RADIOLOGIST 1|Y|1|4|FOLLOW-UP|2020-10-07|83
e|TU|f1835786-c567-4235-9bd1-f7ffcec12741|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|NON-MEASURABLE|RAPHE|LEFT|FRONTAL|HEMI|ANTIMICROBIAL COMBINATION TESTING|||CLINICAL RESEARCH ASSOCIATE|FORENSIC PATHOLOGIST|N|1|2|TREATMENT|2020-08-16|20
e|TU|019eb415-1da3-40fa-b4ba-b1f381ec3cac|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|NEW NON-TARGET|ILIOPSOAS MUSCLE|RIGHT|BASAL|PARTIAL|CONTRAST ENHANCED PET SCAN|||CLINICAL RESEARCH COORDINATOR|RADIOLOGIST 2|N|1|2|SCREENING|2020-08-15|46
e|TU|2506c6e2-018f-4300-b3b5-44ff8d6e13df|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|MEASURED|ANTERIOR TIBIAL VEIN|UNILATERAL|LOWER MEDIAL|HEMI|CINEANGIOGRAPHY||Y|CLINICAL STUDY SPONSOR|OPTOMETRIST|Y|1|7|WASHOUT|2020-09-20|69
e|TU|65c439f8-9658-4ac5-9eae-0837182a90fd|1|[?]|LESIDENT|Lesion Identification|[?]|NON-TARGET ENHANCING|LUNG, RIGHT, INFERIOR LOBE, MEDIAL BASAL SEGMENT|UNILATERAL|FORE|SEGMENT|MICROPARTICLE ENZYME IMMUNOASSAY|||INTERVIEWER|READER|N|1|2|WASHOUT|2020-07-05|41
e|TU|5b73ad4c-bb28-47d1-a2f6-8508444059a5|1|[?]|LESIDENT|Lesion Identification|[?]|NEW TARGET|DISTAL RIGHT CORONARY ARTERY CONDUIT|LEFT|INTERMEDIATE|SINGLE|EEG||Y|NON-HEALTH CARE PROFESSIONAL|ADJUDICATOR|N|1|6|TREATMENT|2020-06-12|10
e|TU|16dcaefa-701c-4863-b010-8ac640aeb55a|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|TARGET NODULE|LACRIMAL BONE|CONTRALATERAL|DORSOLATERAL|ALL|SIZE EXCLUSION CHROMATOGRAPHY|||SIBLING|HEMATOLOGIST|Y|1|1|TREATMENT|2020-08-26|80
e|TU|4c19e870-9195-41d8-9c8a-8a54bb428732|1|[?]|TUMIDENT|Tumor Identification|[?]|TARGET NODAL|ELBOW FLEXOR MUSCLES|RIGHT|FACIAL|HEMI|TARGETED TRANSCRIPTOME SEQUENCING||Y|INTERVIEWER|NEUROLOGIST|N|1|3|FOLLOW-UP|2020-10-18|86
e|TU|7682184f-0801-4315-9c5f-116f7321a2b0|1|[?]|TUMIDENT|Tumor Identification|[?]|BONE LESION|CAUDATE NUCLEUS|LEFT|FORE|MULTIPLE|LIQUID SCINTILLATION COUNTING|Y||NON-HEALTH CARE PROFESSIONAL|READER 2|U|1|3|WASHOUT|2021-01-29|48
e|TU|c40f9cb3-b597-4614-8ba5-d40849030ff9|1|[?]|LESIDENT|Lesion Identification|[?]|DISTANT|WRIST JOINT EXTENSOR TENDONS|LEFT|SUPERIOR|SINGLE|KINYOUN STAIN|||PARENT|RATER|N|1|7|FOLLOW-UP|2021-02-04|64
e|TU|5e850a5f-cfce-4bdd-a8f2-22996b8a6a64|1|[?]|TUSPLIT|Tumor Split|[?]|NOT MEASURED|EYE, ANTERIOR CHAMBER|LATERAL|SUBCORTICAL|SINGLE|OBSERVATION|||SPOUSE|MICROSCOPIST 3|NA|1|3|TREATMENT|2020-11-30|92
e|TU|c9308aa7-f38f-4b54-a919-d3f893b18cd1|1|[?]|LESIDENT|Lesion Identification|[?]|BENIGN|T1 VERTEBRA|UNILATERAL|TEMPORAL|SEGMENT|LIGHT MICROSCOPY|Y|Y|FAMILY MEMBER|ONCOLOGIST 2|U|1|2|TREATMENT|2020-11-22|25
e|TU|e7cfb803-a0be-4020-9982-e0c3cdd90cd1|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|NON-TARGET|RIGHT CORONARY ARTERY OSTIUM|LATERAL|LOWER EXTENSOR SURFACE|SEGMENT|GRAM STAIN|||ADJUDICATOR|NEUROLOGIST|NA|1|1|TREATMENT|2020-10-04|53
e|TU|3da865e8-9680-4112-b6d3-1f5763cfdaae|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|LOCAL|BREAST|UNILATERAL|TEMPORAL|PARTIAL|CLINICAL EVALUATION||Y|NON-HEALTH CARE PROFESSIONAL|PATHOLOGIST 1|NA|1|5|TREATMENT|2021-03-03|52
e|TU|60afc3a3-56b7-4988-9006-e12f3bc1097c|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|NON-TARGET NON-ENHANCING|SACRUM|BILATERAL|ROSTRAL|PARTIAL|THICK SMEAR||Y|INDEPENDENT ASSESSOR|OPTOMETRIST|U|1|4|TREATMENT|2020-11-09|95
e|TU|440119fb-ad46-4348-b236-8e2979c7bf2e|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|TARGET EXTRA NODAL|PROXIMAL INTERPHALANGEAL JOINT 2 OF THE HAND|UNILATERAL|SUBCORTICAL|ENTIRE|KLEIHAUER-BETKE|Y||SIGNIFICANT OTHER|DERMATOLOGIST|U|1|1|TREATMENT|2021-01-14|39
e|TU|af45a9de-c8aa-4602-8e3b-d16998740ebd|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|TARGET NODAL|COLON, SIGMOID|CONTRALATERAL|SUBCORTICAL|ENTIRE|HPLC-FL|Y||DOMESTIC PARTNER|RADIOLOGIST|U|1|2|TREATMENT|2020-06-25|20
e|TU|23306866-3fcb-418d-861b-de3bd779260d|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|NON-MEASURABLE|SALIVARY GLAND|LATERAL|APICAL|SINGLE|NUCLEIC ACID HYBRIDIZATION|||PARENT|PATHOLOGIST 2|Y|1|5|SCREENING|2020-09-17|64
e|TU|144d2eb9-d79a-4a61-91f5-6a807832d8ca|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|REGIONAL|BRAIN VENTRICLE, LATERAL|CONTRALATERAL|ANTEROMEDIAL|SEGMENT|ETDRS EYE CHART|Y||CAREGIVER|OPTOMETRIST|Y|1|2|TREATMENT|2020-10-22|89
e|TU|92855d33-eee6-449f-a9e6-c06a1532571f|1|[?]|TUMIDENT|Tumor Identification|[?]|UNKNOWN|PELVIS|RIGHT|OUTER|SEGMENT|NEXT GENERATION TARGETED SEQUENCING|||CLINICAL STUDY SPONSOR|ONCOLOGIST 1|N|1|2|SCREENING|2021-01-23|65
e|TU|0204e2fc-bc80-44cd-a749-90c1bf21a2bb|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|LOCAL|ILEUM LYMPH NODE|RIGHT|APICAL|HEMI|WHOLE GENOME SEQUENCING|Y||INVESTIGATOR|HEMATOLOGIST|U|1|2|TREATMENT|2021-02-08|20
e|TU|40cb9bc3-abec-4158-bdee-becdeceba727|1|[?]|TUMERGE|Tumor Merged|[?]|BONE LESION|ILIAC LYMPH NODE|CONTRALATERAL|BASAL|ENTIRE|ALCIAN BLUE STAIN|||PARENT|MICROSCOPIST 2|N|1|7|TREATMENT|2020-11-01|23
e|TU|f4dbdcd5-52ca-498c-b72a-1c0209c9a286|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|NON-TARGET EXTRA NODAL|INTERNAL MAMMARY LYMPH NODE|RIGHT|SURFACE|SEGMENT|FLUORESCENT ENZYME IMMUNOASSAY|Y|Y|PROXY|READER 2|U|1|4|WASHOUT|2020-12-18|72
e|TU|616b284a-3fed-4009-bafe-7da10acd537e|1|[?]|TUMERGE|Tumor Merged|[?]|BONE LESION|HEART, RIGHT ATRIAL APPENDAGE|BILATERAL|CRANIAL|HEMI|LANDOLT RING|Y|Y|INVESTIGATOR|PATHOLOGIST 2|N|1|2|FOLLOW-UP|2020-11-15|83
e|TU|d39b53da-187f-4da6-9614-2bd301e9ad05|1|[?]|TUMIDENT|Tumor Identification|[?]|MEASURED|PANCREAS, ENDOCRINE|CONTRALATERAL|INNER|SEGMENT|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|||CLINICAL STUDY SPONSOR|PATHOLOGIST 2|NA|1|3|WASHOUT|2020-11-12|51
e|TU|c2a43fc4-83c4-4522-b3b2-d4cb1a92a4b7|1|[?]|TUMERGE|Tumor Merged|[?]|LOCATION OF INTEREST|PORTAL VEIN BIFURCATION|BILATERAL|APICAL|SINGLE|KINETIC CHROMOGENIC ASSAY|||SPOUSE|RADIOLOGIST|N|1|3|TREATMENT|2021-02-26|94
e|TU|e51cf168-af89-44d9-9e56-14785071f6b0|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|NEW BONE LESION|BUCCAL LYMPH NODE|LATERAL|VENTROLATERAL|PARTIAL|FLOW MICROSCOPY|||SIBLING|MICROSCOPIST 3|N|1|2|TREATMENT|2021-02-05|80
e|TU|8416f8c6-d0e4-43fc-9a66-6a916e853e87|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|NON-TARGET NODAL|JUGULAR VEIN|BILATERAL|NASAL|SEGMENT|CLOT DETECTION|||NON-HEALTH CARE PROFESSIONAL|NEUROLOGIST 1|NA|1|3|SCREENING|2020-08-08|66
e|TU|a110e924-90a1-4e84-b47a-410f800fa201|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|MEASURED|SKIN OF THE SOLE|IPSILATERAL|ANTEROMEDIAL|MULTIPLE|CENTRIFUGATION|||INVESTIGATOR|RATER|Y|1|6|TREATMENT|2021-01-02|75
e|TU|40681cb8-5d49-4e1d-b893-f5fad62a0885|1|[?]|TUSPLIT|Tumor Split|[?]|NEW|CERVICAL VERTEBRA|BILATERAL|TEMPORAL|HEMI|ACRIDINE ORANGE STAIN|||SIGNIFICANT OTHER|OPTOMETRIST|N|1|3|WASHOUT|2020-11-05|99
e|TU|7a7dd1e0-46b7-4a46-bbde-601c5ee3ceeb|1|[?]|LESIDENT|Lesion Identification|[?]|NON-TARGET ENHANCING|SKIN OF THE PALM|LEFT|APICAL|PARTIAL|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|||ADJUDICATION COMMITTEE|OPHTHALMOLOGIST|NA|1|1|TREATMENT|2021-03-12|95
e|TU|96e65c5c-723c-42d9-8e88-0bcb600e9f88|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|NEW BONE LESION|THORACIC ARTERY|LEFT|APICAL|SINGLE|FLUORESCENT MICROSCOPY|||CLINICAL RESEARCH COORDINATOR|MICROSCOPIST|Y|1|1|FOLLOW-UP|2020-09-30|30
e|TU|eaf1edbe-1848-4614-b7b1-dcbcba5f0a15|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|NON-MEASURABLE|PANCREATIC DUCT|IPSILATERAL|MEDIAL|HEMI|CALCOFLUOR WHITE STAIN|||SIGNIFICANT OTHER|OTOLARYNGOLOGIST|NA|1|2|TREATMENT|2020-09-14|74
e|TU|f81742a2-5250-43d7-a6e2-8fcb1625a114|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|NON-TARGET EXTRA NODAL|CLAW|CONTRALATERAL|LOWER MEDIAL|HEMI|OSCILLOMETRY||Y|DOMESTIC PARTNER|RADIOLOGIST|U|1|2|TREATMENT|2020-06-05|16
e|TU|c6bad1d0-3514-4f98-b229-d093a94dfbc4|1|[?]|TUMERGE|Tumor Merged|[?]|NON-TARGET NODAL|INTERPHALANGEAL JOINT 2|LEFT|LOWER|SINGLE|NUCLEIC ACID AMPLIFICATION TEST|Y||GUARDIAN|NEUROLOGIST 2|NA|1|3|FOLLOW-UP|2020-09-11|89
e|TU|84d68bcc-dc7a-4366-9630-40ce8885351d|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|MEASURED|ANTERIOR SUPERIOR ILIAC SPINE|LEFT|OCCIPITAL|MULTIPLE|SPIRAL CT|||CLINICAL STUDY SPONSOR|PATHOLOGIST 1|N|1|4|WASHOUT|2020-08-10|65
e|TU|517f3930-5202-4e0a-b3e1-85ed4bd7e117|1|[?]|NTIND|Non-Target Indicator|[?]|REGIONAL|LUNG, LEFT, INFERIOR LOBE, MEDIAL BASAL SEGMENT|IPSILATERAL|INTERMEDIATE|HEMI|FLUORESCENT SPOT TEST||Y|SIGNIFICANT OTHER|RADIOLOGIST 2|N|1|4|TREATMENT|2021-02-20|53
e|TU|edd73650-27bb-474f-bab7-d2c3d57b2dc4|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|BENIGN|MIDDLE PHALANX 5 OF THE HAND|UNILATERAL|NASAL|PARTIAL|IMMUNOCHROMATOGRAPHY|||SIBLING|PATHOLOGIST|N|1|3|TREATMENT|2021-03-12|91
e|TU|98737dfa-0058-4420-a515-38526f01f90d|1|[?]|LESIDENT|Lesion Identification|[?]|NEW NON-TARGET|DISTAL COMMON BILE DUCT|LEFT|UPPER EXTENSOR SURFACE|ALL|ECHOCARDIOGRAPHY||Y|INTERVIEWER|READER 1|NA|1|3|TREATMENT|2020-10-07|38
e|TU|e713c631-cdd8-428f-a3a6-0195f6fb80b4|1|[?]|TUSPLIT|Tumor Split|[?]|LOCOREGIONAL|CORONARY ARTERY, LEFT|CONTRALATERAL|PERIPHERAL|ALL|HANSEL STAIN|Y|Y|STUDY SUBJECT|ONCOLOGIST 1|Y|1|5|TREATMENT|2020-10-07|14
e|TU|a3964bed-1273-4bce-bbb4-b8d768b30aa3|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|DISTANT|SKIN AROUND THE MOUTH|RIGHT|PERIPHERAL|SEGMENT|VIRUS PLAQUE ASSAY|||INTERVIEWER|PATHOLOGIST 1|U|1|4|TREATMENT|2020-09-28|18
e|TU|b77116ca-2b32-411f-a0ff-fa70d74eb4bd|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|NEW BONE LESION|DISTAL INTERPHALANGEAL JOINT 5 OF THE HAND|LEFT|ANTEROMEDIAL|PARTIAL|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|||CLINICAL RESEARCH COORDINATOR|ONCOLOGIST 1|U|1|7|FOLLOW-UP|2021-01-15|35
e|TU|cedc258a-b0e3-4590-afe1-9ed2b6ba28bc|1|[?]|LESIDENT|Lesion Identification|[?]|NON-TARGET EXTRA NODAL|RETROCRURAL LYMPH NODE|RIGHT|PERIPHERAL|MULTIPLE|MAGNETIC RESONANCE ELASTOGRAPHY|||CAREGIVER|MICROSCOPIST 1|U|1|7|FOLLOW-UP|2020-08-01|63
e|TU|597ff319-c16e-4aae-a7d9-ed2bc25684dc|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|NON-TARGET ENHANCING|ILIAC VEIN|LEFT|VENTROLATERAL|MULTIPLE|MALDI|||FAMILY MEMBER|HEMATOLOGIST|Y|1|4|TREATMENT|2020-06-24|37
e|TU|7d845e3e-8bd1-4647-a3e8-352a52b585cb|1|[?]|TUMERGE|Tumor Merged|[?]|NEW NON-TARGET|URETHRA|LEFT|PARIETO-OCCIPITAL|PARTIAL|NO INFORMATION|||INTERVIEWER|INTERNIST|Y|1|4|TREATMENT|2021-01-12|75
e|TU|7e9f4283-f90b-4f74-939c-b42648e8373c|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|LOCAL|POPLITEAL FOSSA|CONTRALATERAL|FORE|SEGMENT|DOPPLER ULTRASOUND|||NON-HEALTH CARE PROFESSIONAL|ONCOLOGIST|NA|1|2|WASHOUT|2021-02-19|76
e|TU|20a637e6-83d2-4a86-9ecc-8ddb0523997f|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|NON-TARGET NON-ENHANCING|MEDIAN NERVE|LATERAL|APICAL|HEMI|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|Y||ADJUDICATOR|MICROSCOPIST 2|U|1|7|TREATMENT|2020-11-16|26
e|TU|29b5d32c-0c0e-42b2-8dfd-ff92a7a6229e|1|[?]|NTIND|Non-Target Indicator|[?]|REGIONAL|PERICARDIUM|UNILATERAL|OUTER|ALL|PELLI-ROBSON EYE CHART|||PARENT|MICROSCOPIST 2|Y|1|3|TREATMENT|2020-06-01|26
e|TU|595aa95c-4378-47c1-96e9-5512d08fb653|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|NON-TARGET|LACRIMAL GLAND|LEFT|VENTROLATERAL|PARTIAL|DYNAMIC LIGHT SCATTERING|||ADJUDICATOR|PATHOLOGIST|NA|1|2|WASHOUT|2020-09-01|19
e|TU|b528dc24-e791-41b1-95b3-fc0be18da47f|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|NEW|CEREBRAL HEMISPHERE, RIGHT|RIGHT|PARIETO-OCCIPITAL|SINGLE|BIOIMPEDANCE SPECTROSCOPY|||INDEPENDENT ASSESSOR|CLINICAL PATHOLOGIST|Y|1|7|TREATMENT|2021-03-07|80
e|TU|7a43c892-0e7f-4f33-9130-e175e475531f|1|[?]|TUMIDENT|Tumor Identification|[?]|NEW BONE LESION|RADIUS|CONTRALATERAL|ANTERIOR|PARTIAL|LIGHT SCATTERING SPECTROSCOPY|||ADJUDICATION COMMITTEE|RADIOLOGIST 1|Y|1|4|TREATMENT|2020-08-13|98
e|TU|8cce3de1-e56d-4c2c-9b45-cdf1f226dc5e|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|NEW NON-TARGET|DISTAL INTERPHALANGEAL JOINT 5|LATERAL|SUBCORTICAL|PARTIAL|NEXT GENERATION SEQUENCING|Y|Y|CAREGIVER|RADIOLOGIST 2|NA|1|5|SCREENING|2021-02-02|64
e|TU|bde9096e-9ab9-45fe-8e96-1ec9762824a0|1|[?]|TUMIDENT|Tumor Identification|[?]|NEW TARGET|COMMON ILIAC LYMPH NODE|CONTRALATERAL|SUBCORTICAL|HEMI|SURFACE PLASMON RESONANCE|Y||ADJUDICATOR|RATER 2|Y|1|6|FOLLOW-UP|2020-08-23|6
e|TU|ea7907aa-811e-48ec-9fc6-ab8affde8913|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|BONE LESION|PROXIMAL INTERPHALANGEAL JOINT 2 OF THE FOOT|UNILATERAL|INTERMEDIATE|SEGMENT|THERMAL IONIZATION MASS SPECTROMETRY|Y||FAMILY MEMBER|RADIOLOGIST 1|N|1|4|FOLLOW-UP|2020-08-21|64
e|TU|3aa9935c-943d-406a-bb6e-fc067fa8a487|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|UNKNOWN|FINGER EXTENSOR MUSCLES|CONTRALATERAL|ANTERIOR|PARTIAL|TRANSVAGINAL ULTRASOUND|||FAMILY MEMBER|PATHOLOGIST 1|Y|1|5|SCREENING|2020-10-08|52
e|TU|0cac2007-ca12-45ba-9b1c-70f753232f05|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|TARGET NODULE|VERTEBRAL COLUMN|RIGHT|MIDLINE|MULTIPLE|FLAME PHOTOMETRY|||STUDY SUBJECT|ENDOCRINOLOGIST|U|1|6|FOLLOW-UP|2021-01-23|63
e|TU|2339e91a-b93e-426f-9b60-3d3b6969268d|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|NON-TARGET ENHANCING|LOWER GASTROINTESTINAL TRACT LYMPH NODE|BILATERAL|ANTERIOR|SEGMENT|GC/MS/MS||Y|SIGNIFICANT OTHER|RATER 1|N|1|2|TREATMENT|2020-07-01|4
e|TU|0d09e35b-e864-4492-a341-21c71d92b551|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|MEASURED|LUNATE BONE|LEFT|PERIVENTRICULAR|SINGLE|BRDU CELLULAR PROLIFERATION ASSAY|||SIGNIFICANT OTHER|FORENSIC PATHOLOGIST|Y|1|3|FOLLOW-UP|2020-11-30|41
e|TU|0f8b5d32-6c34-4ea3-bab7-816c1d755ffd|1|[?]|NTIND|Non-Target Indicator|[?]|TARGET EXTRA NODAL|BASILIC VEIN|RIGHT|MEDIAL|SINGLE|DUKE INCISION METHOD|||ADJUDICATOR|OTOLARYNGOLOGIST|N|1|2|FOLLOW-UP|2020-08-15|81
e|TU|0a5b1036-cd00-4221-b218-ee2664e5a43e|1|[?]|TUMERGE|Tumor Merged|[?]|MEASURED|DORSALIS PEDIS ARTERY|BILATERAL|INFERIOR|SINGLE|ZIEHL NEELSEN ACID FAST STAIN|||CLINICAL STUDY SPONSOR|MICROSCOPIST 2|NA|1|1|TREATMENT|2021-02-09|48
e|TU|a4f74465-7abc-4cc2-a0be-25d1c802af8c|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|BENIGN|PULMONARY ARTERY BRANCH|CONTRALATERAL|DEEP|HEMI|CLINICAL EVALUATION|||INVESTIGATOR|RATER|U|1|5|TREATMENT|2020-11-05|46
e|TU|2d38f416-c40c-41a1-a4be-bcbfa4a97ad9|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|LOCAL|METACARPOPHALANGEAL JOINT 2|LEFT|ANTEROTEMPORAL|MULTIPLE|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|||CLINICAL STUDY SPONSOR|OTOLARYNGOLOGIST|U|1|5|SCREENING|2021-01-07|66
e|TU|e7262592-01e8-4cb3-b967-ec1037505e81|1|[?]|NTIND|Non-Target Indicator|[?]|TARGET|LATERAL FIRST DIAGONAL BRANCH ARTERY|BILATERAL|ANTERIOR|SINGLE|ACCELERATOR MASS SPECTROMETRY|Y||FRIEND|ADJUDICATOR|NA|1|4|SCREENING|2020-11-14|73
e|TU|bf150829-1b25-418a-9bc6-61716984387c|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|DISEASE SITE|COLON, TRANSVERSE|UNILATERAL|UPPER EXTENSOR SURFACE|HEMI|TONOMETRY|Y||FAMILY MEMBER|ADJUDICATOR|NA|1|3|TREATMENT|2020-08-31|87
e|TU|5c1cc260-97a0-493c-bc11-57f31ffd7455|1|[?]|TUMIDENT|Tumor Identification|[?]|LOCAL|BRAIN VENTRICLE|IPSILATERAL|PERIVENTRICULAR|ENTIRE|LISSAMINE GREEN STAIN|||NON-HEALTH CARE PROFESSIONAL|ENDOCRINOLOGIST|N|1|7|TREATMENT|2020-10-27|61
e|TU|cca2835b-ca8d-4db6-89b4-9f2855968a8a|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|BONE LESION|DISTAL RIGHT CORONARY ARTERY CONDUIT|UNILATERAL|LOWER FLEXOR SURFACE|ALL|ANTIMICROBIAL COMBINATION TESTING|||INVESTIGATOR|DERMATOLOGIST|Y|1|5|TREATMENT|2020-09-02|55
e|TU|420e3ac1-ba3f-4baf-bcfb-121c0fdc947e|1|[?]|TUMIDENT|Tumor Identification|[?]|NON-TARGET|CHOROID|UNILATERAL|ANTERIOR|ALL|FLUORESCENCE ANGIOGRAPHY|||SPOUSE|READER 2|U|1|5|TREATMENT|2020-12-06|70
e|TU|74cd0a4f-f9fe-4df9-93b8-7832512d0828|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|NON-TARGET NODAL|INTERPHALANGEAL JOINT 5|BILATERAL|SUPERIOR|PARTIAL|QUANTITATIVE COMPUTED TOMOGRAPHY|||FAMILY MEMBER|PATHOLOGIST 2|N|1|6|WASHOUT|2020-06-20|46
e|TU|09238251-feaf-45a9-b295-dfed9a75fbb2|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|NON-TARGET|CIRCUMFLEX, OBTUSE MARGINALS, LEFT POSTEROLATERAL AND LEFT POSTERIOR DESCENDING ARTERY BRANCHES|UNILATERAL|UPPER FLEXOR SURFACE|SINGLE|IMMUNOCHEMILUMINOMETRIC ASSAY|||INDEPENDENT ASSESSOR|READER 1|NA|1|4|TREATMENT|2020-07-07|21
e|TU|3e896568-85dc-4a14-ba41-eb3575940a9d|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|NON-MEASURABLE|PANCREAS, EXOCRINE|LEFT|SURFACE|ENTIRE|ORCHIDOMETERY||Y|NON-HEALTH CARE PROFESSIONAL|FORENSIC PATHOLOGIST|Y|1|6|TREATMENT|2021-02-02|17
e|TU|7e759204-4cf5-49fb-9d9e-82e0199c7ccc|1|[?]|NTIND|Non-Target Indicator|[?]|NEW BONE LESION|INTERNAL ILIAC ARTERY|BILATERAL|FRONTAL|SEGMENT|IRON HEMATOXYLIN STAIN||Y|INTERVIEWER|CLINICAL PATHOLOGIST|N|1|7|TREATMENT|2020-12-09|58
e|TU|725c5a91-72b0-4b2c-a51a-d1006303373e|1|[?]|LESIDENT|Lesion Identification|[?]|DISTANT|ABDOMINAL CAVITY|LEFT|SUPERFICIAL|HEMI|CHROMATOGRAPHY|Y|Y|STUDY SUBJECT|ENDOCRINOLOGIST|NA|1|3|SCREENING|2020-12-06|23
e|TU|5bf5b31d-a59d-46b7-8f8f-97919d449565|1|[?]|TUMERGE|Tumor Merged|[?]|UNKNOWN|PREPUTIAL GLAND|BILATERAL|TIP|MULTIPLE|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|Y||STUDY SUBJECT|MICROSCOPIST|NA|1|6|TREATMENT|2021-01-28|37
e|TU|7fc35880-1672-4e64-ba3b-aa3f1e42764b|1|[?]|TUSPLIT|Tumor Split|[?]|NON-TARGET|OVARIAN FOLLICLE|RIGHT|ANTERIOR|HEMI|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|||CLINICAL STUDY SPONSOR|PATHOLOGIST 2|U|1|7|FOLLOW-UP|2020-05-26|10
e|TU|f093c85b-c6bc-414d-a6e3-a8dcb33226ff|1|[?]|TUMIDENT|Tumor Identification|[?]|NON-TARGET NODAL|LEFT MAIN CORONARY ARTERY BIFURCATION|CONTRALATERAL|PARIETO-OCCIPITAL|PARTIAL|NUCLEIC ACID HYBRIDIZATION|||DOMESTIC PARTNER|READER 2|N|1|4|TREATMENT|2020-12-19|76
e|TU|f8878ffd-67af-414c-b346-596dbec640cf|1|[?]|LESIDENT|Lesion Identification|[?]|TARGET NODAL|FINGERNAIL|LEFT|SURFACE|HEMI|NUCLEIC ACID BASED METHOD||Y|DOMESTIC PARTNER|DEVELOPMENTAL PSYCHOLOGIST|U|1|4|TREATMENT|2021-01-15|21
e|TU|d8212248-cd8c-4404-8ad8-2c89c05bee9e|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|NON-MEASURABLE|METACARPOPHALANGEAL JOINT 2|UNILATERAL|OUTER|ALL|BIOPSY|||ADJUDICATION COMMITTEE|MICROSCOPIST 2|Y|1|7|TREATMENT|2020-05-28|27
e|TU|ea9c56ad-d69c-47c2-b486-65ce91e1f60d|1|[?]|TUMERGE|Tumor Merged|[?]|NON-TARGET|EXTRAOCULAR MUSCLE|IPSILATERAL|CRANIAL|HEMI|DUCTOGRAPHY|||FRIEND|READER|NA|1|5|WASHOUT|2020-09-19|89
e|TU|b832144e-88c4-4ad6-b173-abac7802a36c|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|NOT MEASURED|CLAW|LEFT|LATERAL|ALL|REFLECTANCE SPECTROSCOPY|||HEALTH CARE PROFESSIONAL|READER 1|U|1|6|TREATMENT|2021-01-12|8
e|TU|6acacd87-c487-401c-8888-76ccf97b640d|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|DISTANT|SARTORIUS MUSCLE|LATERAL|SUPERFICIAL|SINGLE|TRYPAN BLUE STAIN||Y|FRIEND|PATHOLOGIST|N|1|4|TREATMENT|2020-05-23|8
e|TU|3e9b342f-56c3-45cb-9b9f-5b6e5f555bdf|1|[?]|TUSPLIT|Tumor Split|[?]|NON-TARGET EXTRA NODAL|OVARY|LATERAL|INNER|PARTIAL|CARDIAC THERMODILUTION|||NON-HEALTH CARE PROFESSIONAL|ADJUDICATOR 3|NA|1|4|WASHOUT|2020-07-11|5
e|TU|73988e01-56c0-4b31-84e2-c23ce0bac5ac|1|[?]|TUMIDENT|Tumor Identification|[?]|NON-TARGET EXTRA NODAL|OCULOMOTOR NERVE|IPSILATERAL|LATERAL|PARTIAL|WEBER GREEN STAIN||Y|DOMESTIC PARTNER|MICROSCOPIST 1|NA|1|5|TREATMENT|2021-03-15|81
e|TU|0670f6a3-18c9-4027-91c1-56f5555589a8|1|[?]|TUMIDENT|Tumor Identification|[?]|NEW NON-TARGET|ORBIT|LEFT|SUPERIOR|ENTIRE|SICKLE CELL SOLUBILITY TEST|||CLINICAL RESEARCH COORDINATOR|READER 1|U|1|7|WASHOUT|2020-05-26|23
e|TU|59179734-8784-4a88-aa6b-51b6082ffc1b|1|[?]|NTIND|Non-Target Indicator|[?]|UNKNOWN|ABDOMINAL SKIN|CONTRALATERAL|DORSAL|HEMI|MAPH|||NON-HEALTH CARE PROFESSIONAL|CLINICAL PATHOLOGIST|Y|1|2|TREATMENT|2020-08-31|30
e|TU|ef21c401-3b32-478b-9a7d-e25ccc3e3c60|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|DISEASE SITE|DISTAL INTERPHALANGEAL JOINT 5|IPSILATERAL|ANTERIOR|ENTIRE|HIGH LEVEL AMINOGLYCOSIDE SCREEN|||ADJUDICATOR|CARDIOLOGIST|Y|1|2|TREATMENT|2020-08-16|4
e|TU|01c642f8-48ef-4375-aa2b-d0940b74e580|1|[?]|LESIDENT|Lesion Identification|[?]|NON-TARGET NODAL|DISTAL PHALANX 4 OF THE HAND|BILATERAL|SUBCORTICAL|HEMI|GC/FID|Y||INTERVIEWER|HEMATOLOGIST|Y|1|2|TREATMENT|2020-10-31|52
e|TU|c0e7028c-6f5c-410a-afde-e56af2177983|1|[?]|TUMIDENT|Tumor Identification|[?]|NON-TARGET NON-ENHANCING|UVEA|LEFT|SUPERIOR|SEGMENT|PALPATION|||VENDOR|NEUROLOGIST|Y|1|4|TREATMENT|2020-06-30|4
e|TU|eba928ed-9434-4e75-b49d-169298f966e1|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|BENIGN|GLUTEAL MUSCLE|LATERAL|ANTERIOR|PARTIAL|FLOW CYTOMETRY|||INDEPENDENT ASSESSOR|NEUROLOGIST|NA|1|6|TREATMENT|2020-08-17|15
e|TU|4772aa80-2097-4867-a549-b6f9b140f141|1|[?]|NTIND|Non-Target Indicator|[?]|UNKNOWN|MITRAL VALVE|RIGHT|VOLAR|ALL|ELECTROMYOGRAPHY|||ADJUDICATOR|FORENSIC PATHOLOGIST|U|1|1|SCREENING|2020-09-19|79
e|TU|74acb1a5-6dab-4b9e-ac7b-d242bdd44d26|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|NON-TARGET EXTRA NODAL|GASTROESOPHAGEAL JUNCTION|LEFT|VENTRAL|SINGLE|MRI|||PROXY|ONCOLOGIST 2|N|1|5|SCREENING|2020-07-14|47
e|TU|4d8dd0d0-407d-4374-8345-c11f30603273|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|NON-TARGET EXTRA NODAL|ANTERIOR INFERIOR CEREBELLAR ARTERY|IPSILATERAL|OCCIPITAL|ENTIRE|GIEMSA STAIN|||SPOUSE|UROLOGIST|Y|1|3|TREATMENT|2020-12-27|5
e|TU|6996077b-556a-47b9-bbff-20c1b4df35ea|1|[?]|TUMIDENT|Tumor Identification|[?]|NOT MEASURED|MIDDLE PHALANX 4 OF THE HAND|CONTRALATERAL|LOWER EXTENSOR SURFACE|PARTIAL|CONFOCAL MICROSCOPY|||CAREGIVER|MICROSCOPIST 2|Y|1|7|TREATMENT|2020-09-05|99
e|TU|d79d31c5-d51a-46a7-b22c-20d6d483f46e|1|[?]|NTIND|Non-Target Indicator|[?]|NON-TARGET NODAL|PERONEAL ARTERY|LEFT|LOWER|SEGMENT|RYAN BLUE STAIN|||SIBLING|ENDOCRINOLOGIST|U|1|7|TREATMENT|2020-11-01|19
e|TU|738d539e-a810-4207-8904-fc6a5d055424|1|[?]|TUMIDENT|Tumor Identification|[?]|TARGET|SACRAL TUBEROSITY|LEFT|BASAL|ENTIRE|FLUORIMETRY|||CLINICAL STUDY SPONSOR|ADJUDICATOR 2|U|1|5|WASHOUT|2021-03-29|90
e|TU|95e3cff6-3c61-4e31-97ff-cfcbe1cab4f7|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|TARGET NODULE|BICEPS FEMORIS MUSCLE|CONTRALATERAL|CENTRAL|SEGMENT|FARNSWORTH-MUNSELL 100 HUE TEST|||CAREGIVER|DERMATOLOGIST|N|1|1|TREATMENT|2020-10-10|70
e|TU|20841d37-0444-4d1d-b934-1e805cdacdaf|1|[?]|NTIND|Non-Target Indicator|[?]|LOCAL|RENAL ARTERY|LEFT|VENTROLATERAL|SINGLE|PELLI-ROBSON EYE CHART|||VENDOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|Y|1|2|TREATMENT|2021-01-20|69
e|TU|a96323a5-4d4f-4ea4-b3da-89b8cca46ee0|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|NEW NON-TARGET|RENAL ARTERY|LATERAL|FACIAL|SINGLE|CENTRIFUGATION|||CLINICAL RESEARCH ASSOCIATE|ENDOCRINOLOGIST|Y|1|3|TREATMENT|2021-01-11|81
e|TU|d74682f1-824e-449d-bdf1-db517d8fdf2e|1|[?]|NTIND|Non-Target Indicator|[?]|NOT MEASURED|BUTTOCK|UNILATERAL|ANTEROLATERAL|ENTIRE|OPHTHALMOSCOPY|Y||INDEPENDENT ASSESSOR|NEUROLOGIST|NA|1|7|WASHOUT|2020-09-30|63
e|TU|a3c226dc-d8f4-4fbc-b840-f1dc1b2680dd|1|[?]|NTIND|Non-Target Indicator|[?]|TARGET EXTRA NODAL|BRACHIAL ARTERY|RIGHT|DORSOLATERAL|MULTIPLE|SINGLE-MOLECULE ARRAY|||GUARDIAN|PATHOLOGIST|Y|1|5|TREATMENT|2020-12-02|5
e|TU|33cc0c60-b4f3-4b6c-9c7f-a4b0f536b0ac|1|[?]|NTIND|Non-Target Indicator|[?]|NON-TARGET EXTRA NODAL|INTRATHORACIC LYMPH NODE|BILATERAL|PERIPHERAL|HEMI|INTRAVASCULAR ULTRASOUND|||INTERVIEWER|PEDIATRIC NEUROLOGIST|U|1|6|TREATMENT|2020-07-07|15
e|TU|94c7f1e8-9703-4376-9cb2-6a1344dbf8cd|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|NON-MEASURABLE|LIVER, CAUDATE LOBE|LATERAL|CENTRAL|ALL|OPHTHALMOSCOPY||Y|VENDOR|ADJUDICATOR 3|N|1|5|TREATMENT|2020-12-21|44
e|TU|20abe0d2-bbe5-422b-b9a7-ae645928b0bf|1|[?]|TUMERGE|Tumor Merged|[?]|NEW TARGET|COLON, RIGHT|CONTRALATERAL|DEEP|SEGMENT|IMPEDANCE CONDUCTIVITY|Y|Y|INTERVIEWER|READER|N|1|5|TREATMENT|2020-12-07|51
e|TU|b5644705-65e9-4d9b-9f5c-f8f62d26e257|1|[?]|LESIDENT|Lesion Identification|[?]|NON-MEASURABLE|HEART, RIGHT VENTRICLE|CONTRALATERAL|ANTERIOR|HEMI|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION||Y|NON-HEALTH CARE PROFESSIONAL|ADJUDICATOR|NA|1|3|SCREENING|2021-03-04|80
e|TU|ec82f59b-197a-4ccc-b5e5-d91627a86a27|1|[?]|TUSPLIT|Tumor Split|[?]|NEW|LUNG, LEFT, INFERIOR LOBE, SUPERIOR SEGMENT|BILATERAL|DEEP|MULTIPLE|RULER MEASUREMENT METHOD|Y||CHILD|RATER 2|U|1|7|TREATMENT|2020-06-05|30
e|TU|527fd604-110f-47b1-bd8b-b1de2f5b0d29|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|DISEASE SITE|AORTOPULMONARY WINDOW LYMPH NODE|LATERAL|ANTERIOR|PARTIAL|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|||CLINICAL RESEARCH ASSOCIATE|ENDOCRINOLOGIST|Y|1|4|TREATMENT|2020-11-22|3
e|TU|1e1de453-920a-4132-b2f7-6335ee81ec83|1|[?]|TUMIDENT|Tumor Identification|[?]|DISEASE SITE|FUNDUS UTERI|CONTRALATERAL|ANTEROPOSTERIOR|PARTIAL|SPECTROPHOTOMETRY|Y||CHILD|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|Y|1|2|TREATMENT|2020-12-09|58
e|TU|e553ad8e-96f4-4cb0-a005-51e9b64513b7|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|NON-TARGET ENHANCING|VERTEBRAL ARTERY|UNILATERAL|INTERMEDIATE|PARTIAL|WESTERN BLOT|||PROXY|ADJUDICATOR 3|NA|1|1|FOLLOW-UP|2020-07-08|19
e|TU|9bd9a8ad-dafd-46e0-a51c-c086ca4e9c0c|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|NON-TARGET ENHANCING|MITRAL VALVE, POSTERIOR CUSP|LEFT|SUPERFICIAL|ENTIRE|PERIODIC ACID SCHIFF STAIN||Y|NON-HEALTH CARE PROFESSIONAL|NEUROLOGIST|Y|1|6|FOLLOW-UP|2021-03-01|85
e|TU|c041c7ce-8c14-49cd-a2b2-e7e18b5bc579|1|[?]|NTIND|Non-Target Indicator|[?]|TARGET NODAL|INTERPHALANGEAL THUMB JOINT|UNILATERAL|LOWER|PARTIAL|PET/CT SCAN WITHOUT CONTRAST|||FRIEND|RADIOLOGIST|NA|1|7|TREATMENT|2020-08-25|87
e|TU|2c9752be-9479-4c18-bb2c-19ffa8dfec3a|1|[?]|TUMIDENT|Tumor Identification|[?]|DISEASE SITE|SYNOVIAL FLUID|CONTRALATERAL|FORE|HEMI|RAJI CELL EIA||Y|FRIEND|PATHOLOGIST 2|U|1|7|TREATMENT|2021-01-24|97
e|TU|083f3f2b-c66c-4a98-95c6-fc2bbceecf7e|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|NON-MEASURABLE|BULBAR CONJUNCTIVA|RIGHT|PERIPHERAL|SEGMENT|RIA|||ADJUDICATOR|PATHOLOGIST 1|N|1|6|FOLLOW-UP|2021-02-21|69
e|TU|ad04ec90-9fd5-49f2-ae23-264273eb0a24|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|NON-MEASURABLE|GASTROESOPHAGEAL JUNCTION|UNILATERAL|PERIVENTRICULAR|SEGMENT|GC/MS|||FAMILY MEMBER|MICROSCOPIST 3|N|1|2|TREATMENT|2020-12-25|79
e|TU|a1d203ef-7ee1-4373-988a-370532bae2b1|1|[?]|TUSPLIT|Tumor Split|[?]|NON-TARGET EXTRA NODAL|DIAPHRAGM|LATERAL|UPPER FLEXOR SURFACE|PARTIAL|HEMOCYTOMETRY|||NON-HEALTH CARE PROFESSIONAL|OPHTHALMOLOGIST|Y|1|7|SCREENING|2021-02-23|36
e|TU|4389d158-cb51-4779-b19a-f38dbef0806a|1|[?]|LESIDENT|Lesion Identification|[?]|BONE LESION|BRAIN|BILATERAL|ANTERIOR|ENTIRE|POLYMERASE CHAIN REACTION||Y|SPOUSE|ONCOLOGIST|U|1|2|SCREENING|2020-08-21|70
e|TU|3a973b7a-3583-4383-b59e-3dab51b511bd|1|[?]|TUMIDENT|Tumor Identification|[?]|NON-MEASURABLE|CAPITATE BONE|BILATERAL|DISTAL|SINGLE|TEMPLATE INCISION METHOD|||ADJUDICATOR|CLINICAL PATHOLOGIST|U|1|2|TREATMENT|2021-04-08|89
e|TU|d283591c-2085-459e-94f2-d3eb6b81aea7|1|[?]|TUMERGE|Tumor Merged|[?]|DISEASE SITE|ILEUM|LEFT|POSTERIOR|HEMI|DIGITAL PCR|||PROXY|ADJUDICATOR|NA|1|2|TREATMENT|2020-09-29|11
e|TU|da31f695-9f6a-46b2-8002-5c1c21b55cf3|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|NEW BONE LESION|UVEA|CONTRALATERAL|INTERMEDIATE|ALL|PET SCAN|Y|Y|ADJUDICATOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|NA|1|1|WASHOUT|2020-10-27|36
e|TU|4cd63e56-3d93-403a-8011-3b4fcf26e445|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|NON-TARGET ENHANCING|INFRACLAVICULAR LYMPH NODE|LATERAL|DEEP|ENTIRE|POLYGRAPHY||Y|DOMESTIC PARTNER|ONCOLOGIST 1|NA|1|5|SCREENING|2021-03-26|99
e|TU|379e3838-eef8-45a4-bd0b-5b8b3ec3e204|1|[?]|NTIND|Non-Target Indicator|[?]|NEW|SARTORIUS MUSCLE|UNILATERAL|SUBCORTICAL|SINGLE|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|||VENDOR|RADIOLOGIST 1|U|1|5|WASHOUT|2020-08-10|89
e|TU|f31bab3b-3624-44a5-a62f-f8cf9055eec4|1|[?]|NTIND|Non-Target Indicator|[?]|BENIGN|PULMONARY VALVE, RIGHT CUSP|LATERAL|MIDLINE|PARTIAL|SLIT LAMP|||VENDOR|PHYSIOTHERAPIST|N|1|6|TREATMENT|2020-09-03|35
e|TU|0b5675aa-4ec0-4548-9a0b-a13f8de89883|1|[?]|TUSPLIT|Tumor Split|[?]|NON-TARGET|URETHRA, PENILE|BILATERAL|OUTER|PARTIAL|AUSCULTATION|Y|Y|CLINICAL STUDY SPONSOR|PHYSIOTHERAPIST|Y|1|3|TREATMENT|2020-08-30|73
e|TU|9bdf9856-3b2a-43db-b369-3e13868ef413|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|NON-TARGET NON-ENHANCING|ILEUM|UNILATERAL|INTERMEDIATE|MULTIPLE|APPLANATION TONOMETRY|||NON-HEALTH CARE PROFESSIONAL|UROLOGIST|NA|1|5|TREATMENT|2021-04-08|85
e|TU|5cc53922-60c0-4bce-8d4a-bc59e9203d63|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|BONE LESION|ISCHIORECTAL FOSSA|RIGHT|PERIPHERAL|SINGLE|OPHTHALMOSCOPY|||FAMILY MEMBER|READER 1|U|1|4|SCREENING|2021-02-26|70
e|TU|ae4761e8-2ede-43b6-8ec4-40c97add3cfa|1|[?]|TUSPLIT|Tumor Split|[?]|NEW|DISTAL FEMUR R1|LATERAL|ANTEROPOSTERIOR|SINGLE|LIQUID SCINTILLATION COUNTING|Y||SIGNIFICANT OTHER|NEUROLOGIST 1|NA|1|6|FOLLOW-UP|2021-03-17|88
e|TU|066281d3-27b8-439f-8340-f59115f646ef|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|TARGET NODAL|RETROPHARYNGEAL LYMPH NODE|CONTRALATERAL|SUBCORTICAL|ENTIRE|LIGHT SCATTERING SPECTROSCOPY|||CLINICAL STUDY SPONSOR|READER|Y|1|7|TREATMENT|2020-10-19|8
e|TU|d23cc47e-da96-4042-a69f-60097beaef0e|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|BONE LESION|TRICUSPID VALVE, POSTERIOR CUSP|LATERAL|FACIAL|ALL|COMPLEMENT FIXATION|||SIBLING|DEVELOPMENTAL PSYCHOLOGIST|U|1|5|TREATMENT|2021-04-17|96
e|TU|b896c679-87d0-4e29-ad27-3944cf09b3ec|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|TARGET NODULE|TEMPORAL LOBE|RIGHT|ANTEROLATERAL|HEMI|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|||GUARDIAN|DEVELOPMENTAL PSYCHOLOGIST|NA|1|1|FOLLOW-UP|2021-01-06|14
e|TU|6d0ec221-6eb6-4fed-806e-2bc700968333|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|NON-MEASURABLE|RAMUS INTERMEDIUS ARTERY|IPSILATERAL|MIDLINE|MULTIPLE|KINETIC MICROPARTICLE IMMUNOASSAY|||STUDY SUBJECT|MICROSCOPIST|N|1|1|TREATMENT|2020-07-24|7
e|TU|1ba07712-d5a0-41a5-b5ee-636fa0bce22a|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|DISEASE SITE|PLEURAL CAVITY|LATERAL|LOWER|HEMI|SICKLE CELL SOLUBILITY TEST|||VENDOR|MICROSCOPIST 2|Y|1|5|FOLLOW-UP|2020-11-29|67
e|TU|15e5e7ca-b832-450c-a20c-b21585086328|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|NEW|SPLENIC VEIN|LATERAL|UPPER EXTENSOR SURFACE|SEGMENT|ZIEHL NEELSEN ACID FAST STAIN|||ADJUDICATION COMMITTEE|PEDIATRIC NEUROLOGIST|NA|1|5|WASHOUT|2021-01-16|21
e|TU|b46ff3a2-f257-4803-8064-e29bd1114bfc|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|NON-TARGET NODAL|ORAL MUCOSA|UNILATERAL|VOLAR|SEGMENT|ICC|Y||GUARDIAN|INTERNIST|Y|1|2|TREATMENT|2020-10-05|2
e|TU|b269c0ea-d3db-4052-9dc7-a55ac59d82a6|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|UNKNOWN|PERIUMBILICAL REGION|CONTRALATERAL|LOWER FLEXOR SURFACE|ALL|MICROSCOPY|||VENDOR|OPHTHALMOLOGIST|Y|1|2|FOLLOW-UP|2020-12-03|7
e|TU|a5c667d1-d2ac-49f7-ad44-bf9a44762025|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|TARGET|CERVIX UTERI|BILATERAL|CRANIAL|MULTIPLE|LINE PROBE ASSAY||Y|CHILD|NEUROLOGIST|U|1|4|FOLLOW-UP|2020-12-14|79
e|TU|944a2627-13f1-4ecf-9545-8819a1327138|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|DISTANT|ORAL CAVITY|BILATERAL|OCCIPITAL|ENTIRE|DIRECT SEQUENCING|||DOMESTIC PARTNER|OPHTHALMOLOGIST|Y|1|3|WASHOUT|2021-03-17|69
e|TU|7902955a-6336-45e5-a15d-7c368a28ac4f|1|[?]|NTIND|Non-Target Indicator|[?]|UNKNOWN|INTERVENTRICULAR SEPTUM|IPSILATERAL|APICAL|ENTIRE|RYAN BLUE STAIN|||INTERVIEWER|READER 3|NA|1|5|TREATMENT|2020-07-26|65
e|TU|aeef8a2d-167c-41e7-baa6-a3dc756bbb49|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|NON-TARGET NODAL|ESOPHAGUS, ABDOMINAL|LEFT|SURFACE|MULTIPLE|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|||INTERVIEWER|CLINICAL PATHOLOGIST|NA|1|6|TREATMENT|2021-01-09|30
e|TU|6071d81f-2f38-414f-90ca-4ad80c971054|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|DISTANT|PERICARDIAL CAVITY|LEFT|SUBCORTICAL|SEGMENT|CHROMATOGRAPHY|||CLINICAL RESEARCH ASSOCIATE|HEMATOLOGIST|Y|1|2|TREATMENT|2020-11-28|92
e|TU|22ffaa50-941f-4d52-b73b-84e13d2bb4bd|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|TARGET NODAL|CECUM|LEFT|VENTRAL|MULTIPLE|CLIP|||SIGNIFICANT OTHER|ONCOLOGIST 2|NA|1|7|FOLLOW-UP|2020-12-26|99
e|TU|a046d48d-b1fa-4d46-902e-3984aed00ec7|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|NOT MEASURED|LUMBRICAL MUSCLES OF THE HAND|IPSILATERAL|CENTRAL|ALL|X-RAY|Y||DOMESTIC PARTNER|ADJUDICATOR 1|N|1|6|FOLLOW-UP|2020-09-27|67
e|TU|8b60e1b0-2cd9-419d-b345-9006af042932|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|NON-MEASURABLE|SINUS|RIGHT|CAUDAL|MULTIPLE|ENDOSCOPY|Y||DOMESTIC PARTNER|DERMATOLOGIST|U|1|6|SCREENING|2021-01-09|34
e|TU|712029bc-471a-4e3d-9123-e38b3c38bc6c|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|LOCOREGIONAL|SHOULDER JOINT TENDONS|UNILATERAL|PERIVENTRICULAR|MULTIPLE|FISH||Y|VENDOR|ADJUDICATOR 2|Y|1|6|FOLLOW-UP|2021-03-11|56
e|TU|92c0183d-5704-45ad-9aec-e24bc5777b80|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|LOCATION OF INTEREST|LUNG, RIGHT, SUPERIOR LOBE, ANTERIOR SEGMENT|LEFT|OCCIPITAL|HEMI|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI||Y|SIBLING|OPHTHALMOLOGIST|Y|1|1|SCREENING|2021-03-04|53
e|TU|52ce3b1f-9500-4323-861d-73c8b96f59de|1|[?]|TUMERGE|Tumor Merged|[?]|TARGET NODULE|PRETRACHEAL LYMPH NODE|LEFT|INNER|MULTIPLE|FUNCTIONAL MRI|||VENDOR|OPHTHALMOLOGIST|N|1|3|TREATMENT|2020-12-17|62
e|TU|3655d198-2e7e-419e-8337-d7eea7d795ca|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|BENIGN|COLON|CONTRALATERAL|INNER|PARTIAL|RYAN BLUE STAIN|||ADJUDICATOR|RATER 2|NA|1|7|SCREENING|2021-01-05|53
e|TU|d47da6bf-8abf-4b62-8bb8-797155981158|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|TARGET NODULE|MID/DISTAL LEFT ANTERIOR DESCENDING CORONARY ARTERY AND ALL DIAGONAL CORONARY BRANCHES|LATERAL|UPPER|PARTIAL|TRYPAN BLUE STAIN|||PROXY|NEUROLOGIST|NA|1|2|SCREENING|2020-10-25|55
e|TU|25e81c81-8c23-4c9e-be79-35247384dd1f|1|[?]|TUMERGE|Tumor Merged|[?]|TARGET|INTERPHALANGEAL JOINT 4 OF THE FOOT|RIGHT|PERIPHERAL|ENTIRE|PERFUSION MRI|Y||STUDY SUBJECT|CLINICAL PATHOLOGIST|N|1|6|TREATMENT|2020-09-15|48
e|TU|4fd91c6c-3bc6-498a-a977-ee834c3bcb97|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|NEW|MIDDLE PHALANX 3 OF THE HAND|LEFT|OCCIPITAL|ENTIRE|PALM METHOD|||SPOUSE|NEUROLOGIST 2|U|1|7|SCREENING|2020-08-26|40
e|TU|21d29ae6-bb12-4c5c-b32a-32ab4ddcf547|1|[?]|TUMIDENT|Tumor Identification|[?]|NON-TARGET|COMMON FEMORAL ARTERY|IPSILATERAL|DORSAL|MULTIPLE|DXA SCAN|Y||DOMESTIC PARTNER|ONCOLOGIST|Y|1|6|SCREENING|2020-12-01|29
e|TU|5ba70148-c29b-47af-9280-10d1a942380a|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|REGIONAL|SUPERFICIAL LYMPH NODE|IPSILATERAL|VOLAR|MULTIPLE|BETA LACTAMASE|||CLINICAL RESEARCH COORDINATOR|MICROSCOPIST 3|Y|1|4|FOLLOW-UP|2021-02-11|85
e|TU|93b3c298-d81f-4d71-9c5d-ba5b4d4bdf42|1|[?]|TUMERGE|Tumor Merged|[?]|UNKNOWN|PERIURETHRAL REGION|CONTRALATERAL|SUPERFICIAL|ALL|ELECTROGASTROGRAPHY|||CLINICAL RESEARCH ASSOCIATE|DEVELOPMENTAL PSYCHOLOGIST|U|1|2|TREATMENT|2020-06-09|23
e|TU|2d8f8b1e-7914-400b-afc5-8dc23a626d76|1|[?]|TUSPLIT|Tumor Split|[?]|NEW BONE LESION|RETINAL NERVE FIBER LAYER|LEFT|ANTEROMEDIAL|ALL|IMMUNE REPERTOIRE DEEP SEQUENCING|||NON-HEALTH CARE PROFESSIONAL|READER 1|U|1|7|SCREENING|2020-07-09|30
e|TU|9d3f5b5e-ebd4-4540-8b4d-14733497ed8e|1|[?]|TUMERGE|Tumor Merged|[?]|UNKNOWN|LUNATE BONE|LEFT|LATERAL|ALL|KINETIC MICROPARTICLE IMMUNOASSAY|||CLINICAL STUDY SPONSOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|Y|1|1|TREATMENT|2020-10-31|82
e|TU|a73142e4-e34b-4144-b95f-7a5562574c1b|1|[?]|TUMIDENT|Tumor Identification|[?]|TARGET NODAL|MIDDLE EAR|IPSILATERAL|ANTEROPOSTERIOR|ENTIRE|MAGNETIC RESONANCE ELASTOGRAPHY|Y||ADJUDICATION COMMITTEE|OPTOMETRIST|Y|1|3|WASHOUT|2020-09-30|63
e|TU|a9bdb550-aa73-4194-a4b1-c69fa5dd2d4b|1|[?]|TUMIDENT|Tumor Identification|[?]|TARGET NODAL|ADDUCTOR MAGNUS MUSCLE|LEFT|CAUDAL|HEMI|ULTRASONOGRAPHIC ELASTOGRAPHY|Y||INTERVIEWER|ONCOLOGIST|U|1|5|WASHOUT|2020-06-28|35
e|TU|0f682806-b63c-4c3f-9fda-1e59befbd3a3|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|NON-TARGET ENHANCING|SUBCLAVIAN ARTERY|UNILATERAL|PERIVENTRICULAR|PARTIAL|PULSE OXIMETRY|||INTERVIEWER|OTOLARYNGOLOGIST|U|1|5|WASHOUT|2020-05-30|11
e|TU|1d8aba56-f62e-4116-b447-899dedd3d4df|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|TARGET|SPHENOID SINUS|UNILATERAL|LOWER MEDIAL|PARTIAL|HEMAGGLUTINATION ASSAY|Y||SIGNIFICANT OTHER|ADJUDICATOR|Y|1|1|WASHOUT|2020-10-30|41
e|TU|77bbd5c9-a7c4-43d1-a392-5dd44cfbfe4f|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|NEW BONE LESION|DORSALIS PEDIS ARTERY|IPSILATERAL|ANTERIOR|HEMI|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|||CHILD|MICROSCOPIST 1|Y|1|7|WASHOUT|2020-11-06|94
e|TU|383d3f30-14b7-48c3-b1a8-0f481ef37a50|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|DISEASE SITE|SYNOVIAL FLUID|UNILATERAL|SUPERIOR|ALL|RADIOIMMUNOPRECIPITATION ASSAY|||SIBLING|RATER 2|N|1|1|TREATMENT|2020-06-07|10
e|TU|b4f81b74-fee9-4544-9404-206d931ed8e5|1|[?]|NTIND|Non-Target Indicator|[?]|LOCAL|TRIANGULAR BONE|CONTRALATERAL|ANTEROMEDIAL|ENTIRE|ETDRS EYE CHART||Y|CHILD|FORENSIC PATHOLOGIST|U|1|2|TREATMENT|2020-10-15|7
e|TU|9e69b457-20db-45e5-a535-0cd8ac102fea|1|[?]|TUMIDENT|Tumor Identification|[?]|NON-TARGET ENHANCING|ABDUCTOR POLLICIS BREVIS MUSCLE|RIGHT|FACIAL|ENTIRE|FLOW MICROSCOPY|||ADJUDICATION COMMITTEE|READER 3|Y|1|2|TREATMENT|2020-07-30|63
e|TU|14211798-ddf6-47c8-bd9d-056d95bad8ff|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|LOCOREGIONAL|LEFT VENTRICULAR MID INFEROSEPTAL SEGMENT|RIGHT|DISTAL|HEMI|CLOT DETECTION||Y|GUARDIAN|PATHOLOGIST 1|N|1|5|WASHOUT|2020-11-29|74
e|TU|63f3194e-9b88-491a-9a68-19109ed86e2b|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|DISTANT|LINGULA OF THE LUNG|LEFT|VOLAR|MULTIPLE|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|||INDEPENDENT ASSESSOR|ADJUDICATOR 2|Y|1|3|WASHOUT|2020-09-03|95
e|TU|b6208258-d7c2-4dde-addf-4677946ab165|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|DISTANT|CHIN|LEFT|PROXIMAL VOLAR|HEMI|MAPH|Y|Y|ADJUDICATOR|ADJUDICATOR|N|1|4|TREATMENT|2020-10-12|32
e|TU|a669a7b9-2034-4bca-aa80-0371c5fb46d3|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|DISTANT|ELBOW EXTENSOR MUSCLES|LATERAL|SUPERFICIAL|ALL|TWO-COLOR MICROARRAY|||INTERVIEWER|MICROSCOPIST 3|N|1|3|SCREENING|2021-01-25|9
e|TU|e148c13d-ee41-4503-a7e5-397dd6155f04|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|BONE LESION|AXIAL SKELETON|LEFT|PROXIMAL|SEGMENT|SEQUENCING||Y|SIGNIFICANT OTHER|READER 3|Y|1|2|TREATMENT|2020-07-10|2
e|TU|815de94a-f259-41ee-8951-8df150184a25|1|[?]|TUMIDENT|Tumor Identification|[?]|NEW NON-TARGET|EXTERNAL ILIAC LYMPH NODE|LEFT|SUPERFICIAL|PARTIAL|LYMPHANGIOGRAPHY|||INDEPENDENT ASSESSOR|DEVELOPMENTAL PSYCHOLOGIST|U|1|5|SCREENING|2020-07-10|13
e|TU|c897cd09-0cbc-4a2f-a902-1c736a6c3a02|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|LOCAL|DISTAL INTERPHALANGEAL JOINT 3 OF THE FOOT|UNILATERAL|ROSTRAL|HEMI|FUNDUS PHOTOGRAPHY||Y|HEALTH CARE PROFESSIONAL|CLINICAL PATHOLOGIST|NA|1|6|TREATMENT|2020-08-09|95
e|TU|d68e5fe0-ab34-4565-9e5d-6ff1f72217f1|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|NEW BONE LESION|SUPERIOR SAGITTAL SINUS|LEFT|OUTER|MULTIPLE|PLETHYSMOGRAPHY|||NON-HEALTH CARE PROFESSIONAL|ADJUDICATOR 1|U|1|5|WASHOUT|2021-02-02|18
e|TU|a616ef00-05d6-459a-8474-06ab3eb493b1|1|[?]|TUMERGE|Tumor Merged|[?]|NEW|CIRCUMFLEX, OBTUSE MARGINALS, LEFT POSTEROLATERAL AND LEFT POSTERIOR DESCENDING ARTERY BRANCHES|UNILATERAL|SURFACE|SINGLE|LC/MS||Y|PROXY|OTOLARYNGOLOGIST|U|1|6|TREATMENT|2020-12-16|92
e|TU|a6cbce6b-ec22-4f4e-9990-b2c106a4554e|1|[?]|TUMIDENT|Tumor Identification|[?]|DISEASE SITE|OCCIPITAL SCALP|RIGHT|ROSTRAL|ENTIRE|HPLC/MS/MS||Y|CLINICAL RESEARCH COORDINATOR|RATER|Y|1|3|TREATMENT|2020-10-17|68
e|TU|870f5f68-aa8a-4484-8d9d-febc7d5b83a2|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|REGIONAL|KNEE JOINT|CONTRALATERAL|UPPER FLEXOR SURFACE|ALL|CYSTOMETRY|Y||SIBLING|OTOLARYNGOLOGIST|NA|1|1|WASHOUT|2020-11-02|22
e|TU|ffbb87da-c0a3-4acf-94e2-b1473cbd60e3|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|LOCAL|EXTENSOR HALLUCIS BREVIS MUSCLE|LATERAL|DEEP|MULTIPLE|IN VITRO GENE EXPRESSION ASSAY||Y|FRIEND|RADIOLOGIST|U|1|2|SCREENING|2020-07-06|12
e|TU|2014bcd0-1430-4096-87f5-650a01dae626|1|[?]|LESIDENT|Lesion Identification|[?]|TARGET|ENDOCARDIUM|UNILATERAL|FRONTAL|SINGLE|IN VITRO GENE EXPRESSION ASSAY|||CAREGIVER|NEUROLOGIST 1|U|1|3|WASHOUT|2020-07-28|68
e|TU|e043f1b3-6b65-45c0-bdae-eb783406c263|1|[?]|TUMIDENT|Tumor Identification|[?]|NON-TARGET|HEPATIC LYMPH NODE|LATERAL|ANTEROTEMPORAL|MULTIPLE|MULTIPLEXED BEAD BASED IMMUNOASSAY|Y||INDEPENDENT ASSESSOR|ONCOLOGIST|Y|1|7|WASHOUT|2020-11-20|19
e|TU|45623c39-86de-4b2f-bf2d-998d0e941e92|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|REGIONAL|SARTORIUS MUSCLE|BILATERAL|APICAL|SINGLE|IMMUNO-PET SCAN|||DOMESTIC PARTNER|RATER 1|N|1|7|SCREENING|2020-07-31|19
e|TU|a753f9c8-2f9a-4f54-80e0-b080e82dcb94|1|[?]|LESIDENT|Lesion Identification|[?]|BONE LESION|GASTROINTESTINAL SYSTEM|BILATERAL|UPPER EXTENSOR SURFACE|MULTIPLE|CYSTOMETRY|Y||DOMESTIC PARTNER|OPTOMETRIST|N|1|4|TREATMENT|2020-11-06|29
e|TU|e5a105f7-38ac-4f19-aace-4149ed9b1100|1|[?]|LESIDENT|Lesion Identification|[?]|NON-MEASURABLE|BREAST|UNILATERAL|UPPER|SINGLE|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|||CLINICAL RESEARCH ASSOCIATE|MICROSCOPIST 2|NA|1|2|FOLLOW-UP|2020-11-15|83
e|TU|c568ab93-8e7f-4e4e-9685-f0c13f293606|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|TARGET EXTRA NODAL|HAND DIGIT 3|LATERAL|PERIVENTRICULAR|ALL|NUCLEIC ACID BASED METHOD|||NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST 2|U|1|1|SCREENING|2021-03-20|75
e|TU|bccd8af0-2ecf-4091-92e4-681597b57ca4|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|TARGET NODAL|BLADDER, NECK|RIGHT|UPPER FLEXOR SURFACE|HEMI|IMMUNOCHROMATOGRAPHY|||FRIEND|ONCOLOGIST 2|N|1|5|TREATMENT|2020-10-23|33
e|TU|bf069a02-03a6-4013-b16d-d7c954a6cc3d|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|LOCAL|COLON WALL|LEFT|ANTERIOR|PARTIAL|FLUORESCENCE ANGIOGRAPHY|||DOMESTIC PARTNER|READER 1|U|1|1|WASHOUT|2020-08-02|6
e|TU|c40fc52b-2668-4fab-b051-5b258da72f2c|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|NON-TARGET NODAL|ACUTE MARGINAL ARTERY|IPSILATERAL|SURFACE|SINGLE|GC/MS-CI|||DOMESTIC PARTNER|OTOLARYNGOLOGIST|Y|1|7|SCREENING|2020-11-30|60
e|TU|d7c792d8-fc98-41ab-8a9e-59de1e186a06|1|[?]|TUSPLIT|Tumor Split|[?]|UNKNOWN|MESENTERIC VEIN|BILATERAL|LATERAL|ENTIRE|MICRODENSITOMETRY||Y|STUDY SUBJECT|PATHOLOGIST|NA|1|5|TREATMENT|2020-10-02|76
e|TU|f7773659-f207-4b29-8389-3aa766a6337a|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|NON-TARGET NON-ENHANCING|RETINA|UNILATERAL|LATERAL|ENTIRE|FLUORESCENT IMMUNOASSAY|Y||STUDY SUBJECT|RADIOLOGIST 1|U|1|5|TREATMENT|2021-01-14|97
e|TU|9fa8c7af-c759-420d-a548-cc24c7ddbcdf|1|[?]|NTIND|Non-Target Indicator|[?]|NON-TARGET NODAL|LATERAL RAMUS INTERMEDIUS ARTERY|LEFT|INTERMEDIATE|MULTIPLE|MICROBIAL CULTURE, SOLID|||GUARDIAN|ADJUDICATOR 2|N|1|7|SCREENING|2021-02-16|50
e|TU|c0b85664-0ef6-4f93-8f84-ee87e1ca9f0f|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|DISEASE SITE|SACRUM|LEFT|LOWER EXTENSOR SURFACE|ENTIRE|MICROBIAL CULTURE, SOLID|||CHILD|RADIOLOGIST 1|Y|1|2|TREATMENT|2021-02-12|27
e|TU|700049a2-ef66-466b-b1d8-f0800bcfde43|1|[?]|TUMERGE|Tumor Merged|[?]|NON-TARGET NON-ENHANCING|LATERAL FIRST DIAGONAL BRANCH ARTERY|UNILATERAL|ANTEROPOSTERIOR|ENTIRE|SLOAN LETTER EYE CHART 2.5%||Y|CLINICAL RESEARCH ASSOCIATE|READER 1|N|1|6|WASHOUT|2020-09-10|85
e|TU|00d906a6-2d14-4199-aff9-524388c5117f|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|NOT MEASURED|SKIN OF THE HAND|UNILATERAL|CAUDAL|ENTIRE|ARTERIAL SPIN LABELING FUNCTIONAL MRI||Y|ADJUDICATOR|MICROSCOPIST|U|1|4|SCREENING|2021-01-26|73
e|TU|2fcc5910-bce0-4510-b17e-3925850d6d32|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|REGIONAL|AORTIC VALVE|BILATERAL|SUBCORTICAL|SEGMENT|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI||Y|GUARDIAN|DEVELOPMENTAL PSYCHOLOGIST|N|1|7|FOLLOW-UP|2020-12-26|20
e|TU|a17fa9ed-b1fa-451c-8f51-ed1ab1b75366|1|[?]|TUSPLIT|Tumor Split|[?]|NEW|FLEXOR CARPI ULNARIS MUSCLE|CONTRALATERAL|TEMPORAL|SINGLE|JAEGER EYE CHART||Y|HEALTH CARE PROFESSIONAL|MICROSCOPIST 3|U|1|4|TREATMENT|2020-10-24|64
e|TU|6020ccb5-0bbe-4318-b99f-7a69b10b85a4|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|BENIGN|FUNDUS OF THE EYE|RIGHT|PERIPHERAL|SEGMENT|PHOROPTER|||INDEPENDENT ASSESSOR|DEVELOPMENTAL PSYCHOLOGIST|NA|1|5|FOLLOW-UP|2020-08-21|36
e|TU|b6e22f6b-25a9-4d18-8de1-2bb4c261e4c9|1|[?]|TUMIDENT|Tumor Identification|[?]|TARGET|T7 VERTEBRA|LATERAL|INTERMEDIATE|HEMI|RADIATION DOSIMETRY|||CLINICAL RESEARCH ASSOCIATE|CARDIOLOGIST|N|1|2|WASHOUT|2020-11-06|19
e|TU|ff163542-abec-4260-b257-f15a11e580ee|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|NON-TARGET|HINDLIMB|RIGHT|UPPER FLEXOR SURFACE|SEGMENT|KARYOTYPING|Y||NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST 2|U|1|3|TREATMENT|2020-11-08|94
e|TU|bb73f732-a52f-4013-9ae6-60ff23b9c224|1|[?]|TUMERGE|Tumor Merged|[?]|NON-TARGET EXTRA NODAL|BLADDER, NECK|IPSILATERAL|DISTAL VOLAR|MULTIPLE|MUGA|Y||CHILD|ADJUDICATOR|NA|1|5|TREATMENT|2020-09-24|60
e|TU|56fd91d0-502c-4e19-b7df-1e7dd2ad3cd5|1|[?]|TUSPLIT|Tumor Split|[?]|NOT MEASURED|HEART, LEFT VENTRICLE|LEFT|ANTEROLATERAL|ENTIRE|SLIT LAMP|Y||CAREGIVER|CLINICAL PATHOLOGIST|N|1|4|TREATMENT|2020-10-18|99
e|TU|8e056558-ffd2-4c43-bbfa-40914b38af34|1|[?]|TUMIDENT|Tumor Identification|[?]|NON-TARGET ENHANCING|DIGIT|CONTRALATERAL|UPPER EXTENSOR SURFACE|ALL|MAMMOGRAPHY||Y|NON-HEALTH CARE PROFESSIONAL|OTOLARYNGOLOGIST|N|1|3|TREATMENT|2021-03-12|52
e|TU|b7ffe7f2-7eb9-42a1-a548-9f26ee72799b|1|[?]|NTIND|Non-Target Indicator|[?]|NON-TARGET NON-ENHANCING|SPINAL CORD|CONTRALATERAL|ANTEROMEDIAL|PARTIAL|FLUORESCENT SPOT TEST|Y||INVESTIGATOR|CLINICAL PATHOLOGIST|N|1|4|SCREENING|2020-07-26|68
e|TU|624c1353-347a-417d-9aab-7f1e7077ba7f|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|NON-TARGET ENHANCING|TAIL|BILATERAL|DORSAL|ALL|ELLA||Y|INDEPENDENT ASSESSOR|RADIOLOGIST 2|U|1|1|SCREENING|2020-08-24|6
e|TU|ef1cddb8-f4ce-45c4-8671-32fe95f00993|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|NON-TARGET EXTRA NODAL|INTERATRIAL SEPTUM|UNILATERAL|FRONTAL|HEMI|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|||CLINICAL RESEARCH COORDINATOR|RATER 2|Y|1|6|TREATMENT|2020-08-20|28
e|TU|da6294b5-de91-4bf7-b160-55d22fefcb07|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|BONE LESION|BONE MARROW|IPSILATERAL|LOWER FLEXOR SURFACE|SINGLE|CLIP|||STUDY SUBJECT|RADIOLOGIST 1|NA|1|6|WASHOUT|2020-08-18|61
e|TU|c01c16d4-7a37-421d-9191-1874eba6a1e3|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|TARGET EXTRA NODAL|PENIS, RADIX|UNILATERAL|NASAL|SINGLE|POLYMERASE CHAIN REACTION|Y||ADJUDICATOR|HEMATOLOGIST|Y|1|4|TREATMENT|2020-12-27|89
e|TU|6036407d-5ac8-400d-91f7-afd63f3cab88|1|[?]|TUMIDENT|Tumor Identification|[?]|UNKNOWN|OROPHARYNX|UNILATERAL|MIDLINE|SINGLE|SLOAN LETTER EYE CHART 100%||Y|CHILD|MICROSCOPIST 2|Y|1|3|FOLLOW-UP|2020-07-18|36
e|TU|69cf0c4b-13f6-4955-8046-72a333059d6e|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|NEW NON-TARGET|GINGIVAL MUCOSA|LATERAL|SUBCORTICAL|ENTIRE|SINGLE-SLICE SPIRAL CT|||CAREGIVER|READER 3|N|1|6|FOLLOW-UP|2021-02-02|58
e|TU|19829028-595c-4811-90e3-0ca696a04ba3|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|NON-TARGET ENHANCING|SUBLINGUAL REGION|IPSILATERAL|LOWER|PARTIAL|FLUORESCENT MICROSCOPY|Y||STUDY SUBJECT|ONCOLOGIST 2|U|1|5|TREATMENT|2020-08-19|45
e|TU|562a8182-8e9b-4a68-9b95-bc52df58ed46|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|NON-TARGET NODAL|RENAL PELVIS|LEFT|ANTEROLATERAL|ENTIRE|EPSILOMETER|||INVESTIGATOR|READER|N|1|6|TREATMENT|2020-10-29|64
e|TU|b29e6912-42f4-471b-ad90-1ec446f89ac0|1|[?]|TUSPLIT|Tumor Split|[?]|NEW TARGET|SUBMENTAL LYMPH NODE|LATERAL|NASAL|SEGMENT|SLIT LAMP|||SIBLING|ADJUDICATOR 2|U|1|6|FOLLOW-UP|2021-02-10|32
e|TU|2cb58751-c0c4-432c-8f60-22dba6e1ec9a|1|[?]|LESIDENT|Lesion Identification|[?]|MEASURED|GASTROCNEMIUS MUSCLE, MEDIAL HEAD|UNILATERAL|DEEP|MULTIPLE|MRI|||CLINICAL RESEARCH COORDINATOR|FORENSIC PATHOLOGIST|U|1|6|SCREENING|2020-06-21|22
e|TU|396295ba-9f4c-4689-88c2-f80cb28b567a|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|NEW BONE LESION|HEART, LEFT VENTRICULAR OUTFLOW TRACT|LATERAL|FRONTAL|SINGLE|SPECT/CT SCAN|||CAREGIVER|PHYSIOTHERAPIST|Y|1|3|WASHOUT|2021-01-20|30
e|TU|56072c44-67c3-4c93-8db7-2d1570b2bbbc|1|[?]|TUMIDENT|Tumor Identification|[?]|BENIGN|PROXIMAL LAD ARTERY|UNILATERAL|PERIVENTRICULAR|MULTIPLE|KARYOTYPING||Y|SPOUSE|READER 3|Y|1|5|SCREENING|2020-09-02|17
e|TU|55b23180-01f2-498e-a0af-cb9cd7d81750|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|LOCATION OF INTEREST|AMYGDALA|LEFT|UPPER EXTENSOR SURFACE|HEMI|DIGITAL PCR|||PARENT|RADIOLOGIST|N|1|4|FOLLOW-UP|2020-09-11|82
e|TU|22e2b674-dc3f-476d-b3d7-2b1f4ddeea1a|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|DISTANT|TYMPANIC MEMBRANE|IPSILATERAL|POSTERIOR|PARTIAL|VENTILATION PERFUSION LUNG SCAN|||STUDY SUBJECT|ADJUDICATOR 2|U|1|4|TREATMENT|2021-01-01|63
e|TU|940e4aef-5648-46b3-9c3e-7c40f7930030|1|[?]|NTIND|Non-Target Indicator|[?]|UNKNOWN|BUTTOCK|LATERAL|UPPER EXTENSOR SURFACE|ENTIRE|RYAN BLUE STAIN|||INVESTIGATOR|FORENSIC PATHOLOGIST|U|1|4|TREATMENT|2021-01-21|77
e|TU|e4bece1e-6672-4b55-824f-56aa923e60f9|1|[?]|NTIND|Non-Target Indicator|[?]|DISEASE SITE|BRAIN VENTRICLE, LATERAL|CONTRALATERAL|SUPERIOR|PARTIAL|PHOTOMETRIC CLOT DETECTION||Y|CAREGIVER|HEMATOLOGIST|N|1|5|SCREENING|2020-06-14|2
e|TU|12e607da-f53c-4078-9742-23a111db6f54|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|NON-TARGET ENHANCING|HEPATOBILIARY SYSTEM|LEFT|BASAL|SINGLE|KLEIHAUER-BETKE|||PROXY|READER 2|N|1|3|TREATMENT|2020-12-18|86
e|TU|ca763b7f-2e60-4423-a7a8-b5fad4a74b25|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|TARGET NODULE|ANTECUBITAL FOSSA|LATERAL|LOWER FLEXOR SURFACE|ENTIRE|ELECTRONEUROGRAPHY|||CAREGIVER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|U|1|1|WASHOUT|2021-03-04|47
e|TU|1f6b4ff8-fc33-46c7-8298-fe2e9ea62d60|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|TARGET NODAL|SKIN OF THE NECK|LEFT|PROXIMAL VOLAR|SINGLE|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|||FRIEND|READER 3|N|1|2|FOLLOW-UP|2020-08-21|46
e|TU|3260122d-3bf4-45ff-a026-2379158721d0|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|TARGET NODAL|ACCESSORY RENAL ARTERY|UNILATERAL|SUPERFICIAL|PARTIAL|LIGHT MICROSCOPY|||ADJUDICATOR|PATHOLOGIST|N|1|6|FOLLOW-UP|2020-08-09|76
e|TU|05eb4e29-887e-4cdb-8854-49939a8a13d1|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|NON-TARGET|MEDIASTINUM|LATERAL|LOWER MEDIAL|HEMI|PULSE OXIMETRY|||ADJUDICATION COMMITTEE|RADIOLOGIST|U|1|6|TREATMENT|2020-11-04|9
e|TU|c8390c70-766d-4252-9356-39591651bcdf|1|[?]|TUMIDENT|Tumor Identification|[?]|NON-TARGET NODAL|MEDIAN OR LOWER CERVICAL LYMPH NODE|IPSILATERAL|OCCIPITAL|HEMI|OPTICAL COHERENCE TOMOGRAPHY||Y|GUARDIAN|RADIOLOGIST 1|NA|1|6|SCREENING|2020-09-10|40
e|TU|a40bf877-c070-40b3-89df-d566b942246e|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|LOCOREGIONAL|SMALL SAPHENOUS VEIN|RIGHT|SUPERFICIAL|PARTIAL|FARNSWORTH-MUNSELL 100 HUE TEST|||DOMESTIC PARTNER|PEDIATRIC NEUROLOGIST|U|1|6|WASHOUT|2020-08-22|77
e|TU|e9633621-3d08-4b47-b394-5bd3fa47c07f|1|[?]|LESIDENT|Lesion Identification|[?]|BENIGN|LUNG, RIGHT, MIDDLE LOBE, LATERAL SEGMENT|IPSILATERAL|DISTAL|ENTIRE|OBSERVATION|Y|Y|PROXY|ENDOCRINOLOGIST|U|1|6|TREATMENT|2021-04-02|86
e|TU|ff56cb6e-b6c4-49cc-ad21-9a4d20aad7ee|1|[?]|NTIND|Non-Target Indicator|[?]|TARGET NODAL|DUCTUS ARTERIOSUS|LATERAL|ANTEROMEDIAL|SINGLE|MICROBIAL CULTURE|Y||STUDY SUBJECT|ADJUDICATOR 1|N|1|3|TREATMENT|2020-06-13|15
e|TU|ee525e77-38dd-4b0b-88f4-69759d5dbfd9|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|NON-TARGET NON-ENHANCING|CORPUS CALLOSUM, GENU|LATERAL|SUBCORTICAL|ALL|TEST STRIP|||CHILD|MICROSCOPIST 1|U|1|7|TREATMENT|2020-08-12|37
e|TU|63f43990-e56e-440c-a445-76e7d114cf26|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|TARGET NODULE|LIVER LOBE|IPSILATERAL|FRONTAL|MULTIPLE|OSCILLOMETRY|||FRIEND|ONCOLOGIST 2|U|1|2|TREATMENT|2020-11-01|40
e|TU|380c89f4-2650-4a54-92f5-5e1278b9a91e|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|UNKNOWN|LATISSIMUS DORSI MUSCLE|IPSILATERAL|FRONTAL|ENTIRE|MICROBIAL BIOCHEMICAL IDENTIFICATION||Y|HEALTH CARE PROFESSIONAL|ONCOLOGIST 1|Y|1|3|TREATMENT|2020-12-10|59
e|TU|84c1f5f4-6415-49d8-b854-22e7529d65b6|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|BONE LESION|LIVER LOBE|LATERAL|BASAL|ENTIRE|FARNSWORTH-MUNSELL 100 HUE TEST|||SIGNIFICANT OTHER|INTERNIST|NA|1|6|SCREENING|2020-12-20|25
e|TU|77c26a0c-0c84-44d7-8351-a50f3236e59a|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|LOCAL|METACARPAL BONE 3|BILATERAL|SUPERFICIAL|SINGLE|TOLUIDINE BLUE STAIN|||GUARDIAN|RADIOLOGIST 2|Y|1|1|TREATMENT|2020-07-02|59
e|TU|a201c78a-e826-4f42-a997-7c6a019e2c91|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|NON-TARGET NODAL|MID/DISTAL LEFT ANTERIOR DESCENDING CORONARY ARTERY AND ALL DIAGONAL CORONARY BRANCHES|CONTRALATERAL|SUPERIOR|SEGMENT|DOPPLER ULTRASOUND||Y|CLINICAL STUDY SPONSOR|MICROSCOPIST 3|NA|1|1|TREATMENT|2020-10-16|84
e|TU|c41880bd-1e29-4961-b74d-bb0d979ab00f|1|[?]|TUMIDENT|Tumor Identification|[?]|NON-MEASURABLE|JAW|UNILATERAL|ANTERIOR|ENTIRE|WESTERGREN|||INDEPENDENT ASSESSOR|READER 1|NA|1|3|WASHOUT|2020-11-01|61
e|TU|7de60015-fa9d-4a39-bd19-51c718a624e6|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|DISTANT|THORACIC SPINE|UNILATERAL|DEEP|HEMI|PHOTOMETRIC CLOT DETECTION|||PROXY|ONCOLOGIST 2|N|1|2|TREATMENT|2020-11-25|42
e|TU|34d03f58-155a-4908-bba3-aa979be84610|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|LOCOREGIONAL|ANASTOMOSIS|CONTRALATERAL|APICAL|SEGMENT|DXA SCAN|Y||DOMESTIC PARTNER|PATHOLOGIST 1|Y|1|5|SCREENING|2020-09-10|83
e|TU|3818424f-cbc9-4e79-94b8-7edbc706bdbc|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|BONE LESION|KIDNEY, UPPER LOBE|IPSILATERAL|OCCIPITAL|MULTIPLE|FLOW CYTOMETRY|||STUDY SUBJECT|RADIOLOGIST 1|N|1|1|TREATMENT|2020-08-18|5
e|TU|4191788e-b2dc-4885-87d8-da9feb6deea5|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|NEW NON-TARGET|HAND PHALANX|IPSILATERAL|PERIPHERAL|MULTIPLE|MICROBIAL CONCENTRATION||Y|CAREGIVER|READER 3|NA|1|7|TREATMENT|2020-10-02|31
e|TU|8572a9c4-eb87-4745-81b9-8316bc8de69e|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|BONE LESION|MENINGES|BILATERAL|INTERMEDIATE|PARTIAL|TOTAL BODY RADIOGRAPHY|||CLINICAL STUDY SPONSOR|NEUROLOGIST 2|U|1|7|WASHOUT|2021-02-19|67
e|TU|74c9d1b3-6466-43c1-95b0-b720a0dd6e37|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|LOCAL|BUTTOCK|BILATERAL|DEEP|SINGLE|CELLULAR PROLIFERATION ASSAY|||INTERVIEWER|READER 3|Y|1|7|SCREENING|2021-01-29|74
e|TU|3eceae61-a4a0-49fd-964b-9f142e0da067|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|NON-MEASURABLE|RETINA|IPSILATERAL|MIDLINE|ENTIRE|SPECT/CT SCAN|||CLINICAL STUDY SPONSOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|Y|1|3|TREATMENT|2020-09-20|33
e|TU|fe7ad71c-601d-4909-b56a-401c9a10f00c|1|[?]|LESIDENT|Lesion Identification|[?]|LOCOREGIONAL|GASTROCNEMIUS MUSCLE, MEDIAL HEAD|BILATERAL|DISTAL|PARTIAL|HEMAGGLUTINATION INHIBITION ASSAY|||CHILD|READER 3|N|1|6|WASHOUT|2020-06-19|39
e|TU|cc52d895-5819-46c0-b8e6-b948f1cd2408|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|TARGET NODAL|GASTRIC CURVATURE LYMPH NODE|IPSILATERAL|CENTRAL|PARTIAL|CAPILLARY ELECTROPHORESIS|||SPOUSE|ADJUDICATOR|NA|1|7|SCREENING|2020-08-22|57
e|TU|b56a5fe6-1191-4e36-ad30-2f9fc0a2fb72|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|LOCOREGIONAL|SKIN OF THE INFRASCAPULAR REGION|UNILATERAL|DEEP|PARTIAL|MICROBIAL CULTURE, LIQUID||Y|CLINICAL RESEARCH ASSOCIATE|RATER|Y|1|5|SCREENING|2021-04-10|81
e|TU|1409edea-a372-4938-889b-df6ee93b8543|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|LOCATION OF INTEREST|GLOBUS PALLIDUS|RIGHT|ANTEROLATERAL|MULTIPLE|SEQUENCING||Y|CHILD|RATER 2|U|1|5|TREATMENT|2020-09-14|28
e|TU|3dc16ad2-d49d-4fad-9823-d0197fb57a42|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|NOT MEASURED|SUPRAGLOTTIS|UNILATERAL|UPPER FLEXOR SURFACE|ENTIRE|HPLC-UV|||VENDOR|HEMATOLOGIST|NA|1|7|SCREENING|2020-09-27|33
e|TU|7c244128-0508-422f-88ba-ecce68cec054|1|[?]|NTIND|Non-Target Indicator|[?]|LOCATION OF INTEREST|RIB|CONTRALATERAL|LOWER EXTENSOR SURFACE|PARTIAL|IMMUNOFLUORESCENT STAIN|Y||DOMESTIC PARTNER|ADJUDICATOR|U|1|7|SCREENING|2020-07-31|5
e|TU|247814c7-9fb3-43f2-9e0a-db70b27b3d95|1|[?]|TUMIDENT|Tumor Identification|[?]|NON-TARGET NODAL|UPPER URINARY SYSTEM|LATERAL|LOWER MEDIAL|HEMI|SLOAN LETTER EYE CHART 2.5%|Y||HEALTH CARE PROFESSIONAL|READER 2|U|1|4|SCREENING|2020-12-16|10
e|TU|e870fe2f-b08c-41d9-a672-07da09fe2b99|1|[?]|TUMIDENT|Tumor Identification|[?]|NON-TARGET|MITRAL VALVE, ANTERIOR ANNULUS|RIGHT|ANTEROTEMPORAL|ENTIRE|TRANSTHORACIC ECHOCARDIOGRAPHY|||INTERVIEWER|RATER|NA|1|2|FOLLOW-UP|2020-10-09|68
e|TU|32979638-fb88-4cbb-a110-a4d2016e9bc5|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|DISEASE SITE|HEAD|LEFT|SUBCORTICAL|HEMI|MACRO BROTH DILUTION|||ADJUDICATOR|PHYSIOTHERAPIST|U|1|1|TREATMENT|2020-08-20|46
e|TU|39b8db88-810b-4402-9ca3-c2bab1939c1c|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|NEW|HUMERUS SHAFT|IPSILATERAL|CRANIAL|ENTIRE|QUANTITATIVE COMPUTED TOMOGRAPHY|Y||DOMESTIC PARTNER|ONCOLOGIST|N|1|2|TREATMENT|2021-01-10|66
e|TU|b6cce9a5-9b5d-4dd2-80ad-0c6a5b1ed640|1|[?]|LESIDENT|Lesion Identification|[?]|NON-TARGET EXTRA NODAL|PERIPHERAL NERVE|LATERAL|INNER|SINGLE|MOUSE PROTECTION ASSAY|||VENDOR|READER 1|Y|1|2|FOLLOW-UP|2020-10-05|80
e|TU|bca1f50d-04e6-46f5-afb3-e48aaea1069d|1|[?]|LESIDENT|Lesion Identification|[?]|LOCATION OF INTEREST|TRIANGULAR BONE|LEFT|PROXIMAL|SEGMENT|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|||CLINICAL RESEARCH COORDINATOR|HEMATOLOGIST|Y|1|2|TREATMENT|2020-11-17|24
e|TU|6bddadef-13fb-4fab-b281-aa33aa97aa8f|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|DISTANT|POSTERIOR INFERIOR CEREBELLAR ARTERY|IPSILATERAL|ANTEROTEMPORAL|SEGMENT|FLOCCULATION, CHARCOAL ENHANCED|Y|Y|CLINICAL STUDY SPONSOR|NEUROLOGIST 2|Y|1|1|TREATMENT|2020-05-18|4
e|TU|6edb7414-d8f4-44da-8483-504b93a7e705|1|[?]|TUSPLIT|Tumor Split|[?]|NEW BONE LESION|METATARSAL BONE|CONTRALATERAL|LOWER|HEMI|ENDOSCOPY|||PARENT|DEVELOPMENTAL PSYCHOLOGIST|Y|1|1|TREATMENT|2020-08-30|94
e|TU|3fd8445d-f3b1-46ac-b5ae-a0e5a7f32210|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|LOCOREGIONAL|DISTAL INTERPHALANGEAL JOINT 2|UNILATERAL|FORE|SEGMENT|SISH|||CLINICAL RESEARCH ASSOCIATE|CARDIOLOGIST|NA|1|5|TREATMENT|2020-07-28|83
e|TU|b005dec4-0aed-484d-b20a-bb18cf8ddbe6|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|NEW|CERVICAL SPINE|BILATERAL|VOLAR|ENTIRE|ACCELERATOR MASS SPECTROMETRY|||CLINICAL RESEARCH COORDINATOR|ADJUDICATOR|N|1|3|TREATMENT|2020-08-10|94
e|TU|47d55e87-e559-424d-a6ad-d533a0d77f39|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|TARGET NODULE|FOREHEAD|LATERAL|UPPER EXTENSOR SURFACE|MULTIPLE|DOUBLE IMMUNODIFFUSION|||INVESTIGATOR|FORENSIC PATHOLOGIST|U|1|5|TREATMENT|2021-03-28|85
e|TU|f89c08df-2e24-4c97-a451-1980cecebf14|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|NON-TARGET|PROXIMAL INTERPHALANGEAL JOINT 2 OF THE HAND|IPSILATERAL|SUPERFICIAL|PARTIAL|PHOTOMETRY|||SIBLING|ADJUDICATOR 2|N|1|2|TREATMENT|2021-02-12|66
e|TU|dbb225ed-e322-4946-a60a-0fafd7e22953|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|NON-TARGET NON-ENHANCING|LOWER RESPIRATORY SYSTEM|LEFT|VENTROLATERAL|SINGLE|U-HPLC/MS/MS|||PROXY|NEUROLOGIST|Y|1|2|SCREENING|2021-03-19|64
e|TU|95e61698-43f7-4cc5-aafa-06dac7870743|1|[?]|TUMERGE|Tumor Merged|[?]|MEASURED|METACARPOPHALANGEAL JOINT 2|CONTRALATERAL|SUPERIOR|ENTIRE|WESTERGREN||Y|INTERVIEWER|HEMATOLOGIST|Y|1|4|SCREENING|2021-01-20|36
e|TU|151308c7-03aa-4a0b-b13f-9838edb218ef|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|NOT MEASURED|PAROTID GLAND LYMPH NODE|CONTRALATERAL|OUTER|MULTIPLE|PHASE-CONTRAST MRI|Y||INVESTIGATOR|OPHTHALMOLOGIST|N|1|7|FOLLOW-UP|2020-09-24|21
e|TU|f38e0fff-e3f9-4687-b35b-f11f58b2b5f5|1|[?]|LESIDENT|Lesion Identification|[?]|TARGET NODAL|VASTUS INTERMEDIUS MUSCLE|UNILATERAL|INTERMEDIATE|SEGMENT|TELLER ACUITY CARDS|||ADJUDICATION COMMITTEE|NEUROLOGIST 2|N|1|7|SCREENING|2020-06-22|17
e|TU|23605586-1b30-4f05-bb15-417dd3a79994|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|NON-TARGET NODAL|LIP, UPPER|LATERAL|OCCIPITAL|SEGMENT|POLYGRAPHY|||ADJUDICATOR|ADJUDICATOR 1|Y|1|1|FOLLOW-UP|2020-12-18|58
e|TU|57d15ac0-06a6-40e0-9201-4d947651c9b0|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|TARGET|LUNG, LEFT, SUPERIOR LOBE, SUPERIOR LINGULAR SEGMENT|RIGHT|DEEP|ALL|TEMPLATE INCISION METHOD|Y||INTERVIEWER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|NA|1|7|SCREENING|2020-09-14|27
e|TU|7dbd7e4e-12c2-48c2-9ac2-4d9176922722|1|[?]|TUSPLIT|Tumor Split|[?]|NON-TARGET NON-ENHANCING|SMALL SAPHENOUS VEIN|UNILATERAL|PERIVENTRICULAR|SEGMENT|WESTERGREN|Y||ADJUDICATION COMMITTEE|READER 1|NA|1|4|FOLLOW-UP|2020-10-18|77
e|TU|5dbb73e4-6e14-45c4-bcaa-2c571199c74f|1|[?]|TUMIDENT|Tumor Identification|[?]|NON-TARGET ENHANCING|LUNG, RIGHT|UNILATERAL|NASAL|HEMI|MAGNETIC RESONANCE ELASTOGRAPHY||Y|INTERVIEWER|NEUROLOGIST|NA|1|5|TREATMENT|2020-09-19|29
e|TU|ec2c7d40-5bcb-408d-bf6c-77667a92e2d1|1|[?]|LESIDENT|Lesion Identification|[?]|NON-TARGET NODAL|SPINOUS PROCESS|LEFT|ANTEROMEDIAL|ALL|ELECTROMYOGRAPHY|||ADJUDICATION COMMITTEE|CARDIOLOGIST|N|1|6|TREATMENT|2021-02-13|61
e|TU|24c65d59-8d34-4d91-bf0b-6fc6aaaab8ae|1|[?]|TUMERGE|Tumor Merged|[?]|TARGET NODULE|UPPER RESPIRATORY SYSTEM|IPSILATERAL|CENTRAL|SEGMENT|NO INFORMATION|Y||ADJUDICATOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|NA|1|1|SCREENING|2020-08-27|66
e|TU|81f62132-123e-4888-abbe-8e289599e965|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|NON-TARGET|ESOPHAGUS, CERVICAL|IPSILATERAL|SUBCORTICAL|ALL|HPLC|Y||SIBLING|MICROSCOPIST 1|NA|1|6|TREATMENT|2021-01-26|63
e|TU|c16c0dd1-8d1a-4be6-9017-457db68bb8e4|1|[?]|TUMERGE|Tumor Merged|[?]|LOCAL|FALCIFORM LIGAMENT|LATERAL|OUTER|PARTIAL|ULTRASOUND||Y|NON-HEALTH CARE PROFESSIONAL|ONCOLOGIST 1|U|1|5|TREATMENT|2020-07-01|56
e|TU|49282406-97ec-4108-adf9-e01c18ce59c6|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|LOCOREGIONAL|PONS VAROLII|LEFT|UPPER EXTENSOR SURFACE|ENTIRE|SPIRAL CT SCAN WITHOUT CONTRAST|Y||SPOUSE|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|NA|1|4|WASHOUT|2020-07-15|69
e|TU|310936c8-7d24-4eea-9892-1cd8bb675421|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|NOT MEASURED|TARSUS BONE|RIGHT|SUBCORTICAL|SEGMENT|COULOMETRIC TITRATION|Y||SPOUSE|PATHOLOGIST|NA|1|1|SCREENING|2020-09-11|77
e|TU|034e303b-5675-4188-bcea-fc2e53b155d6|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|BENIGN|LUNG, RIGHT MIDDLE LOBE|LEFT|VOLAR|ENTIRE|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|||CLINICAL RESEARCH ASSOCIATE|DERMATOLOGIST|Y|1|7|WASHOUT|2020-05-26|4
e|TU|b09e4a17-0a71-4cd9-bb8d-97e2cca0f649|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|NEW TARGET|VENA CAVA|LEFT|HIND|ALL|ACRIDINE ORANGE STAIN|||INVESTIGATOR|ADJUDICATOR 2|NA|1|2|TREATMENT|2020-09-04|69
e|TU|c912affb-cbc2-4919-81b4-ecaa03908261|1|[?]|LESIDENT|Lesion Identification|[?]|LOCATION OF INTEREST|LATERAL SECOND OBTUSE MARGINAL BRANCH ARTERY|UNILATERAL|SUPERFICIAL|SINGLE|AUDIOMETRY|Y|Y|VENDOR|ADJUDICATOR 1|U|1|4|TREATMENT|2020-09-11|71
e|TU|5af817f0-5dfb-4046-ac7c-4bae16a90036|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|MEASURED|TRAPEZIUS MUSCLE|RIGHT|PERIVENTRICULAR|SINGLE|ICP-MS|||CAREGIVER|OPTOMETRIST|NA|1|4|TREATMENT|2020-09-09|75
e|TU|dcefd656-a59a-4b71-9260-efcbcecd2132|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|NEW NON-TARGET|NAIL BED|LEFT|CENTRAL|ALL|HIGH RESOLUTION MELT ANALYSIS|Y||SIGNIFICANT OTHER|CLINICAL PATHOLOGIST|NA|1|1|TREATMENT|2020-07-04|40
e|TU|641c8067-941a-4f1a-a7b1-4eea0242f1d7|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|LOCATION OF INTEREST|RIGHT POSTERIOR ATRIOVENTRICULAR ARTERY|RIGHT|NASAL|PARTIAL|DIFFUSION WEIGHTED MRI||Y|CAREGIVER|DERMATOLOGIST|Y|1|5|TREATMENT|2021-01-28|47
e|TU|ab6fb8ca-d455-4141-82f7-cdb7eaf7dfda|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|NEW|BLADDER, FUNDUS|LEFT|SUBCORTICAL|SINGLE|AGAR DILUTION|Y||CLINICAL RESEARCH COORDINATOR|ADJUDICATOR 2|N|1|7|TREATMENT|2020-12-19|96
e|TU|b7a9c5a6-98ed-4ca1-98ea-4cfc03749c0f|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|UNKNOWN|LESSER TROCHANTER|IPSILATERAL|ANTEROMEDIAL|SEGMENT|ENDOSCOPY|||HEALTH CARE PROFESSIONAL|READER 1|N|1|3|FOLLOW-UP|2021-01-28|99
e|TU|46304edd-0b05-4819-8fcb-35cf9c02764d|1|[?]|TUMIDENT|Tumor Identification|[?]|NON-TARGET EXTRA NODAL|DISTAL INTERPHALANGEAL JOINT 3|CONTRALATERAL|UPPER FLEXOR SURFACE|ENTIRE|IMPEDANCE CONDUCTIVITY||Y|PARENT|RATER|U|1|4|FOLLOW-UP|2021-02-21|90
e|TU|3fd6dab2-b35f-4cc5-88dd-b507583d9539|1|[?]|TUSPLIT|Tumor Split|[?]|NEW|PORTA HEPATIS LYMPH NODE|RIGHT|UPPER FLEXOR SURFACE|ALL|IMMUNOCHEMILUMINOMETRIC ASSAY|||FRIEND|READER 3|NA|1|4|TREATMENT|2020-07-18|63
e|TU|daa3b89e-637a-43de-86c1-d0db93f00430|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|BENIGN|LUNG, RIGHT, INFERIOR LOBE, SUPERIOR SEGMENT|LATERAL|CAUDAL|SINGLE|IN VITRO GENE EXPRESSION ASSAY|||ADJUDICATION COMMITTEE|MICROSCOPIST 3|NA|1|3|TREATMENT|2020-10-10|9
e|TU|14e9cde0-92f5-48d4-82ec-cc72f07ba40b|1|[?]|TUMIDENT|Tumor Identification|[?]|NON-TARGET NODAL|T8 VERTEBRA|BILATERAL|APICAL|PARTIAL|NO INFORMATION|Y|Y|ADJUDICATION COMMITTEE|ONCOLOGIST|Y|1|7|TREATMENT|2020-08-22|59
e|TU|c22014f2-2d7b-4897-8ad5-e46785e51837|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|NON-MEASURABLE|PRELARYNGEAL LYMPH NODE|UNILATERAL|POSTERIOR|SEGMENT|TELLER ACUITY CARDS||Y|GUARDIAN|RADIOLOGIST 2|N|1|2|TREATMENT|2020-09-25|53
e|TU|987102b2-fe2f-4d72-b8dc-14a71bf034b5|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|DISTANT|SPLENIC LYMPH NODE|UNILATERAL|TEMPORAL|ENTIRE|IMPULSE OSCILLOMETRY|||CHILD|RADIOLOGIST|Y|1|2|TREATMENT|2020-12-14|74
e|TU|24ce0c77-1921-4b87-91da-3627e2afd399|1|[?]|TUMIDENT|Tumor Identification|[?]|NON-TARGET NON-ENHANCING|INTERPHALANGEAL JOINT 4 OF THE HAND|CONTRALATERAL|DISTAL VOLAR|HEMI|TWO-COLOR MICROARRAY|||CHILD|DEVELOPMENTAL PSYCHOLOGIST|Y|1|7|TREATMENT|2021-04-06|77
e|TU|097351a3-9bb2-4af7-8e96-6d4d9d8ccf87|1|[?]|TUMERGE|Tumor Merged|[?]|NEW BONE LESION|BLADDER WALL|LEFT|INTERMEDIATE|ALL|NEXT GENERATION SEQUENCING|Y||SPOUSE|MICROSCOPIST 3|N|1|3|SCREENING|2020-10-13|64
e|TU|f4b83a72-7cde-4e02-8883-05e789c617a8|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|NOT MEASURED|T3 VERTEBRA|IPSILATERAL|OUTER|HEMI|ORCHIDOMETERY|||ADJUDICATION COMMITTEE|RADIOLOGIST 1|N|1|1|TREATMENT|2021-01-08|24
e|TU|c4087538-422a-4bcf-af25-ed4aab36ed4b|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|NON-TARGET|CARDIAC WALL|UNILATERAL|CENTRAL|HEMI|CRYOSCOPY|||CAREGIVER|UROLOGIST|NA|1|6|SCREENING|2021-01-13|14
e|TU|947aefaf-20c7-47fc-ac56-140f9b6f38f3|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|NON-TARGET|LEFT VENTRICULAR BASAL ANTEROLATERAL SEGMENT|LEFT|DORSOLATERAL|SINGLE|PET SCAN|||FAMILY MEMBER|ONCOLOGIST 1|N|1|4|FOLLOW-UP|2021-01-16|81
e|TU|3a0c00eb-5614-4053-844d-6bdb71efb1cd|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|NON-TARGET EXTRA NODAL|SUBCLAVIAN ARTERY|RIGHT|ANTERIOR|HEMI|COMPLEMENT FIXATION|||STUDY SUBJECT|ONCOLOGIST 2|U|1|6|TREATMENT|2020-08-28|27
e|TU|dc3ce247-24dd-4255-85a8-ec7a58d30c86|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|NON-TARGET|POSTERIOR SUPERIOR ILIAC SPINE|UNILATERAL|VENTRAL|ENTIRE|ENDPOINT DILUTION ASSAY|||INDEPENDENT ASSESSOR|MICROSCOPIST 2|Y|1|2|TREATMENT|2020-11-28|58
e|TU|61c19f94-bdfc-456d-ba7a-c9097ca1c645|1|[?]|LESIDENT|Lesion Identification|[?]|MEASURED|DISTAL INTERPHALANGEAL JOINT 3 OF THE FOOT|LATERAL|BASAL|ALL|PUPILLOMETRY|||CLINICAL RESEARCH ASSOCIATE|OTOLARYNGOLOGIST|Y|1|3|TREATMENT|2020-08-16|53
e|TU|1e577f2d-2c45-477d-b74f-af24b81d6d20|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|NON-TARGET ENHANCING|URETHRAL SPHINCTER|IPSILATERAL|APICAL|HEMI|CALCULATION|||INTERVIEWER|FORENSIC PATHOLOGIST|U|1|7|TREATMENT|2020-11-19|67
e|TU|f845101e-c057-4f84-94b3-6043afb42ac7|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|BONE LESION|CARDIAC WALL|UNILATERAL|DORSOLATERAL|ENTIRE|INFRARED SPECTROMETRY|||INDEPENDENT ASSESSOR|PATHOLOGIST 2|N|1|7|FOLLOW-UP|2020-11-01|15
e|TU|4ddb2076-6837-4028-81bc-3e8057475977|1|[?]|TUSPLIT|Tumor Split|[?]|NON-TARGET EXTRA NODAL|RENAL FOSSA|LATERAL|LOWER|SINGLE|IMMUNORADIOMETRIC ASSAY|||HEALTH CARE PROFESSIONAL|CARDIOLOGIST|N|1|2|TREATMENT|2020-12-23|6
e|TU|c165c69c-2ab2-495c-a190-e32d1204bc4e|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|NEW|HEART, ATRIUM|UNILATERAL|CENTRAL|PARTIAL|POTENTIOMETRY|Y||NON-HEALTH CARE PROFESSIONAL|INTERNIST|NA|1|4|SCREENING|2021-03-02|70
e|TU|fa6801a8-544d-44d7-a3e4-e8e18b2f2f69|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|REGIONAL|POSTERIOR POLE OF THE EYE|RIGHT|ANTEROLATERAL|ALL|SXA SCAN|||PARENT|MICROSCOPIST 3|Y|1|6|TREATMENT|2021-01-13|25
e|TU|024a9f6d-4ff1-4673-8617-3790f831fce7|1|[?]|LESIDENT|Lesion Identification|[?]|LOCATION OF INTEREST|URETER|IPSILATERAL|DISTAL|ENTIRE|BETA LACTAMASE||Y|STUDY SUBJECT|HEMATOLOGIST|NA|1|7|WASHOUT|2020-08-09|67
e|TU|40936fc6-251d-4a17-ae9d-3bd1150f8d20|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|LOCOREGIONAL|SHOULDER JOINT|LEFT|VENTRAL|HEMI|NEXT GENERATION TARGETED SEQUENCING|Y||INTERVIEWER|HEMATOLOGIST|NA|1|7|TREATMENT|2021-02-05|89
e|TU|17b9fa7a-f15d-423a-9671-99cd0cbbd362|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|NEW TARGET|EYE, ANTERIOR SEGMENT|IPSILATERAL|BASAL|SEGMENT|ELLA|||ADJUDICATION COMMITTEE|RADIOLOGIST 2|N|1|7|FOLLOW-UP|2021-01-17|77
e|TU|95c4465b-162a-433d-83c9-6d67dd729c9e|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|UNKNOWN|ABDUCTOR DIGITI MINIMI MUSCLE OF THE HAND|LEFT|MEDIAL|MULTIPLE|HIGH RESOLUTION MELT ANALYSIS|||PARENT|PEDIATRIC NEUROLOGIST|Y|1|5|TREATMENT|2020-12-04|53
e|TU|9a205b50-21a9-4fbc-9ca9-a9378aadd5de|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|TARGET NODAL|INFRARENAL AORTA|BILATERAL|SUPERIOR|MULTIPLE|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|||NON-HEALTH CARE PROFESSIONAL|RADIOLOGIST 1|NA|1|3|TREATMENT|2020-08-13|57
e|TU|beb6b1ab-1264-456a-bf2b-81e28493301d|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|BONE LESION|SCAPHOID-TRAPEZOID JOINT|LATERAL|UPPER|ALL|GRADIENT DIFFUSION|||CLINICAL STUDY SPONSOR|READER|N|1|6|TREATMENT|2020-06-23|23
e|TU|4292c06d-044e-4dff-aea0-830178a6e220|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|BONE LESION|GASTROESOPHAGEAL JUNCTION|LATERAL|FRONTAL|SEGMENT|DOUBLE IMMUNODIFFUSION|||PARENT|MICROSCOPIST 3|U|1|6|SCREENING|2021-02-19|89
e|TU|050c12d2-cf9f-402b-9332-d6a9771ed115|1|[?]|TUMIDENT|Tumor Identification|[?]|NON-TARGET EXTRA NODAL|LUNG, RIGHT, INFERIOR LOBE, SUPERIOR SEGMENT|LATERAL|PERIPHERAL|SINGLE|PULSE OXIMETRY||Y|FRIEND|DEVELOPMENTAL PSYCHOLOGIST|NA|1|3|FOLLOW-UP|2020-09-26|49
e|TU|2f1073e4-607f-423f-a5de-f531b828e2d3|1|[?]|TUMERGE|Tumor Merged|[?]|NON-TARGET|BLADDER, TRIGONE|IPSILATERAL|LATERAL|SEGMENT|POPULATION SEQUENCING|||HEALTH CARE PROFESSIONAL|PATHOLOGIST|NA|1|2|TREATMENT|2021-01-06|93
e|TU|df466903-3212-4e73-bff0-a183447c7408|1|[?]|NTIND|Non-Target Indicator|[?]|NON-TARGET ENHANCING|URETER|IPSILATERAL|PERIPHERAL|SINGLE|FLOCCULATION, CHARCOAL ENHANCED|||DOMESTIC PARTNER|UROLOGIST|NA|1|7|TREATMENT|2020-10-31|9
e|TU|4eeb68ac-cd3a-4d3c-8381-2d715c8fa442|1|[?]|TUSPLIT|Tumor Split|[?]|NEW NON-TARGET|METATARSOPHALANGEAL JOINT 1|IPSILATERAL|ANTEROTEMPORAL|MULTIPLE|MEDIASTINOSCOPY|Y||ADJUDICATION COMMITTEE|OPTOMETRIST|NA|1|3|TREATMENT|2020-07-11|8
e|TU|c37df2f6-be8a-4709-b97d-061ab9754e0d|1|[?]|LESIDENT|Lesion Identification|[?]|NEW TARGET|PERIUMBILICAL REGION|LEFT|DISTAL|ALL|ANGIOGRAPHY|Y||ADJUDICATOR|READER 3|Y|1|7|TREATMENT|2020-09-15|55
e|TU|c0120c9e-c421-4a2e-a85b-170f2d1c0f3f|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|TARGET NODAL|SUPRACLAVICULAR FOSSA|BILATERAL|ANTEROLATERAL|PARTIAL|BETA LACTAMASE|||VENDOR|OPTOMETRIST|U|1|7|TREATMENT|2020-07-08|66
e|TU|cec9e0ce-4d09-470c-9c26-df661d316a69|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|NEW BONE LESION|NASAL SEPTUM|LEFT|TEMPORAL|PARTIAL|ECHOCARDIOGRAPHY|||CHILD|ONCOLOGIST 2|N|1|2|WASHOUT|2021-02-08|44
e|TU|b98b4e19-51ac-40cc-80d5-cb6d8000c112|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|MEASURED|HUMERUS|UNILATERAL|ANTERIOR|HEMI|CONTRAST ENHANCED SPIRAL CT SCAN|Y||PARENT|RATER 2|U|1|5|TREATMENT|2021-04-16|99
e|TU|525e8b0c-b2cf-46b0-a1e1-9f5368ba97df|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|NON-TARGET|METACARPAL BONE 1|UNILATERAL|ROSTRAL|PARTIAL|FLUORESCENT SPOT TEST|||PARENT|NEUROLOGIST 1|N|1|3|TREATMENT|2020-07-14|17
e|TU|4bc30b18-c8d8-41a3-91d5-33b8b064087b|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|NOT MEASURED|AXILLARY LYMPH NODE LEVEL III|CONTRALATERAL|TEMPORAL|ALL|TEST STRIP|||SIGNIFICANT OTHER|MICROSCOPIST 1|N|1|2|TREATMENT|2020-07-06|4
e|TU|7ff27a70-0472-4cc1-b057-6b161ab29568|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|UNKNOWN|RIB|LATERAL|HIND|ALL|MAPH|||FAMILY MEMBER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|Y|1|4|WASHOUT|2020-11-19|10
e|TU|40529b01-9a80-4ada-a8df-96eec0e65043|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|NON-TARGET NODAL|FLANK|IPSILATERAL|MEDIAL|ENTIRE|ENDOSCOPY||Y|FAMILY MEMBER|OTOLARYNGOLOGIST|Y|1|1|WASHOUT|2020-06-21|14
e|TU|f3e22efc-0948-4c6e-9173-8e284d342d33|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|DISTANT|LIMB|LEFT|ANTEROMEDIAL|SINGLE|ANTIMICROBIAL COMBINATION TESTING||Y|NON-HEALTH CARE PROFESSIONAL|ADJUDICATOR 3|N|1|1|TREATMENT|2021-01-22|57
e|TU|919eb5b4-a3df-41c6-86f7-c78501bb4335|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|UNKNOWN|GLOSSOPHARYNGEAL NERVE|RIGHT|LOWER FLEXOR SURFACE|PARTIAL|IMMUNOPRECIPITATION|||ADJUDICATION COMMITTEE|CARDIOLOGIST|NA|1|3|SCREENING|2020-09-26|5
e|TU|f918d6e0-6fc2-4303-b323-521c5d531773|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|REGIONAL|ADDUCTOR BREVIS MUSCLE|LEFT|ANTEROLATERAL|SINGLE|GRAM STAIN|Y|Y|SIGNIFICANT OTHER|ADJUDICATOR 1|NA|1|7|TREATMENT|2020-08-06|16
e|TU|1d9bccfd-ab01-460f-b1b5-9d1859ee7f66|1|[?]|TUMIDENT|Tumor Identification|[?]|UNKNOWN|MALE GENITALIA|CONTRALATERAL|PROXIMAL|HEMI|SLOAN LETTER EYE CHART 1.25%|||INTERVIEWER|RATER 2|U|1|7|TREATMENT|2021-01-29|76
e|TU|4b1e011f-a16d-4ff6-902d-451d5d13ee97|1|[?]|TUMIDENT|Tumor Identification|[?]|TARGET NODAL|STERNUM|UNILATERAL|ANTEROLATERAL|MULTIPLE|IMPEDANCE CONDUCTIVITY|||CLINICAL RESEARCH COORDINATOR|FORENSIC PATHOLOGIST|N|1|3|WASHOUT|2020-08-25|75
e|TU|d6d26e31-eaa0-4d4b-9df3-3c3d6b38f571|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|DISEASE SITE|COLON, DESCENDING|BILATERAL|SURFACE|ENTIRE|KINETIC MICROPARTICLE IMMUNOASSAY||Y|ADJUDICATION COMMITTEE|PATHOLOGIST 2|NA|1|2|TREATMENT|2020-09-07|60
e|TU|b49e6f4b-862e-4ad5-8964-51c94d2a03ec|1|[?]|LESIDENT|Lesion Identification|[?]|NON-TARGET ENHANCING|CHEST|IPSILATERAL|TIP|SEGMENT|TARGETED GENOME SEQUENCING|||ADJUDICATION COMMITTEE|READER 1|N|1|1|TREATMENT|2021-02-23|98
e|TU|5c7645b5-5b4c-4280-878b-f5bd0e4349a7|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|NON-TARGET NODAL|PAROTID GLAND LYMPH NODE|BILATERAL|INTERMEDIATE|ALL|PUPILLOMETRY|||CLINICAL STUDY SPONSOR|PEDIATRIC NEUROLOGIST|U|1|5|SCREENING|2021-02-12|75
e|TU|87cd5d40-3ece-4e63-8f8f-13761cc94a2b|1|[?]|LESIDENT|Lesion Identification|[?]|TARGET NODAL|SYMPATHETIC GANGLIA|LATERAL|INTERMEDIATE|HEMI|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION||Y|SPOUSE|RATER 1|N|1|4|TREATMENT|2020-09-25|91
e|TU|7f1e0661-ebbd-4abd-9031-cb6b424977e2|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|TARGET NODAL|HAIR|UNILATERAL|ANTEROLATERAL|ENTIRE|GC/MS/MS|||INVESTIGATOR|MICROSCOPIST|NA|1|4|TREATMENT|2020-12-17|14
e|TU|324a2c67-4802-4806-aff2-04fb9c7394d4|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|NON-TARGET|DISTAL INTERPHALANGEAL JOINT 4|LEFT|VENTRAL|SEGMENT|NON-INVASIVE DIELECTRIC SENSING|||INDEPENDENT ASSESSOR|NEUROLOGIST|N|1|7|TREATMENT|2020-08-13|88
e|TU|9e6a2b90-c6ec-4d7d-96a3-8445f34ad4e7|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|DISTANT|ETHMOID SINUS|LEFT|OCCIPITAL|HEMI|PHOTOGRAPHY|||CLINICAL RESEARCH ASSOCIATE|READER|NA|1|6|TREATMENT|2021-02-05|58
e|TU|f00837ad-bf06-4fbc-a50b-289ac5c5dc03|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|BENIGN|LINGULA OF THE LUNG|LEFT|POSTERIOR|SINGLE|INTRAVASCULAR ULTRASOUND||Y|DOMESTIC PARTNER|NEUROLOGIST 1|Y|1|6|TREATMENT|2020-11-20|98
e|TU|911dc297-91cb-42b1-8a26-18f6c83c32a6|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|LOCAL|FOREARM|BILATERAL|MIDLINE|SEGMENT|GC/FID|Y|Y|CLINICAL RESEARCH COORDINATOR|MICROSCOPIST|Y|1|1|FOLLOW-UP|2021-01-31|71
e|TU|d87b795c-d158-4429-bdc6-1a2db7dc1a7d|1|[?]|NTIND|Non-Target Indicator|[?]|TARGET NODAL|RETROAURICULAR LYMPH NODE|RIGHT|FORE|ENTIRE|TEST STRIP|||SIBLING|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|U|1|6|SCREENING|2021-02-13|90
e|TU|9bfcd733-2233-4e54-a6cd-641a59fc8a01|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|LOCATION OF INTEREST|MITRAL VALVE ANNULUS|BILATERAL|INTERMEDIATE|MULTIPLE|CONGO RED STAIN||Y|INDEPENDENT ASSESSOR|CARDIOLOGIST|Y|1|5|SCREENING|2020-10-18|74
e|TU|7eb97152-173c-4923-8604-5dad3140cc25|1|[?]|NTIND|Non-Target Indicator|[?]|TARGET|CARDIOVASCULAR SYSTEM|LATERAL|UPPER FLEXOR SURFACE|ENTIRE|TEST STRIP|Y||NON-HEALTH CARE PROFESSIONAL|ENDOCRINOLOGIST|U|1|3|WASHOUT|2020-10-12|47
e|TU|0b2104d0-e1e3-4516-8c4b-de5d42f82784|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|NEW BONE LESION|AZYGOS VEIN|CONTRALATERAL|PARIETO-OCCIPITAL|MULTIPLE|ROMANOWSKY STAIN|Y||NON-HEALTH CARE PROFESSIONAL|READER|NA|1|1|TREATMENT|2020-10-09|72
e|TU|96f68979-6869-403b-a8bd-78c8f965f98a|1|[?]|NTIND|Non-Target Indicator|[?]|DISEASE SITE|EYELASH|BILATERAL|FRONTAL|ALL|MODIFIED ACID FAST STAIN|||STUDY SUBJECT|NEUROLOGIST 2|U|1|6|FOLLOW-UP|2020-05-25|9
e|TU|e0f67610-b86a-4f5a-88eb-905b1e0aa609|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|NON-MEASURABLE|PARIETAL LOBE|UNILATERAL|PERIPHERAL|ENTIRE|PHOTOMETRY|Y||VENDOR|READER 3|N|1|7|WASHOUT|2020-10-12|6
e|TU|d62dc655-8865-4592-af0b-744524d9a24c|1|[?]|TUSPLIT|Tumor Split|[?]|TARGET NODULE|TRICUSPID VALVE, POSTERIOR CUSP|IPSILATERAL|FORE|SEGMENT|FUNDUS PHOTOGRAPHY|Y||VENDOR|RADIOLOGIST 1|Y|1|6|SCREENING|2020-09-26|7
e|TU|6f2a59ba-1a8e-475f-b8c7-d8c6a9bf8b63|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|TARGET NODAL|PREPUTIAL GLAND|IPSILATERAL|ANTEROPOSTERIOR|ALL|ELLA||Y|SIGNIFICANT OTHER|RADIOLOGIST 1|Y|1|6|WASHOUT|2021-03-25|86
e|TU|8005bd56-3bd6-477a-a466-b9a3bd189770|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|NON-TARGET EXTRA NODAL|DISTAL CIRCUMFLEX ARTERY|LEFT|VENTRAL|ENTIRE|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|||ADJUDICATION COMMITTEE|INTERNIST|Y|1|7|WASHOUT|2020-12-23|10
e|TU|078ea33d-4114-4320-9116-740b8385a94e|1|[?]|NTIND|Non-Target Indicator|[?]|NON-TARGET ENHANCING|DENTAL ARCH|RIGHT|MIDLINE|MULTIPLE|SICKLE CELL SOLUBILITY TEST|||VENDOR|CARDIOLOGIST|NA|1|4|TREATMENT|2020-09-30|76
e|TU|1ca91975-9a42-4f4d-9c55-53f7561d82fa|1|[?]|NTIND|Non-Target Indicator|[?]|NON-TARGET NON-ENHANCING|ILIAC VEIN|RIGHT|TIP|MULTIPLE|MICROBIAL CULTURE, LIQUID|||FRIEND|RADIOLOGIST 1|NA|1|5|SCREENING|2020-05-28|4
e|TU|c5f292ad-1729-402b-820f-83ecd29ba00d|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|BONE LESION|INTERPHALANGEAL JOINT 2 OF THE HAND|LEFT|PROXIMAL VOLAR|PARTIAL|RULER MEASUREMENT METHOD|||SPOUSE|READER 2|NA|1|2|SCREENING|2020-07-19|51
e|TU|a746aefb-16c8-43db-a0c4-8e9a4efdb244|1|[?]|LESIDENT|Lesion Identification|[?]|NON-TARGET|EYELID|UNILATERAL|CENTRAL|SINGLE|FLUORESCENT ENZYME IMMUNOASSAY|Y|Y|STUDY SUBJECT|ONCOLOGIST|Y|1|3|TREATMENT|2020-07-07|20
e|TU|7f95b9c0-3b77-4c60-8890-ecc955f97122|1|[?]|NTIND|Non-Target Indicator|[?]|NEW BONE LESION|THROAT|UNILATERAL|DISTAL|MULTIPLE|CISH|||CHILD|OTOLARYNGOLOGIST|U|1|4|TREATMENT|2020-11-25|71
e|TU|2be43c56-83f3-4148-9cb1-97c6d191d20e|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|LOCATION OF INTEREST|KIDNEY, UPPER LOBE|LATERAL|PERIPHERAL|ALL|EIA|||CLINICAL STUDY SPONSOR|ADJUDICATOR 3|NA|1|5|TREATMENT|2020-10-13|20
e|TU|e27e0325-5fbe-46c0-8264-982d83124203|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|NEW NON-TARGET|AORTIC VALVE, LEFT CORONARY CUSP|IPSILATERAL|PERIPHERAL|MULTIPLE|NEPHELOMETRY|||SIBLING|ADJUDICATOR|Y|1|2|WASHOUT|2020-08-03|37
e|TU|9ff51377-d75c-4c9a-aa45-f2f8d6f4ffbf|1|[?]|TUSPLIT|Tumor Split|[?]|NON-TARGET|ASCENDING AORTA, SINUS OF VALSALVA|IPSILATERAL|LOWER FLEXOR SURFACE|SEGMENT|AUTOREFRACTION||Y|HEALTH CARE PROFESSIONAL|ONCOLOGIST 1|N|1|2|TREATMENT|2021-01-13|35
e|TU|29e08650-9eae-461f-981e-f2a20d8d4492|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|DISTANT|EYE, ANTERIOR CHAMBER|UNILATERAL|OCCIPITAL|SINGLE|ENZYMATIC COLORIMETRY|||CLINICAL STUDY SPONSOR|FORENSIC PATHOLOGIST|NA|1|4|TREATMENT|2021-02-03|88
e|TU|2b944a62-10bc-475e-a90d-da3f07a2c4df|1|[?]|TUSPLIT|Tumor Split|[?]|DISEASE SITE|SACRAL VERTEBRA|CONTRALATERAL|ROSTRAL|SINGLE|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY||Y|DOMESTIC PARTNER|ONCOLOGIST 1|U|1|3|TREATMENT|2020-10-25|64
e|TU|d6e51edb-0983-4ffb-b5a6-59afc2696ce8|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|NON-TARGET ENHANCING|JUGULAR VEIN|BILATERAL|PROXIMAL|SEGMENT|EIA|Y||CLINICAL RESEARCH COORDINATOR|ADJUDICATOR|Y|1|5|SCREENING|2020-10-23|54
e|TU|8aa77db3-b078-4073-a7f3-9b9a7fb14570|1|[?]|LESIDENT|Lesion Identification|[?]|NEW TARGET|PRETRACHEAL LYMPH NODE|CONTRALATERAL|UPPER EXTENSOR SURFACE|MULTIPLE|GEL ELECTROPHORESIS|||INVESTIGATOR|HEMATOLOGIST|U|1|1|TREATMENT|2021-01-20|79
e|TU|1fce031b-680b-414f-9b74-d6383e10091d|1|[?]|NTIND|Non-Target Indicator|[?]|NEW|PERIPHERAL NERVE|LEFT|CENTRAL|SEGMENT|AURAMINE STAIN||Y|DOMESTIC PARTNER|PHYSIOTHERAPIST|NA|1|2|FOLLOW-UP|2020-07-15|55
e|TU|dcc67696-e91a-4cef-81dd-f2d2711363ae|1|[?]|NTIND|Non-Target Indicator|[?]|MEASURED|EXTRAHEPATIC BILE DUCT|LEFT|PROXIMAL VOLAR|SEGMENT|CONTRAST ENHANCED PET SCAN|||CLINICAL RESEARCH COORDINATOR|ADJUDICATOR 2|NA|1|7|TREATMENT|2021-02-19|63
e|TU|91e83d7a-186a-4fed-8750-af796d77d356|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|LOCOREGIONAL|ACUTE MARGINAL ARTERY|UNILATERAL|INFERIOR|MULTIPLE|MICRO BROTH DILUTION|||ADJUDICATOR|OPTOMETRIST|U|1|4|WASHOUT|2020-06-30|38
e|TU|fdd8b4e9-8499-45ad-bd93-9de5992faf1e|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|TARGET|ILIAC FOSSA|RIGHT|PERIPHERAL|HEMI|FARR ASSAY|||INTERVIEWER|RADIOLOGIST|U|1|3|WASHOUT|2020-07-18|76
e|TU|0145dfac-a107-4368-b358-bcd136e1ecb3|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|MEASURED|CORONARY SINUS|IPSILATERAL|PROXIMAL VOLAR|MULTIPLE|FLOCCULATION, CHARCOAL ENHANCED|||ADJUDICATOR|DEVELOPMENTAL PSYCHOLOGIST|Y|1|7|WASHOUT|2021-01-10|12
e|TU|cfbbaa65-9742-4682-9ec0-4d503bca0bb1|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|DISTANT|HAMSTRING MUSCLE|UNILATERAL|LOWER FLEXOR SURFACE|SEGMENT|LASER CAPTURE MICRODISSECTION|||FAMILY MEMBER|PATHOLOGIST 2|NA|1|5|TREATMENT|2021-01-06|18
e|TU|d4d79f6a-ba90-4503-934b-8a86286d83d3|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|LOCAL|HEPATIC ARTERY|LEFT|TIP|PARTIAL|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|||INDEPENDENT ASSESSOR|OTOLARYNGOLOGIST|NA|1|1|TREATMENT|2020-11-13|6
e|TU|a329c350-49e2-415d-ba3c-e1ee929aec86|1|[?]|TUSPLIT|Tumor Split|[?]|TARGET EXTRA NODAL|PRELARYNGEAL LYMPH NODE|RIGHT|DORSOLATERAL|ALL|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|Y|Y|DOMESTIC PARTNER|MICROSCOPIST 2|N|1|3|TREATMENT|2020-10-21|77
e|TU|ff0e3543-c1f3-47f8-987f-7b00a4a33704|1|[?]|TUSPLIT|Tumor Split|[?]|NEW BONE LESION|GASTRIC CARDIA|LEFT|UPPER|HEMI|NUCLEIC ACID HYBRIDIZATION|Y||SIGNIFICANT OTHER|PATHOLOGIST|N|1|4|SCREENING|2020-10-01|10
e|TU|128153ce-7bee-4f8d-bb60-fb1776370b6d|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|TARGET NODAL|SUPRARENAL AORTA|LEFT|PERIPHERAL|PARTIAL|PET/MRI SCAN|Y|Y|DOMESTIC PARTNER|ADJUDICATOR 2|Y|1|2|TREATMENT|2021-01-23|22
e|TU|22ee2f20-4a66-458f-a153-9d7e871e1db2|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|NEW NON-TARGET|RADIUS-LUNATE JOINT|UNILATERAL|ANTEROLATERAL|PARTIAL|FLUORESCENT LIFETIME IMAGING MICROSCOPY|||CLINICAL RESEARCH COORDINATOR|UROLOGIST|N|1|5|WASHOUT|2020-07-15|38
e|TU|b7caaa04-bcc7-4350-ad98-85670a19778f|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|DISEASE SITE|GENITALIA|CONTRALATERAL|INFERIOR|SINGLE|MECHANICAL CLOT DETECTION|Y||CLINICAL STUDY SPONSOR|READER|N|1|3|TREATMENT|2020-07-18|22
e|TU|2b58d5fd-3ec8-415b-bb53-a252049f228a|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|NON-TARGET EXTRA NODAL|CORNEA|CONTRALATERAL|PROXIMAL VOLAR|PARTIAL|AURAMINE STAIN|||FAMILY MEMBER|READER 1|U|1|3|TREATMENT|2020-12-22|15
e|TU|60b23345-43f6-42eb-9225-5a674456c9b9|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|DISTANT|EXTRAHEPATIC BILE DUCT|CONTRALATERAL|LOWER FLEXOR SURFACE|ENTIRE|FARNSWORTH-MUNSELL 100 HUE TEST||Y|FRIEND|ADJUDICATOR 3|Y|1|2|TREATMENT|2021-01-13|8
e|TU|7979239e-2a6b-48e3-9d11-41c97b33d229|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|NEW NON-TARGET|MOTOR CORTEX|IPSILATERAL|VENTROLATERAL|PARTIAL|IMMUNOTURBIDIMETRY||Y|STUDY SUBJECT|ADJUDICATOR 1|Y|1|1|SCREENING|2021-03-18|72
e|TU|027cd2f5-6bb8-41b2-8fb7-16ebff6155f1|1|[?]|LESIDENT|Lesion Identification|[?]|DISEASE SITE|LIVER, LEFT LOBE|IPSILATERAL|MEDIAL|PARTIAL|CLIP SEQUENCING|||CHILD|READER 2|NA|1|4|FOLLOW-UP|2020-08-24|28
e|TU|3107cfa6-4eb9-433c-9cc6-79ec64f916f9|1|[?]|TUMIDENT|Tumor Identification|[?]|MEASURED|CHOROID|CONTRALATERAL|ROSTRAL|ALL|MAGNETIC RESONANCE ANGIOGRAPHY|||INVESTIGATOR|FORENSIC PATHOLOGIST|Y|1|5|SCREENING|2021-03-03|67
e|TU|da35fc01-4258-4e4d-99d9-4172e84c46e8|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|NON-TARGET NODAL|GREAT TROCHANTER|BILATERAL|DISTAL|HEMI|MAGNETIC RESONANCE ELASTOGRAPHY|Y||SIBLING|OTOLARYNGOLOGIST|N|1|3|TREATMENT|2020-09-21|71
e|TU|bd163bba-f977-4f1a-8baf-5b6e7ecd94d9|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|BONE LESION|SUPRAGLOTTIS|LATERAL|LOWER EXTENSOR SURFACE|HEMI|INCISION-INDUCED BLEEDING METHOD|||PARENT|FORENSIC PATHOLOGIST|NA|1|5|WASHOUT|2020-10-02|69
e|TU|ddcd6b0e-ca09-4693-bdfc-33e7d7979a6f|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|NON-TARGET ENHANCING|CORNEAL EPITHELIUM|LATERAL|FACIAL|PARTIAL|INFRARED SPECTROMETRY|||GUARDIAN|PATHOLOGIST 2|NA|1|5|TREATMENT|2021-02-08|66
e|TU|31b865ec-cf8f-499f-85e9-931dbfa2cf1c|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|NON-TARGET NON-ENHANCING|HEAD OF THE HUMERUS|CONTRALATERAL|MEDIAL|SINGLE|MICROBIAL BIOCHEMICAL IDENTIFICATION||Y|FAMILY MEMBER|HEMATOLOGIST|NA|1|2|TREATMENT|2020-06-13|14
e|TU|3f5d82c3-eb6c-4b9a-8fb7-10cf59e6d4bd|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|NON-TARGET EXTRA NODAL|TRICUSPID VALVE|LATERAL|INNER|ALL|ISHIHARA COLOR PLATES|Y|Y|DOMESTIC PARTNER|OPHTHALMOLOGIST|N|1|3|TREATMENT|2020-07-30|77
e|TU|136d59c6-9645-447a-a047-68d33dbb708e|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|NON-MEASURABLE|SKIN OF THE HAND|IPSILATERAL|UPPER|HEMI|MULTIPLEXED BEAD BASED IMMUNOASSAY|||CAREGIVER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|NA|1|1|TREATMENT|2020-10-13|29
e|TU|2e393b90-213c-4661-ad55-cabb2008bf14|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|NON-TARGET NODAL|SKIN OF THE INFRASCAPULAR REGION|UNILATERAL|PROXIMAL VOLAR|PARTIAL|ELECTROPHORESIS|||CLINICAL RESEARCH COORDINATOR|READER 2|NA|1|2|WASHOUT|2020-07-21|35
e|TU|f72002d8-262b-49da-84a4-42e6011286f0|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|NON-TARGET NON-ENHANCING|FLEXOR DIGITORUM BREVIS MUSCLE|IPSILATERAL|INFERIOR|SINGLE|DIGITAL PCR ARRAY|||INTERVIEWER|READER 3|Y|1|1|TREATMENT|2020-10-06|2
e|TU|68869dda-531d-4218-b2b0-4f5f46825569|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|BENIGN|ULNAR NERVE|RIGHT|INTERMEDIATE|MULTIPLE|WHOLE GENOME SEQUENCING|||NON-HEALTH CARE PROFESSIONAL|ONCOLOGIST 2|NA|1|6|SCREENING|2021-02-05|69
e|TU|68888445-1819-4f4c-bd0c-a445906476fb|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|DISTANT|KIDNEY, LOWER LOBE|CONTRALATERAL|UPPER FLEXOR SURFACE|PARTIAL|ENDPOINT DILUTION ASSAY|||SIGNIFICANT OTHER|ONCOLOGIST 1|Y|1|6|FOLLOW-UP|2021-01-06|2
e|TU|b2ce31a0-513a-449a-aa2c-7c9668fde275|1|[?]|LESIDENT|Lesion Identification|[?]|BONE LESION|HYPOGLOSSAL NERVE|CONTRALATERAL|ANTEROMEDIAL|PARTIAL|THICK SMEAR|Y||INVESTIGATOR|INTERNIST|N|1|7|TREATMENT|2020-09-01|79
e|TU|6c1d481b-985a-4be0-97ca-ecd06a81b456|1|[?]|NTIND|Non-Target Indicator|[?]|NEW BONE LESION|CORPUS STRIATUM|LATERAL|UPPER|SINGLE|CT SCAN|||INDEPENDENT ASSESSOR|NEUROLOGIST 1|U|1|4|FOLLOW-UP|2020-12-08|74
e|TU|645a9247-efcb-4641-9514-58d6e28560e0|1|[?]|NTIND|Non-Target Indicator|[?]|NON-TARGET ENHANCING|CENTRAL NERVOUS SYSTEM|UNILATERAL|HIND|ENTIRE|SNP ARRAY|||SPOUSE|ENDOCRINOLOGIST|Y|1|1|WASHOUT|2021-01-21|41
e|TU|9e2164c8-0f5b-4951-83b8-487ed7b2d0a7|1|[?]|TUSPLIT|Tumor Split|[?]|BENIGN|MEDIAL FEMORAL CONDYLE|CONTRALATERAL|SUPERIOR|ENTIRE|MRI|||FRIEND|READER 1|NA|1|7|TREATMENT|2020-11-09|65
e|TU|05b05951-b1ba-4c51-b50f-9c842532bc4e|1|[?]|LESIDENT|Lesion Identification|[?]|NEW|ULNAR ARTERY|BILATERAL|UPPER FLEXOR SURFACE|SINGLE|DYNAMIC CONTRAST ENHANCED MRI|||ADJUDICATOR|RATER|Y|1|4|TREATMENT|2020-09-16|60
e|TU|ab38e976-8c2b-48ff-bdba-5a056637ecdd|1|[?]|TUMERGE|Tumor Merged|[?]|LOCATION OF INTEREST|SHOULDER JOINT TENDONS|CONTRALATERAL|LOWER EXTENSOR SURFACE|SINGLE|TARGETED GENOME SEQUENCING|||SIBLING|READER|N|1|3|TREATMENT|2020-11-09|27
e|TU|f19cb801-34fc-42fd-8691-ccfb6c5f8bb6|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|NON-TARGET ENHANCING|SACRUM|LEFT|LOWER|SEGMENT|LC/MS/MS||Y|STUDY SUBJECT|NEUROLOGIST 2|NA|1|6|WASHOUT|2020-10-30|70
e|TU|51a49847-6405-4842-b549-0e2ab99f61b2|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|NON-TARGET NODAL|EYELASH|RIGHT|NASAL|PARTIAL|ELECTRONEUROGRAPHY||Y|HEALTH CARE PROFESSIONAL|RATER|NA|1|6|FOLLOW-UP|2021-03-29|82
e|TU|44dcfb9a-c590-4826-a28c-b5e9f83129d5|1|[?]|TUMERGE|Tumor Merged|[?]|NON-TARGET NON-ENHANCING|ASCENDING AORTA, AORTIC ROOT|UNILATERAL|POSTERIOR|MULTIPLE|TOLUIDINE BLUE STAIN|||FRIEND|ONCOLOGIST|U|1|3|TREATMENT|2020-06-19|39
e|TU|98166d74-caa7-4693-a817-b2cbae947ff8|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|UNKNOWN|HEEL OF THE HAND|BILATERAL|NASAL|HEMI|POPULATION SEQUENCING|||ADJUDICATOR|RADIOLOGIST|NA|1|6|TREATMENT|2021-02-25|55
e|TU|cb07675a-2042-44da-a1f9-8b7783347e88|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|BENIGN|RECTO-UTERINE POUCH|UNILATERAL|INTERMEDIATE|ENTIRE|FLOW MICROSCOPY||Y|INDEPENDENT ASSESSOR|HEMATOLOGIST|NA|1|1|TREATMENT|2021-03-02|97
e|TU|a8a14aa1-4484-4bbc-86bf-c44257146a26|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|BONE LESION|METACARPAL BONE 2|UNILATERAL|TIP|SINGLE|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|||INDEPENDENT ASSESSOR|OPTOMETRIST|Y|1|2|TREATMENT|2020-08-08|48
e|TU|dfa4c661-9317-4bec-b307-a31eeadcaba6|1|[?]|TUMERGE|Tumor Merged|[?]|UNKNOWN|GUT-ASSOCIATED LYMPHOID TISSUE|CONTRALATERAL|DEEP|ALL|SINGLE-SLICE SPIRAL CT|||INDEPENDENT ASSESSOR|RATER 2|Y|1|4|TREATMENT|2020-07-10|46
e|TU|9ed984a9-c153-4729-9dc9-3bb3d9059919|1|[?]|NTIND|Non-Target Indicator|[?]|TARGET EXTRA NODAL|GASTROINTESTINAL TRACT|CONTRALATERAL|OCCIPITAL|ALL|POTENTIOMETRY|||PARENT|READER 1|NA|1|2|FOLLOW-UP|2020-09-30|39
e|TU|fb234b67-3c81-4d55-bc63-2389a23d67b2|1|[?]|TUMIDENT|Tumor Identification|[?]|BONE LESION|ATRIOVENTRICULAR VALVE|BILATERAL|PROXIMAL VOLAR|PARTIAL|U-HPLC/MS/MS|||CLINICAL STUDY SPONSOR|MICROSCOPIST 1|NA|1|2|TREATMENT|2021-03-09|67
e|TU|84d7ff44-cbe2-446f-b667-5bc539de519b|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|REGIONAL|MUSCLE|LATERAL|NASAL|ENTIRE|ECHOCARDIOGRAPHY|Y||CLINICAL STUDY SPONSOR|OTOLARYNGOLOGIST|N|1|5|TREATMENT|2020-07-13|17
e|TU|c96e4485-4aff-4c18-9c65-5f1a800cc6db|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|DISEASE SITE|COSTOCHONDRAL JOINT 1|BILATERAL|POSTERIOR|ENTIRE|RADIOIMMUNOPRECIPITATION ASSAY||Y|GUARDIAN|RADIOLOGIST 1|NA|1|3|SCREENING|2020-12-12|89
e|TU|955188f1-b434-40ab-94c8-0c0fb7f23e84|1|[?]|TUMIDENT|Tumor Identification|[?]|TARGET|DISTAL LAD ARTERY|LEFT|ROSTRAL|ALL|NEURAMINIDASE INHIBITION ASSAY|||INVESTIGATOR|PATHOLOGIST 1|Y|1|4|TREATMENT|2021-01-18|45
e|TU|5a384b5e-954c-4af9-bd60-96aadc72ca44|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|TARGET NODAL|HEART, ATRIUM|BILATERAL|ANTEROLATERAL|PARTIAL|CAPILLARY ELECTROPHORESIS|||CLINICAL RESEARCH ASSOCIATE|HEMATOLOGIST|U|1|3|SCREENING|2020-12-02|64
e|TU|2c2d4104-35dd-4f81-ac31-ab1f84c2bc35|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|REGIONAL|JOINT|CONTRALATERAL|POSTERIOR|MULTIPLE|IRON HEMATOXYLIN STAIN|||SIBLING|CLINICAL PATHOLOGIST|N|1|3|TREATMENT|2020-07-22|30
e|TU|f9432d72-f7d7-4cdf-a173-2e2029258474|1|[?]|TUMERGE|Tumor Merged|[?]|NEW BONE LESION|COSTOCHONDRAL JOINT 1|CONTRALATERAL|POSTERIOR|SEGMENT|TARGETED TRANSCRIPTOME SEQUENCING|||SIGNIFICANT OTHER|UROLOGIST|Y|1|7|FOLLOW-UP|2020-11-30|20
e|TU|1382c3ff-89fd-48e2-b64d-56c8ca9c71d3|1|[?]|TUMERGE|Tumor Merged|[?]|NEW TARGET|HAND DIGIT 2|LATERAL|SUPERIOR|MULTIPLE|NEXT GENERATION TARGETED SEQUENCING|||ADJUDICATOR|PEDIATRIC NEUROLOGIST|NA|1|5|FOLLOW-UP|2021-02-12|65
e|TU|0fc0650f-ed95-422d-b407-dcee93178780|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|NON-TARGET EXTRA NODAL|RIGHT POSTERIOR DESCENDING ARTERY|LEFT|SURFACE|SINGLE|ROMANOWSKY STAIN|Y||DOMESTIC PARTNER|ONCOLOGIST|Y|1|4|TREATMENT|2020-09-19|37
e|TU|3b5e8a1c-1174-4f60-8a95-b2cf413f7e39|1|[?]|TUMIDENT|Tumor Identification|[?]|NEW BONE LESION|SCAPHOID-TRAPEZOID JOINT|CONTRALATERAL|INTERMEDIATE|MULTIPLE|APPLANATION TONOMETRY|||CLINICAL STUDY SPONSOR|INTERNIST|U|1|4|TREATMENT|2020-07-19|56
e|TU|a6f48290-787a-46ad-bee1-ae263ad3c121|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|NON-TARGET|RADIAL NERVE|LATERAL|LATERAL|SINGLE|ACID FAST STAIN|||CHILD|HEMATOLOGIST|U|1|4|TREATMENT|2021-03-30|80
e|TU|565e5c83-9c67-4718-bd54-af34be936427|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|BENIGN|PISIFORM BONE|RIGHT|MEDIAL|ALL|KINETIC MICROPARTICLE IMMUNOASSAY|Y||HEALTH CARE PROFESSIONAL|PATHOLOGIST 2|N|1|3|TREATMENT|2020-07-11|42
e|TU|b238304c-15ef-4c6e-a32c-9cd583a233a9|1|[?]|TUMIDENT|Tumor Identification|[?]|NON-TARGET NODAL|PALM|IPSILATERAL|SUPERIOR|SINGLE|SPECT/CT SCAN|||SIGNIFICANT OTHER|RADIOLOGIST 1|Y|1|4|TREATMENT|2021-03-22|84
e|TU|c273f039-bca9-4d55-8620-5c5db32a6c4b|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|NEW TARGET|SPLENIC HILAR LYMPH NODE|CONTRALATERAL|APICAL|MULTIPLE|IMMUNODIFFUSION||Y|STUDY SUBJECT|DEVELOPMENTAL PSYCHOLOGIST|Y|1|1|TREATMENT|2020-12-20|98
e|TU|2cdb5053-2108-4f50-8906-8afabc855a36|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|TARGET NODAL|HAIR ROOT|BILATERAL|TIP|ALL|IRON HEMATOXYLIN STAIN|||INTERVIEWER|READER 2|NA|1|2|WASHOUT|2020-08-29|11
e|TU|fce7149a-503e-4209-8c62-8044a2ad1c1c|1|[?]|LESIDENT|Lesion Identification|[?]|NON-TARGET|CAPITATE-LUNATE JOINT|UNILATERAL|ROSTRAL|PARTIAL|KNEMOMETRY||Y|SPOUSE|READER 2|N|1|2|TREATMENT|2020-09-03|38
e|TU|c8aad550-11a1-4473-8b35-79b7dfb08122|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|NOT MEASURED|EYE|IPSILATERAL|CENTRAL|ENTIRE|MODIFIED ACID FAST STAIN|||CLINICAL RESEARCH ASSOCIATE|ENDOCRINOLOGIST|Y|1|5|TREATMENT|2020-06-27|28
e|TU|f1967c6e-c520-4482-be7e-01ada4380d87|1|[?]|LESIDENT|Lesion Identification|[?]|BENIGN|HEART, VENTRICLE|UNILATERAL|TEMPORAL|ENTIRE|ENDPOINT DILUTION ASSAY||Y|DOMESTIC PARTNER|MICROSCOPIST 2|NA|1|4|TREATMENT|2021-02-01|37
e|TU|2a5a1c03-f54e-47da-8dda-2104c9423e94|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|TARGET NODAL|SKIN OF THE BACK|LATERAL|VENTRAL|ALL|HPLC|Y|Y|PROXY|RATER|N|1|2|TREATMENT|2021-03-15|83
e|TU|8f98bac3-8010-4902-8ae1-783dc5fea72d|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|NEW TARGET|INTERPHALANGEAL JOINT 4 OF THE HAND|CONTRALATERAL|VOLAR|MULTIPLE|SINGLE-SLICE SPIRAL CT|Y||CLINICAL RESEARCH COORDINATOR|ONCOLOGIST 1|NA|1|6|SCREENING|2020-08-21|63
e|TU|0fd7cece-4d9d-4d8c-82e0-df0c75613888|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|TARGET EXTRA NODAL|SUBMENTAL LYMPH NODE|RIGHT|UPPER|HEMI|DC SHEATH FLOW|||VENDOR|PATHOLOGIST|Y|1|6|TREATMENT|2021-02-16|77
e|TU|1ade93f5-35f2-4bcc-9b9b-519c3f13baf9|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|LOCAL|MIDDLE PHALANX 3 OF THE HAND|UNILATERAL|VOLAR|SINGLE|MAGNETIC RESONANCE ENTEROGRAPHY||Y|HEALTH CARE PROFESSIONAL|READER|NA|1|5|FOLLOW-UP|2020-08-03|61
e|TU|4be1ea69-9baf-45b4-873b-13a879544d9c|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|REGIONAL|URETHRA, ANTERIOR|CONTRALATERAL|DEEP|HEMI|CLIP SEQUENCING|||NON-HEALTH CARE PROFESSIONAL|OPTOMETRIST|NA|1|7|SCREENING|2021-04-04|78
e|TU|7480ca7e-bffc-455b-a08e-c732ac6c8b4e|1|[?]|NTIND|Non-Target Indicator|[?]|TARGET NODULE|RAMUS INTERMEDIUS ARTERY|RIGHT|NASAL|PARTIAL|PERFUSION MRI|||SPOUSE|READER 3|U|1|6|SCREENING|2020-12-19|61
e|TU|16720f71-55b5-478f-b041-00b61ae19ac9|1|[?]|LESIDENT|Lesion Identification|[?]|BENIGN|LAD SEPTAL PERFORATOR ARTERY|BILATERAL|HIND|SINGLE|CALIPER MEASUREMENT METHOD|||SPOUSE|ADJUDICATOR|NA|1|6|WASHOUT|2021-01-24|24
e|TU|4349f45e-f18b-4606-9a72-fd45e64e17dc|1|[?]|LESIDENT|Lesion Identification|[?]|LOCAL|VERTEBRA|IPSILATERAL|SURFACE|ALL|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|Y|Y|VENDOR|NEUROLOGIST 1|NA|1|3|TREATMENT|2021-01-24|23
e|TU|32e36ec1-6895-42ff-bf33-52977e72b338|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|NEW|GASTROCNEMIUS MUSCLE, LATERAL HEAD|LEFT|ANTEROLATERAL|SEGMENT|FUNDUS PHOTOGRAPHY|||PARENT|NEUROLOGIST|Y|1|2|TREATMENT|2020-09-19|24
e|TU|e546f2d8-baea-4a6e-93cb-c7ec7292b423|1|[?]|TUSPLIT|Tumor Split|[?]|NON-TARGET ENHANCING|PANCREAS, BODY|LATERAL|SUPERFICIAL|ALL|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY||Y|SIBLING|HEMATOLOGIST|U|1|1|TREATMENT|2020-11-28|44
e|TU|0329de16-fc7a-4941-900c-b390dac637aa|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|UNKNOWN|HEART, RIGHT ATRIUM|LATERAL|FORE|ALL|DIFFUSION TENSOR MRI|||STUDY SUBJECT|NEUROLOGIST 2|NA|1|6|FOLLOW-UP|2020-11-18|62
e|TU|89d364c9-1338-472b-af0b-19280e45508b|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|TARGET|HEART, LEFT ATRIUM|BILATERAL|TIP|ENTIRE|MICROBIAL CONCENTRATION|||STUDY SUBJECT|ONCOLOGIST 2|Y|1|1|TREATMENT|2020-12-17|73
e|TU|ecd8ff7b-9c30-4b74-ad95-f8555c59ab5e|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|UNKNOWN|LIVER, CAUDATE LOBE|BILATERAL|INNER|SEGMENT|IMMUNOFIXATION ELECTROPHORESIS|||CLINICAL RESEARCH COORDINATOR|READER 3|Y|1|7|TREATMENT|2020-08-20|95
e|TU|f53c6f33-e2a6-4153-b1d6-9073f4ddefd1|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|NON-TARGET ENHANCING|INTERNAL MAMMARY LYMPH NODE|UNILATERAL|LOWER MEDIAL|ENTIRE|OPTICAL COHERENCE TOMOGRAPHY|Y||INDEPENDENT ASSESSOR|MICROSCOPIST 1|Y|1|6|FOLLOW-UP|2020-12-23|82
e|TU|0c103005-efae-48ed-91e3-35d38fa1d359|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|BENIGN|EPIGASTRIC REGION|IPSILATERAL|UPPER|ENTIRE|SLOAN LETTER EYE CHART 1.25%|||CLINICAL RESEARCH ASSOCIATE|ADJUDICATOR 2|N|1|2|TREATMENT|2020-07-03|46
e|TU|c9808184-3432-448c-a5e5-50176715effa|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|TARGET EXTRA NODAL|THORACIC VERTEBRA|IPSILATERAL|NASAL|SEGMENT|FARNSWORTH-MUNSELL 100 HUE TEST|||DOMESTIC PARTNER|NEUROLOGIST|N|1|6|TREATMENT|2021-01-20|32
e|TU|c3d7d293-975f-44de-bd35-0168eec40ac9|1|[?]|TUSPLIT|Tumor Split|[?]|REGIONAL|HEPATIC LYMPH NODE|LEFT|UPPER FLEXOR SURFACE|SEGMENT|ICP-MS|||ADJUDICATION COMMITTEE|RATER|N|1|2|WASHOUT|2021-03-07|72
e|TU|2db1f07d-a7db-4cc3-8943-536e24378f08|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|NON-TARGET EXTRA NODAL|SUPRARENAL AORTA|LEFT|BASAL|MULTIPLE|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|||STUDY SUBJECT|PATHOLOGIST 2|NA|1|6|TREATMENT|2020-08-06|65
e|TU|c343ba98-87d7-40bc-b0e8-b866e42d3a21|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|NEW BONE LESION|TRAPEZIUM-TRAPEZOID JOINT|LATERAL|MEDIAL|ENTIRE|OPHTHALMOSCOPY|||CLINICAL STUDY SPONSOR|MICROSCOPIST 3|NA|1|2|TREATMENT|2021-03-04|89
e|TU|d2b31ba9-9718-43ce-82ca-3276c28ac42a|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|MEASURED|INTERPHALANGEAL JOINT 4|RIGHT|LOWER|SEGMENT|ELECTROGASTROGRAPHY||Y|INDEPENDENT ASSESSOR|UROLOGIST|U|1|3|TREATMENT|2021-02-25|93
e|TU|4aa77a8a-bbbe-4b7f-91fb-1edb3b61b711|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|MEASURED|OCCIPITAL SCALP|CONTRALATERAL|HIND|ENTIRE|SNP ARRAY|||VENDOR|NEUROLOGIST|NA|1|6|TREATMENT|2020-08-24|42
e|TU|0a42f96a-49c3-492f-a272-bf9989e53e9d|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|MEASURED|COMMON ILIAC LYMPH NODE|BILATERAL|LOWER FLEXOR SURFACE|SINGLE|COULOMETRIC TITRATION|||FAMILY MEMBER|ADJUDICATOR 1|U|1|4|WASHOUT|2021-02-07|22
e|TU|a78e7287-581c-4bf2-b3ca-ad2476c010cd|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|NEW|KIDNEY|RIGHT|DORSOLATERAL|MULTIPLE|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|||STUDY SUBJECT|OTOLARYNGOLOGIST|NA|1|6|TREATMENT|2021-03-10|71
e|TU|d3651e5f-bc38-4c96-afbf-5a65873ff306|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|TARGET EXTRA NODAL|GRACILIS MUSCLE|LEFT|DISTAL|SEGMENT|CLIP SEQUENCING|||ADJUDICATION COMMITTEE|RATER|U|1|4|TREATMENT|2020-10-24|98
e|TU|4dca1d91-f6fe-4ee7-b4c3-062972eb5f37|1|[?]|LESIDENT|Lesion Identification|[?]|TARGET EXTRA NODAL|TONGUE|BILATERAL|SURFACE|SEGMENT|ELECTROPHORESIS|||ADJUDICATOR|MICROSCOPIST 1|N|1|3|WASHOUT|2020-06-14|13
e|TU|f50537d2-e098-4dae-8f91-16f2357d709c|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|NON-MEASURABLE|ARM|CONTRALATERAL|NASAL|SINGLE|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|||HEALTH CARE PROFESSIONAL|RATER|N|1|7|FOLLOW-UP|2021-02-26|91
e|TU|7fedb0fd-d2ff-434c-9208-ffabb26d1a98|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|DISEASE SITE|ENDOMETRIAL CAVITY|IPSILATERAL|PERIPHERAL|MULTIPLE|DIFFUSION WEIGHTED MRI|||GUARDIAN|ONCOLOGIST 1|U|1|6|TREATMENT|2020-08-08|30
e|TU|489870ed-9da5-4df6-a5ef-17821c449c84|1|[?]|TUMIDENT|Tumor Identification|[?]|NEW TARGET|FEMUR SHAFT|BILATERAL|CAUDAL|SEGMENT|KLEIHAUER-BETKE|||HEALTH CARE PROFESSIONAL|OPTOMETRIST|N|1|2|TREATMENT|2020-08-30|41
e|TU|90fe992f-5a11-4829-b3b0-1c8314f53012|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|TARGET NODAL|MEDIAN BASILIC VEIN|LATERAL|DEEP|HEMI|FUNCTIONAL MRI|Y||ADJUDICATOR|DEVELOPMENTAL PSYCHOLOGIST|Y|1|4|FOLLOW-UP|2020-12-13|91
e|TU|74be8de0-3307-4cc3-9044-05068b60f7e0|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|LOCAL|MEDIAL FEMORAL CONDYLE|IPSILATERAL|LOWER|PARTIAL|FLOW CYTOMETRY|Y|Y|FRIEND|PEDIATRIC NEUROLOGIST|N|1|4|TREATMENT|2021-01-04|86
e|TU|b95317e6-0acc-4be7-9525-4f6ca6cfe0fc|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|NON-TARGET ENHANCING|PORTAL LYMPH NODE|IPSILATERAL|LOWER EXTENSOR SURFACE|HEMI|HPLC/MS||Y|SIBLING|PATHOLOGIST 2|Y|1|4|FOLLOW-UP|2020-08-31|91
e|TU|8825b806-fa76-49d7-b281-d36fc42fee1e|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|MEASURED|FEMORAL VEIN|RIGHT|CRANIAL|SEGMENT|PERIPHERAL ANGIOGRAPHY|||ADJUDICATION COMMITTEE|READER 2|U|1|6|SCREENING|2020-08-27|8
e|TU|c075ec99-ae16-4a7d-b5da-d0f1db78bbac|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|BENIGN|SUBMANDIBULAR LYMPH NODE|RIGHT|TEMPORAL|ALL|IMMUNOFLUORESCENT STAIN|Y||SIGNIFICANT OTHER|NEUROLOGIST 2|N|1|2|TREATMENT|2020-08-03|86
e|TU|def2ec82-35be-4ef5-a1fd-a7212b2d1a1e|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|NON-TARGET NON-ENHANCING|THIRD RIGHT POSTEROLATERAL ARTERY|LATERAL|UPPER EXTENSOR SURFACE|ENTIRE|FLUORESCENCE ANGIOGRAPHY|||PROXY|ENDOCRINOLOGIST|U|1|7|SCREENING|2021-03-06|61
e|TU|b36220d8-c129-48bf-8c41-542a954b819a|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|BENIGN|LEFT VENTRICULAR MID INFERIOR SEGMENT|BILATERAL|PROXIMAL VOLAR|MULTIPLE|HEMOCYTOMETRY|Y||VENDOR|RATER 1|Y|1|7|SCREENING|2020-05-30|16
e|TU|92d3477b-7460-4ce8-b237-38ca4c55fc91|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|LOCOREGIONAL|THYROID GLAND|LEFT|ANTERIOR|SEGMENT|PHOTOMETRY|||ADJUDICATION COMMITTEE|RATER 2|NA|1|4|FOLLOW-UP|2020-09-03|30
e|TU|62b4fc8f-517b-4fa2-ac96-2420934bfd7d|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|NON-TARGET NODAL|CINGULATE CORTEX|LATERAL|CAUDAL|HEMI|ANTIBIOTIC AGAR SCREEN|Y||NON-HEALTH CARE PROFESSIONAL|READER 1|NA|1|2|SCREENING|2021-01-11|36
e|TU|db13afe0-14f6-445b-869a-b0d9fe87e5b9|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|DISTANT|PALPEBRAL CONJUNCTIVA|BILATERAL|DEEP|ENTIRE|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|Y|Y|CAREGIVER|RADIOLOGIST 2|NA|1|2|FOLLOW-UP|2020-09-05|24
e|TU|3f75a463-1348-4c7f-8b29-7472d29628c8|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|TARGET EXTRA NODAL|TOENAIL|BILATERAL|VOLAR|ENTIRE|BIOIMPEDANCE SPECTROSCOPY|Y|Y|STUDY SUBJECT|INTERNIST|Y|1|1|WASHOUT|2020-09-18|78
e|TU|d1644413-1ed4-4ac9-b68f-f7ccb3cf6e42|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|MEASURED|SCAPHOID BONE|BILATERAL|LOWER FLEXOR SURFACE|SEGMENT|IMMUNE REPERTOIRE DEEP SEQUENCING|Y|Y|HEALTH CARE PROFESSIONAL|READER 3|Y|1|2|WASHOUT|2021-03-30|69
e|TU|4b00b9ef-ddc3-4669-8a73-f69c73743bce|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|UNKNOWN|LIMB, UPPER|LATERAL|OUTER|SINGLE|SLOAN LETTER EYE CHART 2.5%|||DOMESTIC PARTNER|ONCOLOGIST 1|Y|1|1|FOLLOW-UP|2020-10-03|82
e|TU|a125efdf-aec8-47a1-b492-cdaf8b619a78|1|[?]|TUSPLIT|Tumor Split|[?]|NON-TARGET NON-ENHANCING|GASTROINTESTINAL SYSTEM|BILATERAL|VENTROLATERAL|PARTIAL|CLIP SEQUENCING|Y||HEALTH CARE PROFESSIONAL|CLINICAL PATHOLOGIST|N|1|2|TREATMENT|2020-12-23|94
e|TU|9171362e-0166-46f2-ab2d-2748d8c291d5|1|[?]|TUMERGE|Tumor Merged|[?]|NEW TARGET|TRAPEZOID BONE|RIGHT|CRANIAL|SINGLE|NUCLEIC ACID AMPLIFICATION TEST|||PROXY|READER 2|U|1|4|TREATMENT|2021-02-10|39
e|TU|9b150e38-dc85-4a28-aad3-43f7620be460|1|[?]|TUMIDENT|Tumor Identification|[?]|DISEASE SITE|AORTIC ARCH|UNILATERAL|VENTROLATERAL|ALL|DIFFUSION TENSOR MRI|||ADJUDICATOR|ONCOLOGIST|N|1|6|TREATMENT|2020-07-21|9
e|TU|2a595fc0-7621-4ec9-bd77-74444886052e|1|[?]|LESIDENT|Lesion Identification|[?]|NON-TARGET NODAL|VERTEBRAL COLUMN|BILATERAL|PERIPHERAL|HEMI|IMMUNOASSAY|||SPOUSE|NEUROLOGIST 2|Y|1|3|TREATMENT|2020-11-07|23
e|TU|0bab89c8-cf57-4d19-9b95-884a2e9da523|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|NEW BONE LESION|DISTAL INTERPHALANGEAL JOINT 5|CONTRALATERAL|ANTEROLATERAL|MULTIPLE|TOLUIDINE BLUE STAIN|||INVESTIGATOR|READER 3|U|1|7|FOLLOW-UP|2021-01-27|48
e|TU|84edaa9d-ce48-4866-ab43-af91bee126ae|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|NEW TARGET|RADIUS SHAFT|IPSILATERAL|PARIETO-OCCIPITAL|PARTIAL|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|||FAMILY MEMBER|ADJUDICATOR|Y|1|5|TREATMENT|2020-07-11|71
e|TU|0a955f0d-058a-49ac-bc7f-4f8ef9690f5a|1|[?]|NTIND|Non-Target Indicator|[?]|NON-TARGET EXTRA NODAL|ALVEOLUS|LATERAL|DISTAL VOLAR|SEGMENT|BRDU CELLULAR PROLIFERATION ASSAY||Y|PARENT|READER 1|N|1|5|SCREENING|2020-10-06|74
e|TU|9734ec2a-d06b-43e1-82a5-37764af17890|1|[?]|LESIDENT|Lesion Identification|[?]|LOCOREGIONAL|ANTERIOR INFERIOR CEREBELLAR ARTERY|UNILATERAL|SURFACE|ENTIRE|TARGETED TRANSCRIPTOME SEQUENCING|Y|Y|PARENT|ENDOCRINOLOGIST|U|1|2|TREATMENT|2020-10-12|23
e|TU|9a0ce525-7f10-4651-885a-f64bd9c8925e|1|[?]|NTIND|Non-Target Indicator|[?]|TARGET|LIP, UPPER|LATERAL|LOWER EXTENSOR SURFACE|ALL|ERGOSPIROMETRY|Y||VENDOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|Y|1|7|TREATMENT|2021-02-20|94
e|TU|f2cd01c4-b765-4ac5-8e8d-c9fef7366720|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|NEW BONE LESION|LARGE INTESTINE|LATERAL|APICAL|ALL|LASER CAPTURE MICRODISSECTION|||FAMILY MEMBER|PATHOLOGIST 2|NA|1|6|TREATMENT|2020-08-05|31
e|TU|4ba88073-0003-461a-a950-4504ef7680e7|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|NON-TARGET EXTRA NODAL|BASAL GANGLIA|UNILATERAL|FRONTAL|HEMI|ERGOSPIROMETRY||Y|INDEPENDENT ASSESSOR|ADJUDICATOR 2|Y|1|1|SCREENING|2020-10-23|61
e|TU|a0079507-0ad8-45e3-94f9-bfe0a80c7c4d|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|NON-TARGET EXTRA NODAL|SKIN AROUND THE MOUTH|IPSILATERAL|ANTEROTEMPORAL|ENTIRE|ELLA||Y|INVESTIGATOR|MICROSCOPIST 1|U|1|4|TREATMENT|2020-11-28|98
e|TU|f552fa78-d78f-44c5-9590-30a737e6652d|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|TARGET EXTRA NODAL|ABDUCTOR DIGITI QUINTI MUSCLE|CONTRALATERAL|OUTER|SEGMENT|SPECT SCAN|Y||FRIEND|NEUROLOGIST|U|1|4|TREATMENT|2020-10-02|7
e|TU|38d83f86-d8ce-461a-a288-95aebe498d22|1|[?]|TUMIDENT|Tumor Identification|[?]|BENIGN|PARASYMPATHETIC GANGLIA|LATERAL|HIND|MULTIPLE|SPIRAL CT|||FRIEND|ENDOCRINOLOGIST|N|1|4|TREATMENT|2020-10-22|68
e|TU|b31e8820-cc17-4ce5-af30-358dbeb12ba2|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|NOT MEASURED|RIGHT ATRIAL ENDOCARDIUM|RIGHT|SUPERFICIAL|HEMI|GC/MS-CI|||SIBLING|ADJUDICATOR 1|NA|1|6|SCREENING|2020-10-12|70
e|TU|cf39d5bd-7682-4546-8495-5bcf48600a69|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|NEW NON-TARGET|ARM SKIN|CONTRALATERAL|INNER|SINGLE|ACID FAST STAIN|Y|Y|INDEPENDENT ASSESSOR|RATER 2|U|1|3|TREATMENT|2021-03-15|64
e|TU|84c17e7b-8d56-4726-96a5-9ca41fb9d894|1|[?]|TUSPLIT|Tumor Split|[?]|TARGET|PONS VAROLII|BILATERAL|FRONTAL|HEMI|AMSLER GRID|||GUARDIAN|READER 3|Y|1|7|WASHOUT|2020-12-15|31
e|TU|6e557fd7-efaf-4c86-806d-9bd66c7de7da|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|NEW|AMYGDALA|IPSILATERAL|LOWER EXTENSOR SURFACE|SEGMENT|IMPULSE OSCILLOMETRY|Y||HEALTH CARE PROFESSIONAL|PATHOLOGIST|Y|1|3|WASHOUT|2021-03-26|68
e|TU|2b25e1f9-929c-4bdc-8758-79f33b832026|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|UNKNOWN|SECOND DIAGONAL BRANCH ARTERY|UNILATERAL|ANTEROPOSTERIOR|SEGMENT|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|Y|Y|PARENT|OPTOMETRIST|Y|1|2|TREATMENT|2020-11-13|35
e|TU|d02c7553-17f5-44ec-8c24-469234d080e8|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|NEW TARGET|LINGULA OF THE LUNG|LATERAL|DISTAL VOLAR|MULTIPLE|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|Y||INVESTIGATOR|ADJUDICATOR 1|U|1|2|TREATMENT|2021-02-02|17
e|TU|e819939e-548d-4e05-83e3-7976790de7e1|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|NON-TARGET NODAL|KIDNEY, LOWER LOBE|RIGHT|DISTAL|ENTIRE|IMMUNOFIXATION ELECTROPHORESIS|||SIBLING|RADIOLOGIST 2|Y|1|2|TREATMENT|2020-10-08|41
e|TU|3b35f16c-38c8-45a2-8872-fe0f0f30b0d9|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|TARGET|ENDOCERVIX|LATERAL|CAUDAL|PARTIAL|HPLC/MS|||SIGNIFICANT OTHER|MICROSCOPIST 3|N|1|6|TREATMENT|2020-10-23|76
e|TU|ea5229ad-6469-4147-be40-546d27c04c4c|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|UNKNOWN|LOWER GASTROINTESTINAL TRACT LYMPH NODE|RIGHT|INFERIOR|ALL|BIOIMPEDANCE SPECTROSCOPY||Y|SPOUSE|FORENSIC PATHOLOGIST|U|1|4|TREATMENT|2020-07-27|58
e|TU|0a566742-0f71-4603-85f0-875e2c3395e7|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|NOT MEASURED|STERNEBRA|IPSILATERAL|VOLAR|SEGMENT|FUNDUS PHOTOGRAPHY|||CHILD|READER|Y|1|3|FOLLOW-UP|2021-03-11|72
e|TU|fdcd8f25-f7bd-477e-a7f6-4a279380d98f|1|[?]|TUMIDENT|Tumor Identification|[?]|NOT MEASURED|ILIAC LYMPH NODE|CONTRALATERAL|ANTERIOR|SEGMENT|ENZYMATIC COLORIMETRY||Y|ADJUDICATOR|ADJUDICATOR 2|U|1|5|TREATMENT|2020-05-13|9
e|TU|48103500-0f3d-4108-9167-6afee1098773|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|NEW|HYPOTHALAMUS|UNILATERAL|HIND|HEMI|TRIPLE-PHASE MRI SCAN|||ADJUDICATION COMMITTEE|NEUROLOGIST 2|N|1|3|TREATMENT|2020-08-11|98
e|TU|9855fc59-f162-48ba-8c51-e8c6c54b72f3|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|NON-TARGET|PAW|UNILATERAL|DORSOLATERAL|SINGLE|RADIATION DOSIMETRY|||CHILD|RADIOLOGIST|Y|1|3|TREATMENT|2020-09-13|60
e|TU|ceab42b0-3a7e-4aad-b599-5da311398148|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|LOCAL|ILIAC FOSSA|RIGHT|ANTERIOR|SEGMENT|CONTRAST ENHANCED X-RAY|||INDEPENDENT ASSESSOR|PATHOLOGIST 1|Y|1|6|TREATMENT|2020-08-30|80
e|TU|c6fed210-d4a7-41f9-b3ff-ece262a91a5f|1|[?]|TUMIDENT|Tumor Identification|[?]|NEW|NUCLEUS ACCUMBENS|UNILATERAL|POSTERIOR|ALL|RADIOGRAPHY|Y|Y|INTERVIEWER|READER 3|N|1|3|SCREENING|2020-07-31|32
e|TU|6fdbc6f3-431d-48ca-b51b-992f2340b9f5|1|[?]|TUMIDENT|Tumor Identification|[?]|NON-TARGET NODAL|TRICUSPID VALVE, SEPTAL CUSP|LATERAL|INTERMEDIATE|PARTIAL|IMMUNE REPERTOIRE DEEP SEQUENCING||Y|PARENT|RATER 1|Y|1|4|TREATMENT|2020-08-27|58
e|TU|36a54b72-6368-460e-ab4c-952923e0fd14|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|NEW|SKIN OF THE LIP|RIGHT|VENTROLATERAL|HEMI|MICROBIAL CULTURE, SOLID|||INVESTIGATOR|CARDIOLOGIST|U|1|6|SCREENING|2020-05-21|16
e|TU|84e56692-9a33-472a-9ddc-545d3342da34|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|LOCOREGIONAL|GASTROINTESTINAL TRACT, LOWER|BILATERAL|LOWER FLEXOR SURFACE|SEGMENT|SPECT SCAN|||INVESTIGATOR|PEDIATRIC NEUROLOGIST|N|1|3|WASHOUT|2021-01-04|26
e|TU|d917a86c-f13b-4ed8-aa0a-cc36ac57647e|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|LOCOREGIONAL|FLEXOR DIGITORUM PROFUNDUS MUSCLE|UNILATERAL|ANTEROLATERAL|SINGLE|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|||CAREGIVER|OPHTHALMOLOGIST|Y|1|3|SCREENING|2020-07-15|55
e|TU|917f909f-fd5d-47ad-9e2a-f7c6953cfbd1|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|LOCATION OF INTEREST|T4 VERTEBRA|CONTRALATERAL|ROSTRAL|PARTIAL|MRI||Y|INDEPENDENT ASSESSOR|OPHTHALMOLOGIST|Y|1|2|WASHOUT|2020-07-14|44
e|TU|ae0e05c1-3953-4406-bfae-299295c1fa4c|1|[?]|TUMERGE|Tumor Merged|[?]|NOT MEASURED|RADIAL NERVE|LATERAL|FORE|ENTIRE|FLUORESCENT MICROSCOPY|||CAREGIVER|READER|Y|1|6|TREATMENT|2021-02-22|51
e|TU|7bbe20e7-3dcc-41ea-bba8-fc03ff83a28b|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|NON-TARGET EXTRA NODAL|SUPERFICIAL FEMORAL ARTERY|LEFT|DISTAL|PARTIAL|ISHIHARA COLOR PLATES|||ADJUDICATION COMMITTEE|RADIOLOGIST 2|Y|1|7|SCREENING|2021-02-02|27
e|TU|ab09e76d-8bbf-4126-a60d-08d6b5292836|1|[?]|TUSPLIT|Tumor Split|[?]|TARGET EXTRA NODAL|PREAURICULAR LYMPH NODE|BILATERAL|ANTERIOR|ENTIRE|STRESS ECHOCARDIOGRAPHY|||FAMILY MEMBER|PATHOLOGIST|NA|1|2|TREATMENT|2021-01-05|21
e|TU|8b7e3909-4115-4736-b07a-e0b6c382aa7e|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|BONE LESION|MIDDLE PHALANX 2 OF THE HAND|LEFT|OCCIPITAL|ALL|SPECT SCAN|||SIGNIFICANT OTHER|ONCOLOGIST 2|NA|1|6|TREATMENT|2020-10-05|96
e|TU|187b2279-526f-4978-89d4-d2da56cc2257|1|[?]|NTIND|Non-Target Indicator|[?]|DISTANT|PARAPHARYNGEAL LYMPH NODE|UNILATERAL|DORSAL|MULTIPLE|PLETHYSMOGRAPHY||Y|SPOUSE|ENDOCRINOLOGIST|U|1|5|TREATMENT|2020-09-15|96
e|TU|53506a04-dedb-495b-8e35-0576cdf1b323|1|[?]|TUSPLIT|Tumor Split|[?]|NON-TARGET NODAL|LAD SEPTAL PERFORATOR ARTERY|CONTRALATERAL|UPPER|PARTIAL|REFRACTOMETRY|||FAMILY MEMBER|UROLOGIST|NA|1|7|FOLLOW-UP|2020-11-17|20
e|TU|defa600c-4205-476e-a40c-690cb16769b3|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|NEW TARGET|PLEURAL CAVITY|LEFT|ANTEROLATERAL|MULTIPLE|MRI WITHOUT CONTRAST|Y||CHILD|ADJUDICATOR 2|U|1|4|FOLLOW-UP|2021-03-27|72
e|TU|e5092583-4259-40ba-a6a2-eeef6607263b|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|NOT MEASURED|INTERPHALANGEAL JOINT 5 OF THE HAND|BILATERAL|PARIETO-OCCIPITAL|HEMI|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS||Y|CLINICAL RESEARCH COORDINATOR|READER 3|N|1|4|SCREENING|2020-10-15|39
e|TU|461196d1-1213-4e5f-9bac-71f097b6cfdb|1|[?]|TUMIDENT|Tumor Identification|[?]|NOT MEASURED|HEART, LEFT ATRIUM|UNILATERAL|LOWER MEDIAL|SEGMENT|TRANSVAGINAL ULTRASOUND|Y||HEALTH CARE PROFESSIONAL|READER|N|1|5|FOLLOW-UP|2021-01-23|81
e|TU|4c82922a-55d0-45b9-a7bb-4edac32b0f68|1|[?]|NTIND|Non-Target Indicator|[?]|LOCATION OF INTEREST|ELBOW JOINT|BILATERAL|CENTRAL|SEGMENT|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|||FRIEND|ONCOLOGIST 2|N|1|1|TREATMENT|2021-03-08|99
e|TU|57971bdc-14df-4d9e-a59a-2665703c12ab|1|[?]|NTIND|Non-Target Indicator|[?]|LOCOREGIONAL|FEMORAL NECK|IPSILATERAL|PARIETO-OCCIPITAL|SINGLE|KLEIHAUER-BETKE|Y||CHILD|FORENSIC PATHOLOGIST|NA|1|1|SCREENING|2020-08-25|97
e|TU|dacea2da-9101-41e9-97aa-1cb8445b1320|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|REGIONAL|LUNG, LEFT UPPER LOBE|LATERAL|UPPER|SINGLE|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|||CLINICAL RESEARCH ASSOCIATE|OPHTHALMOLOGIST|N|1|5|WASHOUT|2020-11-24|56
e|TU|cbf5d05e-e934-4946-b991-5fef63a01888|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|NOT MEASURED|LUNG, LEFT, SUPERIOR LOBE, APICOPOSTERIOR SEGMENT|BILATERAL|LOWER|ENTIRE|SLIT LAMP PHOTOGRAPHY||Y|SPOUSE|OPHTHALMOLOGIST|N|1|7|TREATMENT|2020-12-24|58
e|TU|be18633c-0ff9-4775-9737-dc8a9524fd2c|1|[?]|TUMIDENT|Tumor Identification|[?]|NEW TARGET|CORONARY ARTERY, ANTERIOR DESCENDING|UNILATERAL|FACIAL|HEMI|VIRUS PLAQUE ASSAY|||NON-HEALTH CARE PROFESSIONAL|ADJUDICATOR|N|1|2|TREATMENT|2020-11-19|42
e|TU|f7eba9b8-94fb-46b8-842a-0322eb68a355|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|NON-TARGET ENHANCING|ELBOW JOINT|CONTRALATERAL|VOLAR|PARTIAL|VENTILATION PERFUSION LUNG SCAN||Y|CLINICAL RESEARCH COORDINATOR|RADIOLOGIST 1|Y|1|4|TREATMENT|2020-06-02|31
e|TU|903199e2-56e1-41e4-8904-d33cc6846ee3|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|REGIONAL|UVEA|BILATERAL|INFERIOR|MULTIPLE|NUCLEAR RADIOLOGY|||HEALTH CARE PROFESSIONAL|READER 3|Y|1|6|SCREENING|2021-02-15|38
e|TU|32567f8d-e746-44e1-a269-d95ba3bb0b11|1|[?]|TUMIDENT|Tumor Identification|[?]|TARGET EXTRA NODAL|PROFUNDA FEMORIS VEIN|BILATERAL|LOWER MEDIAL|PARTIAL|CONGO RED STAIN|||CAREGIVER|HEMATOLOGIST|U|1|2|TREATMENT|2020-11-24|32
e|TU|ecdc54eb-c02f-4112-8e85-8a3352470b3b|1|[?]|NTIND|Non-Target Indicator|[?]|NON-TARGET ENHANCING|ILEUM, TERMINAL|UNILATERAL|INFERIOR|PARTIAL|IN SITU HYBRIDIZATION|||CLINICAL RESEARCH ASSOCIATE|PEDIATRIC NEUROLOGIST|U|1|7|SCREENING|2021-01-28|88
e|TU|6885a3d0-5bd9-4f2f-a126-35b8030ad1b8|1|[?]|TUMIDENT|Tumor Identification|[?]|NEW TARGET|DISTAL INTERPHALANGEAL JOINT 5 OF THE FOOT|LATERAL|SUPERIOR|ALL|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|Y||DOMESTIC PARTNER|OTOLARYNGOLOGIST|U|1|3|TREATMENT|2020-07-20|21
e|TU|5d7241ec-120d-486d-ab39-b9e14ab4ce90|1|[?]|NTIND|Non-Target Indicator|[?]|TARGET|HAND PHALANX|LEFT|OCCIPITAL|SINGLE|CRYOSCOPY|||DOMESTIC PARTNER|FORENSIC PATHOLOGIST|U|1|1|TREATMENT|2020-08-14|23
e|TU|17fdb337-01e4-42ce-b3f0-1f4beeafc26c|1|[?]|TUMIDENT|Tumor Identification|[?]|DISTANT|FEMORAL LYMPH NODE|RIGHT|SUBCORTICAL|ALL|RAJI CELL EIA|||SIGNIFICANT OTHER|INTERNIST|NA|1|5|SCREENING|2020-06-08|17
e|TU|8efc2f2c-fa89-4ceb-a43c-c77bc2ff6319|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|MEASURED|EYELASH|IPSILATERAL|FRONTAL|MULTIPLE|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING||Y|HEALTH CARE PROFESSIONAL|RATER|N|1|4|TREATMENT|2020-09-05|73
e|TU|a69c6182-9c35-4365-b732-b238e0584ba7|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|BONE LESION|TRICUSPID VALVE, ANTERIOR CUSP|IPSILATERAL|OUTER|SINGLE|DYNAMIC LIGHT SCATTERING||Y|INVESTIGATOR|NEUROLOGIST 1|N|1|7|TREATMENT|2020-09-25|59
e|TU|1b9896cf-160e-4a56-8737-9759cd83e784|1|[?]|NTIND|Non-Target Indicator|[?]|LOCAL|LEFT CIRCUMFLEX CORONARY ARTERY|UNILATERAL|DISTAL VOLAR|SINGLE|PERIODIC ACID SCHIFF STAIN|||GUARDIAN|OPHTHALMOLOGIST|Y|1|4|SCREENING|2021-02-25|86
e|TU|ea87b553-e331-40cf-bd86-d2bd22694476|1|[?]|TUMIDENT|Tumor Identification|[?]|NEW|GASTROINTESTINAL TRACT|LATERAL|INTERMEDIATE|MULTIPLE|SPECT SCAN|||INDEPENDENT ASSESSOR|INTERNIST|N|1|2|TREATMENT|2020-09-26|62
e|TU|7aebcf72-ac09-4814-ade2-0c0b2add2d8c|1|[?]|NTIND|Non-Target Indicator|[?]|BENIGN|CHEST WALL|RIGHT|BASAL|ALL|ELECTROPHORESIS||Y|ADJUDICATOR|PATHOLOGIST|N|1|3|WASHOUT|2020-08-18|29
e|TU|051dc064-be6f-43eb-aa51-7ed8634d6e23|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|BONE LESION|RIGHT CORONARY ARTERY OSTIUM|IPSILATERAL|PROXIMAL VOLAR|HEMI|QUANTITATIVE ULTRASOUND|||INDEPENDENT ASSESSOR|RATER|N|1|4|SCREENING|2020-07-19|21
e|TU|9d85acbf-5a26-4bcd-aee8-e1ab2834a2f9|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|TARGET NODULE|METACARPAL BONE 1|CONTRALATERAL|VENTROLATERAL|SINGLE|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|Y||INDEPENDENT ASSESSOR|RATER 1|N|1|4|WASHOUT|2020-07-19|56
e|TU|7a17fe21-b640-4bc5-bf19-b1bceb393dab|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|NON-MEASURABLE|NASAL CAVITY|RIGHT|PROXIMAL|HEMI|ENDOSCOPY|||FAMILY MEMBER|DERMATOLOGIST|N|1|6|TREATMENT|2020-09-17|25
e|TU|d2080dd2-03ad-4c43-be69-eeb8151cc9b5|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|NON-MEASURABLE|PITUITARY GLAND|IPSILATERAL|ROSTRAL|HEMI|SPECULAR MICROSCOPY|||PARENT|UROLOGIST|NA|1|1|WASHOUT|2021-02-08|29
e|TU|f1d0daec-aa97-4838-9c53-e16dae3e17b2|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|NEW|AORTOCAVAL LYMPH NODE|LEFT|PROXIMAL|SEGMENT|CONTRAST ENHANCED CT SCAN|||NON-HEALTH CARE PROFESSIONAL|OPHTHALMOLOGIST|U|1|2|SCREENING|2020-08-03|51
e|TU|835594ab-e93c-402b-8129-6af659be5ae1|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|UNKNOWN|FEMORAL VEIN|LATERAL|LOWER MEDIAL|MULTIPLE|TEST STRIP|||SIBLING|RADIOLOGIST|Y|1|1|TREATMENT|2021-01-01|71
e|TU|c3c85786-d24b-4620-9ee0-c13b1cc4f951|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|NON-MEASURABLE|FOOT DIGIT 1|IPSILATERAL|UPPER|HEMI|PET SCAN|Y||NON-HEALTH CARE PROFESSIONAL|UROLOGIST|N|1|1|SCREENING|2020-12-24|88
e|TU|5354e3c4-4106-4e4c-85c3-2dbbd001688c|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|LOCOREGIONAL|EYELASH|BILATERAL|ANTERIOR|PARTIAL|LC-FL|Y||ADJUDICATION COMMITTEE|INTERNIST|Y|1|1|FOLLOW-UP|2020-12-25|50
e|TU|f10e9188-ef7b-46f9-a80a-0669436eb4dd|1|[?]|TUMERGE|Tumor Merged|[?]|NON-MEASURABLE|SOLE|IPSILATERAL|POSTERIOR|SINGLE|IMPULSE OSCILLOMETRY|Y||INTERVIEWER|DERMATOLOGIST|NA|1|5|FOLLOW-UP|2020-08-12|59
e|TU|f5c49bb8-c1c4-42fc-a5a0-4a39d95604eb|1|[?]|TUMIDENT|Tumor Identification|[?]|DISTANT|TRICUSPID VALVE ANNULUS|RIGHT|APICAL|MULTIPLE|DC SHEATH FLOW|||PARENT|OPTOMETRIST|U|1|3|FOLLOW-UP|2020-10-21|79
e|TU|000b5b99-a92d-4c84-9edc-ee08930d8a2e|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|TARGET NODAL|GASTRIC CARDIA|RIGHT|DISTAL VOLAR|ALL|CLIP SEQUENCING|Y||NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST|U|1|7|FOLLOW-UP|2020-10-12|7
e|TU|4f919ad0-fdb4-49d8-ba63-bb9e1680bca5|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|TARGET|GREATER CURVATURE OF THE STOMACH|IPSILATERAL|INTERMEDIATE|MULTIPLE|CARDIAC THERMODILUTION|Y|Y|SIGNIFICANT OTHER|MICROSCOPIST 2|Y|1|6|SCREENING|2020-05-28|6
e|TU|11b2b359-d4a1-411d-a676-075b26e1453c|1|[?]|NTIND|Non-Target Indicator|[?]|NON-TARGET ENHANCING|FEMORAL LYMPH NODE|RIGHT|VENTRAL|MULTIPLE|MICRONEUTRALIZATION ASSAY||Y|STUDY SUBJECT|PATHOLOGIST|NA|1|3|WASHOUT|2020-10-07|27
e|TU|293f673d-af6a-473e-8bce-118bb85bbd9e|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|NEW BONE LESION|LEFT VENTRICULAR APEX SEGMENT|CONTRALATERAL|SUPERIOR|HEMI|BALLPOINT PEN TECHNIQUE||Y|HEALTH CARE PROFESSIONAL|NEUROLOGIST|N|1|5|WASHOUT|2021-01-07|90
e|TU|0f60ab31-ee13-4846-93d2-6bcac139006f|1|[?]|TUMIDENT|Tumor Identification|[?]|LOCAL|PREPUTIAL GLAND|LEFT|DORSAL|PARTIAL|NUCLEIC ACID SEQUENCING|Y||CLINICAL RESEARCH ASSOCIATE|NEUROLOGIST 2|N|1|2|TREATMENT|2020-07-02|10
e|TU|d49f37ce-2d6e-4ebb-91af-7ed32322f824|1|[?]|TUMIDENT|Tumor Identification|[?]|NEW|SOFT TISSUE|CONTRALATERAL|SUPERFICIAL|MULTIPLE|SPIRAL CT SCAN WITHOUT CONTRAST|||GUARDIAN|ONCOLOGIST 1|U|1|6|SCREENING|2020-08-30|9
e|TU|76dd2fe2-bc9e-48e4-870c-af7ece70009a|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|NON-TARGET NODAL|CORONARY ARTERY, RIGHT|UNILATERAL|PROXIMAL|SINGLE|X-RAY FLUORESCENCE SPECTROMETRY|||HEALTH CARE PROFESSIONAL|NEUROLOGIST|U|1|5|FOLLOW-UP|2020-07-21|25
e|TU|5ac0fe16-cde1-41ea-9948-0b79e72fd8ad|1|[?]|TUSPLIT|Tumor Split|[?]|NON-TARGET NON-ENHANCING|UVEA|LEFT|LOWER EXTENSOR SURFACE|ENTIRE|SPECT/CT SCAN|Y||CLINICAL RESEARCH ASSOCIATE|READER 2|Y|1|5|FOLLOW-UP|2020-12-27|43
e|TU|78778706-6b5b-4ad8-90af-f56d602863ae|1|[?]|TUSPLIT|Tumor Split|[?]|LOCAL|INTERPHALANGEAL JOINT 3 OF THE FOOT|LATERAL|HIND|PARTIAL|ALCIAN BLUE STAIN|||CAREGIVER|DERMATOLOGIST|N|1|5|TREATMENT|2020-06-21|49
e|TU|a6954aa1-4860-412a-b988-7f708aca2ab2|1|[?]|TUMIDENT|Tumor Identification|[?]|NON-MEASURABLE|POSTERIOR TIBIAL ARTERY|IPSILATERAL|UPPER|SEGMENT|OPHTHALMOSCOPY|||SIBLING|DEVELOPMENTAL PSYCHOLOGIST|NA|1|1|WASHOUT|2020-10-14|37
e|TU|0a970eb4-f958-42ad-ad8b-60bb427c9cba|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|TARGET NODAL|LATERAL HUMERAL EPICONDYLE|UNILATERAL|DISTAL VOLAR|HEMI|PUPILLOMETRY|Y|Y|HEALTH CARE PROFESSIONAL|READER 1|NA|1|3|WASHOUT|2020-06-15|42
e|TU|dd6179f5-d2f5-4258-ac74-cf8e7a2d8673|1|[?]|LESIDENT|Lesion Identification|[?]|UNKNOWN|LEFT ANTERIOR DESCENDING ARTERY OSTIUM|CONTRALATERAL|TIP|ENTIRE|POTENTIOMETRY|Y||VENDOR|MICROSCOPIST 2|N|1|2|FOLLOW-UP|2021-04-05|79
e|TU|fae58cd9-1ff0-47dc-9ecb-916fb9f4187b|1|[?]|LESIDENT|Lesion Identification|[?]|LOCATION OF INTEREST|LEFT MAIN CORONARY ARTERY OSTIUM|BILATERAL|MIDLINE|MULTIPLE|SINGLE-SLICE SPIRAL CT|Y||INDEPENDENT ASSESSOR|MICROSCOPIST 1|N|1|7|TREATMENT|2020-11-13|91
e|TU|9b268a13-dc40-4eb6-8729-c131ac302dd3|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|NEW BONE LESION|CEREBRAL HEMISPHERE, LEFT|UNILATERAL|LOWER MEDIAL|SEGMENT|X-RAY|||SIGNIFICANT OTHER|FORENSIC PATHOLOGIST|N|1|6|SCREENING|2020-07-09|65
e|TU|fa11534a-92f9-4887-828b-25b7637b8f57|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|BENIGN|PARACOLIC GUTTER|IPSILATERAL|PROXIMAL VOLAR|ALL|PATHOLOGICAL EVALUATION|||SIBLING|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|N|1|3|SCREENING|2020-12-14|11
e|TU|f305f7a3-8c8b-4eca-afb2-4a376f811170|1|[?]|TUMIDENT|Tumor Identification|[?]|NON-TARGET EXTRA NODAL|FRONTAL SINUS|LATERAL|PROXIMAL|HEMI|WHOLE EXOME SEQUENCING|||PARENT|ONCOLOGIST|NA|1|4|WASHOUT|2020-12-12|79
e|TU|6e4ed6b3-e419-464c-a40e-f100a6894baa|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|LOCATION OF INTEREST|SCAPHOID BONE|CONTRALATERAL|FRONTAL|SEGMENT|SLIT LAMP|||INDEPENDENT ASSESSOR|RADIOLOGIST 2|Y|1|5|FOLLOW-UP|2020-06-02|5
e|TU|1e5e6ccc-a4b2-4aec-8048-988d1708caf0|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|NEW TARGET|POSTERIOR SUPERIOR ILIAC SPINE|BILATERAL|VENTROLATERAL|SEGMENT|LC/MS|||PARENT|RATER|Y|1|6|FOLLOW-UP|2020-08-31|33
e|TU|5d25ac6d-428d-41eb-9549-c23df035a54e|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|BONE LESION|THORACIC AORTA|CONTRALATERAL|PARIETO-OCCIPITAL|SINGLE|COULOMETRIC TITRATION||Y|INDEPENDENT ASSESSOR|UROLOGIST|U|1|2|TREATMENT|2020-08-08|97
e|TU|7d7dde17-c060-4ad3-9821-6faa49ddd1b2|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|TARGET NODULE|THORACIC CAVITY|IPSILATERAL|FRONTAL|ALL|POLYMERASE CHAIN REACTION|||NON-HEALTH CARE PROFESSIONAL|ADJUDICATOR 2|NA|1|5|TREATMENT|2020-11-08|19
e|TU|173aea61-964d-4f4a-8d48-56a1a58de6d8|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|DISTANT|EXTRAHEPATIC PERIHILAR BILE DUCT REGION|LEFT|ROSTRAL|SEGMENT|PLETHYSMOGRAPHY|Y|Y|CHILD|NEUROLOGIST|NA|1|4|TREATMENT|2020-10-12|9
e|TU|45d1adb8-9b3b-4f06-87cb-740205448680|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|NON-TARGET NODAL|LUNG, HILUM|LATERAL|ANTEROMEDIAL|SINGLE|PET/SPECT SCAN|||INVESTIGATOR|MICROSCOPIST 1|N|1|4|SCREENING|2020-09-08|63
e|TU|7403ad67-7ed5-4716-a874-c360429845bc|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|NOT MEASURED|URACHAL TRACT|IPSILATERAL|INTERMEDIATE|ENTIRE|NEURAMINIDASE INHIBITION ASSAY||Y|CLINICAL RESEARCH ASSOCIATE|DERMATOLOGIST|Y|1|7|TREATMENT|2020-07-05|46
e|TU|8be919ce-34da-4e49-ac7a-3679c7af632d|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|LOCAL|SECOND RIGHT POSTEROLATERAL ARTERY|BILATERAL|DORSOLATERAL|ENTIRE|HPLC/MS||Y|CAREGIVER|DEVELOPMENTAL PSYCHOLOGIST|NA|1|4|FOLLOW-UP|2021-02-23|51
e|TU|9c44967b-914e-43d5-be1e-6829804e04ab|1|[?]|LESIDENT|Lesion Identification|[?]|LOCOREGIONAL|DISTAL COMMON BILE DUCT|CONTRALATERAL|CRANIAL|SINGLE|AGAR DILUTION||Y|SIGNIFICANT OTHER|ONCOLOGIST 2|N|1|3|TREATMENT|2021-04-04|80
e|TU|36b6c36e-3cba-4d15-85e2-9f9bfc4c05e1|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|NEW TARGET|PISIFORM BONE|LATERAL|VOLAR|SEGMENT|IODINE STAIN|Y|Y|SIGNIFICANT OTHER|NEUROLOGIST 2|N|1|3|TREATMENT|2020-08-27|37
e|TU|cad8c553-739f-4046-a898-d939eb286dba|1|[?]|TUSPLIT|Tumor Split|[?]|BENIGN|EPITROCHLEAR LYMPH NODE|CONTRALATERAL|LOWER MEDIAL|SINGLE|GRADIENT DIFFUSION|Y||SIGNIFICANT OTHER|HEMATOLOGIST|N|1|7|TREATMENT|2020-06-13|37
e|TU|0bd95d1b-a993-4ae6-9ed0-3e3256ee1648|1|[?]|TUMERGE|Tumor Merged|[?]|DISEASE SITE|PROXIMAL URETHRA|UNILATERAL|FRONTAL|SEGMENT|PAP STAIN||Y|GUARDIAN|PATHOLOGIST 1|Y|1|1|SCREENING|2020-11-07|67
e|TU|81e934f8-7bcc-48d2-8d15-5270e51f2870|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|UNKNOWN|T6 VERTEBRA|UNILATERAL|DORSAL|ENTIRE|ERGOSPIROMETRY||Y|VENDOR|MICROSCOPIST 3|N|1|5|SCREENING|2021-03-09|54
e|TU|5713cabe-4d79-4f77-8ddc-daad1242a837|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|BENIGN|WRIST JOINT FLEXOR MUSCLES|LATERAL|ANTEROTEMPORAL|ALL|INTERRUPTER TECHNIQUE||Y|INTERVIEWER|HEMATOLOGIST|NA|1|3|TREATMENT|2020-10-11|42
e|TU|414d20c7-8dc8-49ad-8ae9-f113b9610109|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|NON-MEASURABLE|LUNG, RIGHT LOWER LOBE|LEFT|INTERMEDIATE|MULTIPLE|PYROSEQUENCING|||HEALTH CARE PROFESSIONAL|PATHOLOGIST 2|U|1|7|SCREENING|2020-07-25|25
e|TU|21e16094-23bd-4d20-b5f8-10d45858160e|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|NEW TARGET|ADRENAL GLAND|UNILATERAL|FRONTAL|SEGMENT|THICK SMEAR||Y|INTERVIEWER|ENDOCRINOLOGIST|Y|1|1|WASHOUT|2020-11-20|74
e|TU|2346613e-6734-476a-a414-511606c2d753|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|LOCATION OF INTEREST|TRICUSPID VALVE|BILATERAL|SUPERIOR|MULTIPLE|ELLA|||CLINICAL STUDY SPONSOR|ENDOCRINOLOGIST|U|1|6|TREATMENT|2020-09-19|7
e|TU|6a8bda83-1b5a-481e-af4f-77fe74bc37be|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|BENIGN|TRICUSPID VALVE ANNULUS|LATERAL|UPPER|MULTIPLE|ELECTROPHORESIS|||INTERVIEWER|ADJUDICATOR|N|1|1|TREATMENT|2020-12-26|40
e|TU|748ef401-3def-4674-8d5e-4a198709d672|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|NEW BONE LESION|PROXIMAL INTERPHALANGEAL JOINT 5 OF THE FOOT|LATERAL|DEEP|HEMI|DOPPLER ULTRASOUND|||GUARDIAN|ADJUDICATOR|N|1|5|TREATMENT|2020-06-04|6
e|TU|03c399c1-77b9-4879-a6e8-42ba58ca68d4|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|REGIONAL|EXTRAHEPATIC PERIHILAR BILE DUCT REGION|BILATERAL|UPPER FLEXOR SURFACE|ALL|RADIATION DOSIMETRY|||PROXY|MICROSCOPIST|Y|1|4|TREATMENT|2020-07-17|12
e|TU|b8afdaf1-5c4d-408f-b8ba-381461f15bde|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|NOT MEASURED|LEFT MAIN CORONARY ARTERY OSTIUM|CONTRALATERAL|POSTERIOR|HEMI|RYAN BLUE STAIN|||INDEPENDENT ASSESSOR|MICROSCOPIST 3|Y|1|6|TREATMENT|2021-01-12|70
e|TU|8115d6e8-0908-4491-a82a-08f43ccf1f0d|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|NON-TARGET NODAL|PARALARYNGEAL LYMPH NODE|IPSILATERAL|POSTERIOR|SINGLE|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|||STUDY SUBJECT|FORENSIC PATHOLOGIST|U|1|7|WASHOUT|2020-12-27|39
e|TU|fbd7ecb2-905f-40a9-babc-ebaf310cc372|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|NEW|PARALARYNGEAL LYMPH NODE|RIGHT|MIDLINE|HEMI|OPHTHALMOSCOPY|||SIGNIFICANT OTHER|NEUROLOGIST 2|N|1|6|SCREENING|2020-09-20|92
e|TU|1a0e1a66-82dd-4945-9c9f-179fba9d781e|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|BONE LESION|CORPUS STRIATUM|CONTRALATERAL|NASAL|PARTIAL|KNEMOMETRY|||SIBLING|OPTOMETRIST|NA|1|2|FOLLOW-UP|2021-01-18|50
e|TU|b3ab1879-3dc7-41fa-be53-f4484af21fbd|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|TARGET|FEMORAL CONDYLE|IPSILATERAL|FRONTAL|SINGLE|ECHOCARDIOGRAPHY|Y|Y|SIBLING|ADJUDICATOR 3|NA|1|6|FOLLOW-UP|2020-12-12|33
e|TU|bc71ddfa-c71c-447b-9684-005e4c112172|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|TARGET EXTRA NODAL|TRICUSPID VALVE ANNULUS|RIGHT|LOWER FLEXOR SURFACE|PARTIAL|JAFFE REACTION||Y|PARENT|DEVELOPMENTAL PSYCHOLOGIST|U|1|3|WASHOUT|2020-07-18|17
e|TU|ed3ae3f4-892a-4e68-9f3d-e81b2f2e09c0|1|[?]|LESIDENT|Lesion Identification|[?]|NON-TARGET NON-ENHANCING|INFRARENAL AORTA|IPSILATERAL|PERIPHERAL|SINGLE|REFRACTOMETRY|Y||CLINICAL RESEARCH ASSOCIATE|NEUROLOGIST 1|N|1|2|TREATMENT|2020-12-25|26
e|TU|88d03ea3-dc55-4fb5-9296-3b94037a1aa6|1|[?]|TUMERGE|Tumor Merged|[?]|TARGET|WAIST|UNILATERAL|LOWER MEDIAL|SINGLE|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|||CLINICAL STUDY SPONSOR|ADJUDICATOR 1|NA|1|2|TREATMENT|2020-11-29|94
e|TU|b1b3e113-8c73-4446-8095-3341f8912bd7|1|[?]|NTIND|Non-Target Indicator|[?]|BONE LESION|PENIS|CONTRALATERAL|DISTAL VOLAR|PARTIAL|HPLC/IEX|||CAREGIVER|PEDIATRIC NEUROLOGIST|U|1|3|FOLLOW-UP|2021-04-11|84
e|TU|caed12ff-3dfa-42cd-95e8-9a3dfd10184d|1|[?]|LESIDENT|Lesion Identification|[?]|TARGET NODULE|FIRST RIGHT POSTEROLATERAL ARTERY|LEFT|FRONTAL|SEGMENT|DNA MICROARRAY||Y|INDEPENDENT ASSESSOR|NEUROLOGIST|U|1|1|SCREENING|2021-02-18|98
e|TU|8ef3d6ea-49e3-4646-90ba-4b8b5b65e799|1|[?]|TUMERGE|Tumor Merged|[?]|NON-TARGET NON-ENHANCING|PERINEUM|RIGHT|ANTEROPOSTERIOR|PARTIAL|PUPILLOMETRY|Y||CLINICAL STUDY SPONSOR|ADJUDICATOR|NA|1|3|FOLLOW-UP|2020-09-24|59
e|TU|3b83c7a0-e22b-45b1-b065-71971f014039|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|BENIGN|METACARPAL BONE 4|RIGHT|PROXIMAL VOLAR|SINGLE|SPIROMETRY|||INDEPENDENT ASSESSOR|RATER 2|Y|1|4|SCREENING|2020-09-17|26
e|TU|92c849ce-12b8-4c38-baab-f91c44a007b9|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|LOCATION OF INTEREST|RADIAL ARTERY|RIGHT|SURFACE|SEGMENT|MICROSCOPY|||VENDOR|PHYSIOTHERAPIST|Y|1|1|WASHOUT|2021-01-04|63
e|TU|f2101018-c983-435e-a453-148f182388f7|1|[?]|TUSPLIT|Tumor Split|[?]|MEASURED|SEBACEOUS GLAND|BILATERAL|HIND|PARTIAL|LIQUID SCINTILLATION COUNTING|||CHILD|READER 1|N|1|4|TREATMENT|2020-09-21|30
e|TU|613284eb-edbe-446b-b4fe-f96f1510e626|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|NEW TARGET|COLON, SPLENIC FLEXURE|CONTRALATERAL|DEEP|ENTIRE|ICC|Y||VENDOR|RATER|NA|1|4|FOLLOW-UP|2020-12-26|59
e|TU|65e8391b-0c34-4687-a0ab-cb291a4cdf36|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|NON-TARGET NODAL|RIB 5|UNILATERAL|TEMPORAL|SINGLE|MULTIPLE BREATH WASHOUT|||ADJUDICATOR|ADJUDICATOR 3|Y|1|6|FOLLOW-UP|2020-07-20|15
e|TU|2350438a-0bc8-4da5-b6c9-99a6c012b454|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|DISEASE SITE|ISCHIAL TUBEROSITY|LEFT|INNER|SEGMENT|IN SITU HYBRIDIZATION|Y||HEALTH CARE PROFESSIONAL|ONCOLOGIST 2|N|1|5|SCREENING|2020-08-28|17
e|TU|ddfe1ae3-a8d4-4011-b2d0-753ef49d0bb8|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|LOCATION OF INTEREST|PELVIC LYMPH NODE|CONTRALATERAL|OUTER|MULTIPLE|FORCED OSCILLATION TECHNIQUE|||STUDY SUBJECT|PATHOLOGIST|U|1|3|SCREENING|2020-12-21|45
e|TU|416fe99b-1258-4e72-b1df-48b989f8f8ed|1|[?]|TUMERGE|Tumor Merged|[?]|MEASURED|HEART, VENTRICULAR WALL|IPSILATERAL|INNER|ALL|DC SHEATH FLOW|Y||PARENT|NEUROLOGIST 2|NA|1|2|WASHOUT|2020-08-28|10
e|TU|16a9e070-3e5d-444c-9ac1-6a1abfac0370|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|LOCATION OF INTEREST|FUNDUS OF THE STOMACH|LATERAL|PERIVENTRICULAR|SINGLE|TURBIDIMETRY||Y|HEALTH CARE PROFESSIONAL|CLINICAL PATHOLOGIST|Y|1|5|TREATMENT|2020-08-13|89
e|TU|1497a00d-55b1-4e02-a957-cf15e3d15512|1|[?]|LESIDENT|Lesion Identification|[?]|NON-TARGET ENHANCING|RESPIRATORY SYSTEM|RIGHT|FACIAL|PARTIAL|DUCTOGRAPHY|||GUARDIAN|FORENSIC PATHOLOGIST|NA|1|3|WASHOUT|2021-01-31|16
e|TU|9c188f41-b137-4d5a-bfbf-1783b1e0d3df|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|REGIONAL|LEFT VENTRICULAR APICAL LATERAL SEGMENT|BILATERAL|VENTRAL|ENTIRE|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|||ADJUDICATION COMMITTEE|FORENSIC PATHOLOGIST|U|1|5|WASHOUT|2020-10-17|98
e|TU|b5e44703-e5e2-43b8-af6b-b74af0ae3ede|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|LOCATION OF INTEREST|SKIN OF THE FINGER|BILATERAL|APICAL|HEMI|DC SHEATH FLOW|Y||FAMILY MEMBER|RATER 2|NA|1|2|TREATMENT|2021-01-24|56
e|TU|80f006d0-1a4f-4ee7-9492-3ab1f6d7caef|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|NON-TARGET|EXTRAHEPATIC BILE DUCT|UNILATERAL|ANTEROLATERAL|SINGLE|MAGNETIC RESONANCE ANGIOGRAPHY|||CLINICAL STUDY SPONSOR|PATHOLOGIST|NA|1|3|FOLLOW-UP|2020-11-24|29
e|TU|8aa15baf-9164-4dc8-b7c2-30e435b9e6bd|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|LOCATION OF INTEREST|COLON, ASCENDING|IPSILATERAL|UPPER FLEXOR SURFACE|ENTIRE|ACID FAST STAIN||Y|DOMESTIC PARTNER|READER 2|NA|1|4|WASHOUT|2020-07-13|57
e|TU|2216086b-197e-4780-8e10-28123eb090c5|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|TARGET NODAL|GINGIVAL MUCOSA|UNILATERAL|SURFACE|ALL|ENZYMATIC SPECTROPHOTOMETRY|Y||DOMESTIC PARTNER|ENDOCRINOLOGIST|NA|1|7|TREATMENT|2021-03-03|91
e|TU|7280f69c-a0f4-48b5-b714-1e272193168c|1|[?]|TUMIDENT|Tumor Identification|[?]|DISTANT|FRONTAL SINUS|RIGHT|POSTERIOR|PARTIAL|WHOLE GENOME SEQUENCING|Y|Y|STUDY SUBJECT|RADIOLOGIST 2|NA|1|1|SCREENING|2020-10-03|55
e|TU|4ce0546d-d8d9-42cb-bf2a-8e002536dd65|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|NOT MEASURED|NOSTRIL|LEFT|PROXIMAL VOLAR|SEGMENT|MEDIASTINOSCOPY|||STUDY SUBJECT|RATER 1|U|1|7|SCREENING|2020-08-23|32
e|TU|25c6812b-9200-4dc4-a954-6879183a2c54|1|[?]|TUMERGE|Tumor Merged|[?]|NEW BONE LESION|HEART, RIGHT VENTRICLE|UNILATERAL|APICAL|HEMI|TRYPAN BLUE STAIN||Y|VENDOR|NEUROLOGIST 1|U|1|5|TREATMENT|2021-03-11|87
e|TU|10dca475-f364-42f3-9192-faf762832adf|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|LOCATION OF INTEREST|HEPATIC LYMPH NODE|BILATERAL|INTERMEDIATE|ENTIRE|HEMOCYTOMETRY|Y||ADJUDICATOR|PATHOLOGIST|U|1|3|SCREENING|2020-09-26|11
e|TU|caf54095-56c3-428f-8342-ce45c6c9a287|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|NON-MEASURABLE|ELBOW JOINT|LEFT|ANTEROPOSTERIOR|ENTIRE|PANENDOSCOPY|||HEALTH CARE PROFESSIONAL|PATHOLOGIST 1|U|1|4|WASHOUT|2021-01-26|47
e|TU|f833ca56-d426-420b-a6d3-fedeabc02734|1|[?]|TUSPLIT|Tumor Split|[?]|BENIGN|LOWER JUGULAR LYMPH NODE|CONTRALATERAL|OCCIPITAL|PARTIAL|AGAR DILUTION|||CHILD|DERMATOLOGIST|NA|1|4|TREATMENT|2020-08-03|54
e|TU|03c8e2c7-b70d-4d46-8064-c99370eab232|1|[?]|TUMIDENT|Tumor Identification|[?]|NON-TARGET ENHANCING|MITRAL VALVE, POSTERIOR CUSP|BILATERAL|LOWER|HEMI|FREEZING POINT DEPRESSION|||CLINICAL RESEARCH COORDINATOR|READER|N|1|7|SCREENING|2021-01-04|46
e|TU|944617c7-c5e6-4e06-b114-499c3020dbbd|1|[?]|LESIDENT|Lesion Identification|[?]|NEW|ACROMION|LEFT|APICAL|MULTIPLE|ACID FAST STAIN||Y|CLINICAL STUDY SPONSOR|FORENSIC PATHOLOGIST|Y|1|2|SCREENING|2020-11-15|34
e|TU|e4878c66-1e2b-49bb-838e-85139d160dd4|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|TARGET NODULE|ULNAR ARTERY|BILATERAL|UPPER|PARTIAL|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|||CLINICAL STUDY SPONSOR|ONCOLOGIST 1|Y|1|3|WASHOUT|2020-11-25|45
e|TU|6873e227-baef-4d6e-8600-0bb61d60fe49|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|DISEASE SITE|PROXIMAL INTERPHALANGEAL JOINT 3|BILATERAL|UPPER FLEXOR SURFACE|ALL|SPECT/CT SCAN|||SIBLING|MICROSCOPIST 2|Y|1|4|SCREENING|2020-07-14|48
e|TU|bad01879-9b97-4d9c-9eec-58871168bd57|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|BONE LESION|FINGER FLEXOR TENDONS|CONTRALATERAL|UPPER EXTENSOR SURFACE|ALL|MULTIPLE BREATH WASHOUT|||CLINICAL RESEARCH COORDINATOR|MICROSCOPIST 3|N|1|6|TREATMENT|2021-01-01|88
e|TU|10d97d12-b3e9-4e58-87a2-d0c81ceeac17|1|[?]|TUMIDENT|Tumor Identification|[?]|DISEASE SITE|SUBSCAPULARIS MUSCLE|IPSILATERAL|ANTEROLATERAL|ENTIRE|MUGA|Y|Y|HEALTH CARE PROFESSIONAL|DEVELOPMENTAL PSYCHOLOGIST|U|1|2|WASHOUT|2021-01-21|87
e|TU|0df77775-6e65-4f77-9f8f-7faaa1471141|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|NOT MEASURED|C4 VERTEBRA|LATERAL|OUTER|SEGMENT|ISHIHARA COLOR PLATES|Y|Y|INVESTIGATOR|OTOLARYNGOLOGIST|NA|1|6|TREATMENT|2020-09-02|19
e|TU|adc5359a-f1d5-428b-97d8-fce67cfeeaea|1|[?]|VSLIDENT|Vessel Lesion Identification|[?]|BENIGN|DISTAL INTERPHALANGEAL JOINT 4 OF THE HAND|BILATERAL|FRONTAL|PARTIAL|NO INFORMATION||Y|NON-HEALTH CARE PROFESSIONAL|INTERNIST|N|1|2|FOLLOW-UP|2020-10-10|59
e|TU|cd68296c-95d4-489e-8b64-b2404f16316c|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|REGIONAL|DISTAL EXTRAHEPATIC BILE DUCT REGION|CONTRALATERAL|PARIETO-OCCIPITAL|SINGLE|LANDOLT RING||Y|INDEPENDENT ASSESSOR|RATER 2|Y|1|6|TREATMENT|2020-12-21|11
e|TU|fe137506-d1ce-4b08-a043-9366d86c421e|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|NEW BONE LESION|MIDDLE PHALANX 2 OF THE HAND|BILATERAL|PROXIMAL VOLAR|HEMI|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|||FAMILY MEMBER|HEMATOLOGIST|N|1|3|TREATMENT|2020-09-16|85
e|TU|b112c524-42c8-4e9e-8699-209e739972a7|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|NON-TARGET NODAL|EPIGASTRIC LYMPH NODE|LATERAL|VENTROLATERAL|MULTIPLE|ULTRASOUND|||CHILD|OPTOMETRIST|NA|1|5|TREATMENT|2021-01-20|27
e|TU|e6e32df8-8b66-49a5-a626-fd385297dd6f|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|TARGET NODAL|JUGULAR VEIN|BILATERAL|ROSTRAL|MULTIPLE|MALDI|Y|Y|PARENT|PATHOLOGIST 2|N|1|4|FOLLOW-UP|2020-11-29|98
e|TU|4dbfcc27-dc5a-4f04-a104-0eeb83561ab9|1|[?]|NTIND|Non-Target Indicator|[?]|MEASURED|COSTOCHONDRAL JOINT 7|CONTRALATERAL|PARIETO-OCCIPITAL|SEGMENT|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|||INVESTIGATOR|CARDIOLOGIST|N|1|1|SCREENING|2020-12-14|97
e|TU|5002de57-45df-4525-a6b7-b6cc33c22229|1|[?]|TUSPLIT|Tumor Split|[?]|NEW NON-TARGET|SUPRACLAVICULAR LYMPH NODE|LATERAL|INNER|MULTIPLE|HPLC|||INTERVIEWER|ADJUDICATOR 3|N|1|5|TREATMENT|2021-01-19|17
e|TU|298f2081-bb11-4856-9e88-4be3b9b2250d|1|[?]|TUMERGE|Tumor Merged|[?]|NEW TARGET|FOOT PHALANX|LEFT|VENTRAL|PARTIAL|PHOTOGRAPHY|||ADJUDICATION COMMITTEE|DEVELOPMENTAL PSYCHOLOGIST|Y|1|7|TREATMENT|2020-11-16|52
e|TU|7c864bb9-ff9d-4e5f-ae93-6e32ad859ac2|1|[?]|LESIDENT|Lesion Identification|[?]|BONE LESION|DISTAL PHALANX 5 OF THE HAND|UNILATERAL|TEMPORAL|SINGLE|CONTRAST ENHANCED PET SCAN|Y|Y|NON-HEALTH CARE PROFESSIONAL|ADJUDICATOR|Y|1|2|TREATMENT|2021-01-19|31
e|TU|a9e7f609-df5e-4a99-bf27-2a90cb7deebb|1|[?]|TUSPLIT|Tumor Split|[?]|DISTANT|SCLERA|LEFT|ROSTRAL|ENTIRE|ICP-MS|||CLINICAL RESEARCH ASSOCIATE|NEUROLOGIST|NA|1|7|SCREENING|2020-07-04|63
e|TU|18c21176-db5e-4650-a1af-beb2042c31d8|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|DISEASE SITE|T7 VERTEBRA|RIGHT|VOLAR|PARTIAL|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|Y||CLINICAL RESEARCH COORDINATOR|RADIOLOGIST 2|U|1|5|TREATMENT|2020-10-24|65
e|TU|7808abd1-7d6f-4090-aa08-916a804c95f5|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|NON-TARGET ENHANCING|INCISOR|IPSILATERAL|BASAL|SEGMENT|SPIROMETRY||Y|ADJUDICATOR|DERMATOLOGIST|NA|1|1|FOLLOW-UP|2020-09-12|94
e|TU|57553b78-e761-4577-aae2-5c693a2dc303|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|MEASURED|T5 VERTEBRA|UNILATERAL|POSTERIOR|SINGLE|OBSERVATION|Y||INTERVIEWER|ADJUDICATOR 3|NA|1|5|FOLLOW-UP|2021-03-28|96
e|TU|40883550-4627-4f92-974a-7eeb5bde74c5|1|[?]|TUMERGE|Tumor Merged|[?]|NON-TARGET EXTRA NODAL|METACARPOPHALANGEAL JOINT 1|CONTRALATERAL|DISTAL|PARTIAL|AURAMINE STAIN|||CLINICAL RESEARCH COORDINATOR|NEUROLOGIST 2|U|1|6|TREATMENT|2020-10-29|26
e|TU|4199b549-d021-4bfd-97e6-95630d407183|1|[?]|TUSPLIT|Tumor Split|[?]|LOCATION OF INTEREST|WRIST JOINT EXTENSOR MUSCLES|LEFT|DORSAL|ENTIRE|FLUORESCENT IMMUNOASSAY|||CLINICAL RESEARCH COORDINATOR|DERMATOLOGIST|Y|1|3|WASHOUT|2020-12-25|33
e|TU|6366647f-62fa-48dc-9d77-1677fce62fc7|1|[?]|TUMIDENT|Tumor Identification|[?]|DISTANT|ABDUCTOR HALLUCIS MUSCLE|LEFT|PROXIMAL|ALL|CALCOFLUOR WHITE STAIN|||FAMILY MEMBER|PATHOLOGIST|N|1|3|WASHOUT|2020-08-17|44
e|TU|29fe31ae-bf22-4cfb-bdd3-f35ddf68cbc8|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|NEW TARGET|PELVIS|IPSILATERAL|SUBCORTICAL|ALL|GEL ELECTROPHORESIS||Y|STUDY SUBJECT|ADJUDICATOR 1|NA|1|1|TREATMENT|2020-05-18|15
e|TU|637d7d5f-78d3-47fb-b6dc-d877d92b9001|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|DISTANT|POPLITEAL FOSSA|UNILATERAL|ANTEROTEMPORAL|ALL|GEL ELECTROPHORESIS|Y||CAREGIVER|DEVELOPMENTAL PSYCHOLOGIST|U|1|2|TREATMENT|2020-06-25|32
e|TU|696cd04a-cde7-4481-b5e2-fad1877ec284|1|[?]|TUSPLIT|Tumor Split|[?]|MEASURED|CARPOMETACARPAL JOINT 3|CONTRALATERAL|ANTEROMEDIAL|MULTIPLE|IMMUNOBLOT|||GUARDIAN|DERMATOLOGIST|Y|1|7|TREATMENT|2020-10-06|46
e|TU|ce4699cb-66f1-4c13-8428-84064255b765|1|[?]|TUMERGE|Tumor Merged|[?]|REGIONAL|METATARSAL BONE|RIGHT|LOWER|HEMI|NEPHELOMETRY|||INDEPENDENT ASSESSOR|READER 3|N|1|3|TREATMENT|2020-12-20|28
e|TU|015b391b-23c7-478d-b9d1-226d3cb9edcf|1|[?]|METIND|Metastatic Tumor Site Indicator|[?]|LOCAL|RIB 7|UNILATERAL|ANTEROMEDIAL|PARTIAL|ATOMIC ABSORPTION SPECTROMETRY||Y|INDEPENDENT ASSESSOR|READER 3|N|1|2|TREATMENT|2021-02-23|96
e|TU|b510a277-c5ee-4a32-b111-b2dbc72c8a27|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|NON-TARGET NON-ENHANCING|PARASYMPATHETIC GANGLIA|RIGHT|OUTER|PARTIAL|LC-FL|Y|Y|FAMILY MEMBER|CLINICAL PATHOLOGIST|U|1|6|SCREENING|2020-06-26|29
e|TU|9e9acf6b-d29a-4c11-96d6-b580c721f462|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|DISTANT|SUBMANDIBULAR GLAND|LATERAL|APICAL|ALL|CLAUSS METHOD|Y||INVESTIGATOR|MICROSCOPIST|U|1|1|WASHOUT|2020-10-18|69
e|TU|da69b157-7dab-49c5-b8fb-bd312a21fcf0|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|TARGET NODAL|BASAL GANGLIA|IPSILATERAL|INNER|PARTIAL|ELISPOT|||FRIEND|ADJUDICATOR 3|U|1|4|FOLLOW-UP|2020-08-30|53
e|TU|0e94ec23-3ef8-4a1f-b6e0-72ce49abba5d|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|NON-TARGET NODAL|ULNAR NERVE|BILATERAL|ANTERIOR|ALL|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|||ADJUDICATOR|ADJUDICATOR 3|U|1|6|WASHOUT|2020-06-02|14
e|TU|77c97d1e-e223-4485-b2de-59daa4e5b01f|1|[?]|TUMERGE|Tumor Merged|[?]|NON-TARGET|HEEL OF THE FOOT|IPSILATERAL|OUTER|HEMI|PYROSEQUENCING|Y||PROXY|PATHOLOGIST 1|N|1|4|FOLLOW-UP|2020-07-02|23
e|TU|9ea26788-8e26-4cbf-9a5a-58cb49686fc6|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|NON-TARGET NODAL|PRELARYNGEAL LYMPH NODE|LEFT|CRANIAL|MULTIPLE|WESTERGREN||Y|STUDY SUBJECT|PATHOLOGIST|N|1|6|TREATMENT|2020-12-17|74
e|TU|af049bb3-79a3-4a4c-8c2c-05d5b8c82967|1|[?]|NTIND|Non-Target Indicator|[?]|NEW|SKIN OF THE INFRASCAPULAR REGION|IPSILATERAL|DORSOLATERAL|PARTIAL|NUCLEIC ACID AMPLIFICATION TEST|||ADJUDICATION COMMITTEE|INTERNIST|N|1|3|TREATMENT|2020-12-01|40
e|TU|9eb6e591-d266-4e05-85b6-230e8a02d494|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|NON-TARGET NON-ENHANCING|DISTAL RADIOULNAR JOINT|RIGHT|NASAL|ALL|PET/MRI SCAN|||GUARDIAN|CARDIOLOGIST|U|1|6|TREATMENT|2020-08-31|74
e|TU|6a6e040d-6a09-4004-9fab-f4f82ba00eae|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|NEW BONE LESION|SKIN OF THE CHIN|LATERAL|SUPERIOR|PARTIAL|SINGLE-SLICE SPIRAL CT||Y|INVESTIGATOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|Y|1|1|TREATMENT|2020-06-30|10
e|TU|5d4845ae-b8b5-4a5d-91b9-bfd391e7829e|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|NON-TARGET NODAL|PERIPANCREATIC LYMPH NODE|BILATERAL|HIND|SINGLE|POLYSOMNOGRAPHY|||INDEPENDENT ASSESSOR|CLINICAL PATHOLOGIST|NA|1|7|TREATMENT|2020-10-11|65
e|TU|6c7d2865-ecfa-40fc-aae1-3d1083bc7e40|1|[?]|TUMERGE|Tumor Merged|[?]|NEW NON-TARGET|SPINOUS PROCESS|LATERAL|NASAL|MULTIPLE|AUTOMATED COUNT||Y|ADJUDICATOR|READER 2|U|1|6|TREATMENT|2021-01-23|14
e|TU|81eefadb-c9b5-49c5-8bc0-3d243fc67e23|1|[?]|DRCRLTLC|Disease Recurrence Relative Location|[?]|NEW NON-TARGET|ULNAR NERVE|IPSILATERAL|VENTROLATERAL|SINGLE|HPLC/IEX|||HEALTH CARE PROFESSIONAL|DEVELOPMENTAL PSYCHOLOGIST|Y|1|2|TREATMENT|2020-05-13|11
e|TU|ba99022a-d398-4c60-828c-876f119459e1|1|[?]|TUMERGE|Tumor Merged|[?]|NOT MEASURED|COLON, SPLENIC FLEXURE|LATERAL|ANTEROMEDIAL|PARTIAL|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT||Y|CLINICAL STUDY SPONSOR|MICROSCOPIST 2|NA|1|7|TREATMENT|2021-02-10|81
e|TU|d713869e-061c-4e95-8a50-da2e1ec47b3c|1|[?]|TUMIDENT|Tumor Identification|[?]|BENIGN|SKIN AROUND THE EYE|LATERAL|OUTER|ENTIRE|DIRECT SEQUENCING|||SIBLING|RADIOLOGIST|NA|1|2|FOLLOW-UP|2020-08-19|84
e|TU|fcebb64c-e0e6-4f29-9c52-15fa91f60018|1|[?]|TUMERGE|Tumor Merged|[?]|NON-TARGET ENHANCING|DISTAL INTERPHALANGEAL JOINT 5|CONTRALATERAL|ANTERIOR|MULTIPLE|ELECTRICAL IMPEDANCE MYOGRAPHY|||INDEPENDENT ASSESSOR|ADJUDICATOR 2|N|1|1|SCREENING|2020-07-07|6
e|TU|e443f82e-43a8-4710-bff4-fd2b2f4d512f|1|[?]|NTIND|Non-Target Indicator|[?]|LOCATION OF INTEREST|ELBOW FLEXOR MUSCLES|LATERAL|HIND|ENTIRE|NO INFORMATION|Y|Y|INVESTIGATOR|OPHTHALMOLOGIST|NA|1|7|SCREENING|2021-03-22|90
e|TU|d9f6cfa7-1321-4e08-bf1c-8a4cba4fc57d|1|[?]|TUMERGE|Tumor Merged|[?]|NON-TARGET ENHANCING|TALUS|BILATERAL|SUPERFICIAL|HEMI|KINETIC CHROMOGENIC ASSAY|||ADJUDICATOR|READER 3|Y|1|6|TREATMENT|2020-07-14|32
e|TU|8a2147b1-2deb-410e-a298-d028a5efc555|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|REGIONAL|COSTOCHONDRAL JOINT 1|LEFT|ANTEROTEMPORAL|MULTIPLE|CLIP|||SPOUSE|OPTOMETRIST|N|1|4|TREATMENT|2021-01-04|76
e|TU|033db3bf-17fb-4872-afdb-1eea3dac6d85|1|[?]|TUMIDENT|Tumor Identification|[?]|LOCAL|DISTAL INTERPHALANGEAL JOINT 4|BILATERAL|UPPER FLEXOR SURFACE|HEMI|HPLC-UV|Y||INDEPENDENT ASSESSOR|DERMATOLOGIST|Y|1|4|TREATMENT|2020-08-04|40
e|TU|e6bd8fdb-3af0-41c3-a23a-912ccd0cfce5|1|[?]|LESIDENT|Lesion Identification|[?]|LOCAL|HIP JOINT|BILATERAL|DISTAL VOLAR|HEMI|TRICHROME STAIN|||PROXY|OPTOMETRIST|N|1|3|TREATMENT|2020-07-24|45
e|TU|8dd493b7-a892-4cab-8f69-701471c51d99|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|NOT MEASURED|RESPIRATORY SYSTEM|LATERAL|ANTEROLATERAL|MULTIPLE|WHOLE TRANSCRIPTOME SEQUENCING|Y|Y|FRIEND|ONCOLOGIST 2|Y|1|3|FOLLOW-UP|2021-01-08|6
e|TU|a13bbcb3-2c6d-4de3-a3ee-f5651042a9fa|1|[?]|MEASIND|Measurable Tumor Indicator|[?]|TARGET|LUNG, LEFT, INFERIOR LOBE, POSTERIOR BASAL SEGMENT|RIGHT|VENTROLATERAL|MULTIPLE|MULTIPLE BREATH WASHOUT||Y|FRIEND|PEDIATRIC NEUROLOGIST|Y|1|7|TREATMENT|2020-12-27|60
e|TU|a77d90cb-2f8e-49c7-aa09-ed432432ecc9|1|[?]|NTIND|Non-Target Indicator|[?]|LOCAL|HEART, RIGHT VENTRICULAR FREE WALL|RIGHT|FRONTAL|HEMI|OBSERVATION|||SPOUSE|NEUROLOGIST 2|Y|1|5|TREATMENT|2020-10-11|47
e|TU|40319f6b-5d5f-41d2-b96e-6bc8443b85e3|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|NON-TARGET|RECTUS FEMORIS MUSCLE|IPSILATERAL|NASAL|SINGLE|RAJI CELL RIA|||HEALTH CARE PROFESSIONAL|UROLOGIST|NA|1|7|FOLLOW-UP|2020-12-05|25
e|TU|b49ef90c-a17e-4554-9fa6-af72b4d56a06|1|[?]|PTSIND|Primary Tumor Site Indicator|[?]|BONE LESION|SKIN OF THE BUTTOCK|RIGHT|FACIAL|MULTIPLE|CISH|||NON-HEALTH CARE PROFESSIONAL|OTOLARYNGOLOGIST|U|1|7|TREATMENT|2021-03-21|85
e|TU|df041193-ee4e-4835-8db9-5be9b832ded0|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|DISTANT|LEFT ANTERIOR DESCENDING ARTERY OSTIUM|RIGHT|ROSTRAL|ENTIRE|ANALYTICAL ULTRACENTRIFUGATION||Y|PROXY|DEVELOPMENTAL PSYCHOLOGIST|NA|1|6|FOLLOW-UP|2021-02-15|92
e|TU|e41a4505-a5aa-4cac-895b-04fe85737ca9|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|MEASURED|SKULL|LATERAL|DISTAL|SINGLE|DNA MICROARRAY||Y|INDEPENDENT ASSESSOR|READER 3|N|1|3|FOLLOW-UP|2021-02-05|33
e|TU|64424aa7-ac36-4c85-bf35-44f8dca3ec4d|1|[?]|TUMERGE|Tumor Merged|[?]|TARGET NODULE|GENITALIA|CONTRALATERAL|SUPERFICIAL|PARTIAL|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|||ADJUDICATION COMMITTEE|PATHOLOGIST|U|1|4|SCREENING|2021-03-17|71
e|TU|8d572dcc-917b-463d-b8f6-2e3e888c5fb6|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|UNKNOWN|RIB 2|CONTRALATERAL|ANTEROLATERAL|SINGLE|NUCLEIC ACID BASED METHOD||Y|SPOUSE|MICROSCOPIST 2|U|1|3|TREATMENT|2021-02-21|81
e|TU|5abbbb78-2eeb-4d21-85ac-f5d18294c603|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|NON-TARGET ENHANCING|TENTORIUM CEREBELLI|BILATERAL|SURFACE|SINGLE|SLIT LAMP PHOTOGRAPHY|||CLINICAL RESEARCH COORDINATOR|PEDIATRIC NEUROLOGIST|U|1|2|TREATMENT|2021-03-15|59
e|TU|109fe46d-ac1f-47fe-8ecb-6049a577d38c|1|[?]|NTIND|Non-Target Indicator|[?]|DISTANT|MAIN BRONCHUS, RIGHT|RIGHT|MEDIAL|SEGMENT|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|||INVESTIGATOR|ONCOLOGIST 1|N|1|4|TREATMENT|2020-06-25|46
e|TU|cdb18d0a-5fca-4437-9b6e-0e46b0930521|1|[?]|LMLIDENT|Limb Lesion Identification|[?]|NON-TARGET NON-ENHANCING|BRACHIOCEPHALIC ARTERY|IPSILATERAL|SUPERIOR|ENTIRE|WHOLE TRANSCRIPTOME SEQUENCING|||CAREGIVER|RATER 1|U|1|5|TREATMENT|2020-09-14|21
e|TU|e515b916-5d28-4236-8835-2ff43b498ab3|1|[?]|CVLIND|Cardiovascular Lesion Indicator|[?]|NON-TARGET ENHANCING|VOMER|IPSILATERAL|LOWER EXTENSOR SURFACE|MULTIPLE|OSCILLOMETRY|||ADJUDICATION COMMITTEE|HEMATOLOGIST|N|1|6|TREATMENT|2020-08-08|87
e|TU|158af2a8-d447-45e5-8c58-3b950f1bd889|1|[?]|GRLIDENT|Graft Lesion Identification|[?]|BONE LESION|FINGERNAIL|LATERAL|DEEP|PARTIAL|IMMUNOPRECIPITATION|Y||HEALTH CARE PROFESSIONAL|ONCOLOGIST|U|1|1|WASHOUT|2020-07-01|42
e|TU|e9a930d5-ca57-4069-8251-c164273df082|1|[?]|LESIDENT|Lesion Identification|[?]|DISTANT|NASOPHARYNX|CONTRALATERAL|INFERIOR|SEGMENT|WESTERGREN|||FAMILY MEMBER|MICROSCOPIST 2|N|1|2|WASHOUT|2020-07-14|64
e|TU|e654e37e-1c95-4f25-83b1-9233186626c6|1|[?]|LESIDENT|Lesion Identification|[?]|NEW|PANCREAS, BODY|RIGHT|PARIETO-OCCIPITAL|PARTIAL|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|||STUDY SUBJECT|CARDIOLOGIST|NA|1|1|TREATMENT|2020-09-10|47
e|TU|808ee0ac-e668-4e8e-aa0a-889476cbe631|1|[?]|FIBLIND|Fibrotic Lesion Indicator|[?]|NON-TARGET NON-ENHANCING|NAIL BED|IPSILATERAL|TEMPORAL|SINGLE|PHOTOGRAPHY|Y||INDEPENDENT ASSESSOR|ADJUDICATOR 1|NA|1|2|SCREENING|2020-06-13|4
